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Is the Increasing Frequency of Laparoscopic
Bile Duct Injury Justifiable?
Roger G. Keith, MD, FRCSC
Chairman, Department o f Surgery, University o f Saskatchewan, Saskatoon, Sask. Coeditor,

Canadian Journal of Surgery

n this issue (pages 509 to 516)
Roy and colleagues report on 21
cases of serious bile duct injuries
managed at two Canadian Universi
ty centres between June 1991 and
June 1993. During that time the
majority of general surgeons in the
two catchment areas changed from
open to laparoscopic cholecystecto
my as the procedure of choice for
biliary tract disease. Because the
population at risk is indeterminate
for this study, a true incidence of
bile duct injury during laparoscopic
cholecystectomy could not be as
sessed. None the less, this report
has merit in identifying a problem
of increasing frequency.
Girard and Morin1 studied over
10 000 open cholecystectomies ac
crued between 1971 and 1990 at
one of the university centres con
tributing to the present report.
Twenty-four (0.26%) bile duct inju
ries occurred in 9339 patients hav
ing cholecystectomy alone; howev
er, only 7 (0.07%) of the injuries
involved transection or resection si
milar to those reported by Roy and
colleagues. Extrapolation of the
higher injury frequency to average
accrual for Girard and Morin’s se
ries would yield 1.26 injuries in 492
open cholecystectomies per year.
The number of bile duct injuries
reported by Roy and colleagues is
10.5 per annum. To recognize an
incidence comparable to that for
open cholecystectomy, it would re

I

quire that 4100 laparoscopic chole
cystectomies be performed annually
in the catchment area served by the
authors. If the data of Deziel and
associates,2 who reported on
77 604 laparoscopic cholecystecto
mies performed in the United States
at hospitals with over 50-bed capac
ity, were taken into consideration,
Roy and colleagues would require
that all bile duct injuries from lapa
roscopic cholecystectomy in 60 hos
pitals be referred to the two report
ing centres.
Whether the incidence of biliary
injury has plateaued or is increasing
is debatable. Regardless, the com
bined rate of early and late biliary
injuries is higher than that which
became tolerable for open cholecys
tectomy during the past decade.
In 1991, Cuschieri and associ
ates3 reported a 0.33% rate of bile
duct injury from seven European
centres of excellence for laparo
scopic cholecystectomy. Other good
results2-4'6 report incidences .of up to
0.6%. Recently, Moosa and col
leagues,7 Adams and associates8
and Davidoff and associates9 have
reported an alarmingly high fre
quency of bile duct injuries after
laparoscopic cholecystectom y.
Wexler and colleagues,10 in a Cana
dian survey, noted that injuries oc
curred beyond the learning curve.
As Roy and colleagues indicate in
their paper, the nature of bile duct
injuries associated with laparoscop

ic cholecystectomy is more serious
than that with the open technique.
Frequently the bile duct is resected,
the proximal injury is high and the
duct diameter is small. The high
failure rate after attempted primary
duct-to-duct anastomosis must be
emphasized because the subsequent
repairs will be at the level of the
hilum or above. Recurrent stricture,
biliary cirrhosis and transplantation
can be avoided by technically expert
biliary enteric reconstruction when
the injury is first repaired. Referral
should not be considered an admis
sion of inability but rather evidence
of wise judgement.
The responsibility of surgical de
partments during the new era in
health care delivery will include
critical audit as part of the changes
engendered by quality management.
Lowered incidence of biliary injury
associated with laparoscopic chole
cystectomy will be expected as part
of continuous quality improvement.
In order to comply, it will be neces
sary to record accurately the fre
quency of injury per case volume
per surgeon, institution and region.
Prospective data collection may
yield true figures for purposes that
are not necessarily aligned with
clinical research. It is justifiable to
report, within the profession, the
concerns expressed by Roy and col
leagues so that the surgical com
munity will recognize the need for
self-modulation without legislation.
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MacLean-Mueller Prize
Jonathan L. Meakins, MD. FRCSC; Roger G. Keith, MD, FRCSC
Coeditors, Canadian Journal of Surgery

he Editorial Board of the Cana
dian Journal o f Surgery (CJS)
and the Director of Publications of
the Canadian Medical Association
take pride in announcing the cre
ation of the MacLean-Mueller
Prize. This award will be presented
annually for the best manuscript
written by a resident or fellow from
a specialty program affiliated with
one of the five sponsoring associa
tions and societies of the CJS.
The prize recognizes the contri
butions made by Drs. C. Barber
Mueller and Lloyd D. MacLean dur
ing their terms as coeditors of the
Journal. They have been responsi
ble for sustaining broad support

T
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and contributions to the Journal
from the Canadian surgical special
ty societies, which currently con
tribute in financial terms, through
scholarly editorial input and sub
mission of papers. It is fitting that
this award will be presented for the
work of residents who are contrib
uting to surgery through publica
tion, a medium to which these two
pillars of Canadian surgery made a
lifelong commitment.
The Canadian Medical Associa
tion, as publisher of the CJS, has
established an award of $1000, and
the prize winner will also receive a
certificate. At the time of submis
sion of the manuscript, the resident

or fellow must not have completed
training nor have assumed a faculty
position. Deadlines for each calen
dar year will be in keeping with
those of annual meetings or resi
dent research presentations of the
specific societies, but papers must
be in the Journal’s Saskatoon office
by Oct. 1, 1994, for the first com
petition. Papers should be submit
ted through the sponsoring society.
The winning paper will be published
in the first issue of the CJS of the
succeeding year.
The coeditors are pleased to in
form the readership of this award
on behalf of the Editorial Board and
the Canadian Medical Association.*
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Anterior Mediastinal Masses
After Cancer Therapy:
Recurrences or Benign
Lesions?

5 X 3 X 2 cm. The patient was
asymptomatic. Gallium scanning
showed an abnormal uptake in the
upper chest. Sternotomy with thy
mectomy revealed a massive thymic
hyperplasia with no evidence of ma
lignant disease.

To the editors. The development of
an anterior mediastinal mass in the
follow-up of a patient treated for
malignant disease is always wor
risome for the clinician. Although
recurrent malignant disease is al
ways a possibility, an increasing
number of reports have raised the
possibility of a benign lesion of the
thymus. Recently, we have seen two
cases of thymic lesions, in patients
treated for lymphomatous disease.

Case 2
A 17-year-old previously healthy
patient was admitted in September
1990 for investigation of a right
supraclavicular mass and an en
larged mediastinum. There were no
other palpable lymph nodes. After a
complete work-up, which included
lymphangiography, CT of the chest
and abdomen, gallium scanning, a
bone marrow biopsy and a biopsy of
the supraclavicular mass, a diagno
sis of stage I1A Hodgkin’s disease
of the sclerosing nodular type, with
“bulky mediastinal disease” was
made. The patient received six cy
cles of combination chemotherapy,
including, mechlorethamine, vin
cristine, procarbazine, prednisone,
Adriamycin, bleomycin, vinblastine
(MOPP/ABV) followed by mediasti
nal and cervical irradiation over a
25-day period for a total of 36 Gy.
Follow-up CT of the abdomen
and thorax in July 1991 showed a
large mass, 7 cm in dimension, in
the anterior mediastinum. Gallium
scanning gave negative results. The
mass was excised and found to be a
combination of thymic involution
scarring and multiple retention
cysts. As of September 1992 he was
free of disease.

Case Reports
Case 1
A 40-year-old woman was first
seen in November 1989 for investi
gation of an enlarged cervical node
and lower-limb edema. A complete
work-up, including computed to
mography (CT) of the chest and
abdomen, gallium scanning and
bone marrow and cervical node bi
opsies revealed a nonHodgkin’s
lymphoma of the mixed diffuse and
nodular type, classified as stage
IIIA (the National Panel Working
Formulation classification1). Over a
6-month period, this woman re
ceived seven cycles of combination
chemotherapy, including cyclophos
phamide, vincristine, prednisone,
bleomycin, Adriamycin and procar
bazine (COP-BLAM). Follow-up CT
of the chest and abdomen in May
1990 showed no abnormalities.
However, repeat follow-up CT 1
year later revealed a large mass in
the anterior mediastinum measuring
504
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Comment
When masses develop after thera
py for cancer, recurrence of the
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malignant disease has to be ruled
out first. If the mass is in the
anterior mediastinum, thymoma is a
possibility, although most of the
cases followed immunosuppression
with cyclosporine in experimental
animals and in transplant patients.2
Thymic hyperplasia was reported
after chemotherapy in children and
adolescents as a rebound phenome
non.3 Some authors4'5 have postu
lated that the development of thym
ic hyperplasia after treatment of
malignant disease is a good prog
nostic sign because it indicates res
toration of the host’s immunity.
Surgery in these cases was required
in the early experience from the
M.D. Anderson Hospital in Hous
ton, Tex., but in the later cases a
steroid test eliminated the need for
biopsy.6 In adults, most of the cases
have been reported after treatment
for lymphomas or germ cell tu
mours,7'8 and in most cases, surgery
was performed through a thoracot
omy or a sternotomy to excise the
abnormal mass. Gallium scanning in
these situations is not helpful be
cause abnormal uptake is seen both
in recurrence and thymic hyperpla
sia. Recognition of the possibility of
thymic hyperplasia and steroid test
ing will eliminate unnecessary sur
gery.46 In fact, as Ford and associ
ates6 showed, these patients should
be treated with predisone, orally, at
a dosage of 60 m g/m 2 daily for 7
days if the initial diagnosis is not
steroid-sensitive leukemia or lym
phoma. If the mediastinal changes
regress, the patient should be fol
lowed up by serial chest radiogra
phy. If the mass remains unchanged
or enlarges, then an open biopsy of
the mass should be performed.
continued on page 536
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Beware of the Trendelenburg Position
During Prolonged Laparoscopic Procedures
Josee Gagnon MD; Eric C. Poulin MD, FRCSC
any laparoscopic surgical pro
cedures are currently being
evaluated. Some, like laparoscopic
sigmoid resection, require place
ment of the patient in the Tren
delenburg position to maintain the
small bowel above the pelvic rim
and to improve exposure during
surgery. This increases the possibil
ity of brachial plexus injury during
prolonged surgery, as our recent
experience demonstrated.

M

Case Report
A 48-year-old woman underwent
an uncomplicated 3-hour laparo
scopic sigmoid resection for recur
rent diverticulitis. The next morn
ing it was obvious that she had
sustained a left brachial plexus inju
ry. She had a flaccid and numb left
arm and forearm and a partial Horn
er syndrome with complete involve
ment of the plexus. Her condition
resolved completely over a period of
5 months.

Comments
The patient’s positioning had
been standard for a general surgical
procedure. Her head had been cen

tred and her upper extremities
placed at 80° on armboards with a
locking mechanism to forestall
hyperextension.
The cause of most peripheral
nerve injuries in anesthetized pa
tients is ischemia of the vasa ner
vorum. This results from stretching
of a nerve and then compression of
that already vulnerable nerve. Inju
ries occur more readily during gen
eral anesthesia when muscle tone is
diminished and when the uncon
scious patient cannot respond to
postural insults. Nerve palsy can be
produced within 30 minutes if the
patient is in an unfavourable posi
tion.
The brachial plexus is the most
susceptible of all nerve groups to
damage from malpositioning during
anesthesia. It has a long, mobile,
superficial course in the axilla be
tween two firm points of fixation —
the vertebrae and the axillary fascia.
It also lies close to a number of
freely movable bony structures.
Damage is produced by any factor
that increases the distance between
the points of fixation. The plexus
may be depressed caudally by being
stretched over the head of the hu
merus with the extremity abducted
when the patient is in the Tren
delenburg position (Fig. 1). Five

situations are then especially haz
ardous:1
• When the patient’s head is in
dorsal extension and lateral flexion
to the opposite side. This widens
the angle between the head and the
shoulder and stretches the plexus.
• When the upper extremity is
abducted from the table at an angle
of more than 90°. The plexus is
then stretched by the head of the
humerus and coracoid process, es
pecially if the extremity is external
ly rotated and dorsally extended.
• When shoulder braces are

FIG. 1. Diagram of relationship be
tween brachial plexus and surrounding
bony structures. Arrows indicate direc
tions of pressure applied.
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used and placed too medially. In
this situation they depress the clavi
cle caudally and posteriorly, com
pressing and stretching the plexus.
• When shoulder braces are
placed too laterally, pushing the
humeral head downward, carrying
the plexus with it.
• When the patient is held by
wristlets. In this case the humeral
head is pulled downward, carrying
the plexus with it.
Other factors that enhance the

risk of nerve injury include the
following: abnormal anatomy (hy
pertrophy of the scalenus muscles,
cervical rib), pre-existing metabolic
conditions such as diabetes, athero
sclerosis, anemia, blood dyscrasias
and anticoagulant therapy, hypo
thermia, hypotension and the dura
tion of malposition.2
After decades of use of the Tren
delenburg position for diagnostic
laparoscopic procedures in gynecol
ogy, brachial plexus injury was not

NOTICE OF CHANGE OF ADDRESS
AVIS DE CHANGEMENT D’ADRESSE
To ensure that you continue to receive the Canadian Journal o f Surgery
without interruption, please fill in and mail this form before you move.
Avant de demenager, assurez-vous de recevoir sans interruption le Journal
canadien de chirurgie en completant et en expediant le formulaire suivant.
Please print / En lettres moulees, svp
Name / Norn.......................................
Old address / Ancienne adresse

New address / Nouvelle adresse

Date effective / Date de prise d’effet.
Subscribers please mail to: Information Technology, Canadian Medical Association,
PO Box 8650, Ottawa, ON K1G 0G8.
Abonnes, veuillez expedier a : Technologie de l’information, Association
medicale canadienne, CP 8650, Ottawa, ON K1G 0G8.
US address changes / Les Postes americaines enverront les changements
d’adresse a : CJS, PO Box 1518, Champlain, NY 12919-1518.

even mentioned as a complication in
a 1982 survey of 125 560 laparo
scopic sterilizations.3 The explana
tion may be that this procedure is
of shorter duration or that in the
gynecologic setting armboards are
seldom used. In general surgery,
since we cannot avoid using the
Trendelenburg position for some
laparoscopic procedures, special
precautions should be taken.
• The upper limbs should be
kept at the patient’s side, with the
palms down or facing the thighs
and a draw-sheet extending well
above the elbows to hold the posi
tion. Wristlets should not be used
to restrain the extremity.
• Shoulder braces should not be
used to prevent the patient from
sliding on the operating table. If the
mattress is held firmly to the oper
ating table, the patient seldom
slides on the mattress. If braces are
used, they must be placed over the
acromia, and they should never be
used with an abducted upper ex
tremity.
• The patient’s head should re
main in the midline.
• The extreme Trendelenburg
position should be avoided.
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cas, this history of medicine, or rather
the history of different kinds of
medicine, is found here in illustrated
form — a rigorous and elegant syn
thesis and chronology in 13 chapters.
Professor Jean-Charles Sournia
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B ile Duct Injury During Laparoscopic
Cholecystectomy
Andre F. Roy, MD, FRCSC;* Ronald B. Passi, MD, FACS, FRCSC;* Real W. Lapointe, MD, FRCSC;t
Vivian C. McAlister, MD, FRCSC, FRCSI;* Michel H. Dagenais, MD, FRCSC;t William J. Wall, MD, FRCSC*
Objective: To determine the nature of bile duct injuries during laparoscopic cholecystectomy, the
treatment of these injuries and patient outcome.
Design: Case series review.
Setting: Two tertiary care hospitals.
Patients: Twenty-one patients (average age 37 years) who sustained bile duct injuries during
laparoscopic cholecystectomy over a 2-year period. Two groups were analysed: patients whose injury
was recognized intraoperatively (9 patients) and patients in whom it was diagnosed postoperatively (12
patients).
Interventions: Laparoscopic cholecystectomy, duct-to-duct repair over a T tube, Roux-en-Y
hepaticojejunostomy, endoscopic cholangiopancreatography (ERCP), percutaneous transhepatic
cholangiography (PTC).
Results: Misidentification of the common duct during laparoscopic cholecystectomy, resulting in
accidental division or resection of a portion of the duct, and obstruction o f the duct by hemodips were
the most common types of injury. Pain, jaundice and bile collections were the typical presenting
features of injuries that became evident after laparoscopic cholecystectomy. ERCP and PTC accurately
defined the injuries. Immediate duct-to-duct repair over a T tube was associated with a high failure
rate. Twenty of the 21 patients required Roux-en-Y hepaticojejunostomy for definitive treatment. There
were no deaths.
Conclusions: Proper identification of the pertinent anatomy will prevent the majority of these injuries.
Prompt radiographic visualization of the biliary tract is indicated in patients who have pain, jaundice
and bile collections postoperatively. A hepaticojejunostomy is the procedure of choice for repair of
these bile duct injuries.
Objectif: Determiner la nature des lesions du choledoque qui surviennent durant une cholecystectomie
laparoscopique, comment ces lesions sont traitees et avec quels resultats.
Conception : L’examen d’une serie de cas.
Contexte : Deux hopitaux de soins tertiaires.
Patients : Vingt-et-un patients (age moyen, 37 ans) qui, au cours d’une periode de 2 ans, subirent des
lesions du choledoque durant une cholecystectomie laparoscopique. Deux groupes ont ete analyses : les
patients dont les lesions furent reconnues durant l’intervention (9 patients) et ceux chez qui elles
furent diagnostiquees en postoperatoire (12 patients).
Interventions : Cholecystectomie laparoscopique, reparation bout a bout sur tube en T ,
hepaticojejunostomie de Roux en Y, cholangiopancreatographie endoscopique (ERCP),
cholangiographie transhepatique percutanee (CTP).
Resultats : Les lesions les plus frequentes etaient reliees a une mauvaise identification du choledoque
durant la cholecystectomie laparoscopique, resultant en une division ou une resection accidentelle
d’une partie du canal, ou a l’obstruction du canal par une pince hemostatique. Douleur, ictere et
collections de bile representaient les signes cliniques caracteristiques des lesions qui se manifesterent
apres l’intervention. Une ERCP et une CTP permirent de definir les lesions avec precision. Une
reparation immediate bout a bout sur un tube en T donna le plus haut taux d’echec. Vingt des 21
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patients necessiterent une hepaticojejunostomie de Roux en Y comme traitement definitif. II n’y eut
aucun deces.
Conclusions : Une bonne identification anatomique permettrait de prevenir la majorite de ces lesions.
Une visualisation radiographique immediate est indiquee chez les patients qui presentent de la douleur,
de 1 ictere ou des collections biliaires en postoperatoire. Une hepaticojejunostomie est l’intervention de
premier choix pour reparer ces blessures du choledoque.

O

ver the past 3 years, laparo
scopic cholecystectomy (LC)
has replaced open cholecystectomy
(OC) as the preferred surgical man
agement for symptomatic gall
stones. The distinct advantages of
LC for patients in terms of short
hospital stay, minimal pain and
quick recovery have been amply and
convincingly demonstrated.1-4 An
overall complication rate of approxi
mately 5% has been reported, and
most complications are minor.1’56
The most serious complication of
LC, excluding death, is injury to
the bile duct. During the era of OC,
large surveys reported injury to the
common duct in 1 to 2 cases per
thousand cholecystectomies.7-9 It
has become evident that the inci
dence of common duct injuries is
several times higher with LC.1 Al
though some reports document that
injury of the duct tends to be more
common earlier in a surgeon’s expe
rience with the operation,110 a re
cent Canadian survey suggests that
the incidence may not decrease with
experience.11 Regardless of whether
injuries of the duct will become less
frequent, it is important to docu
ment how they occur and how they
are managed. Only through this
type of analysis will it be under
stood how bile duct injuries are best
avoided during LC and, just as
importantly, what is the ideal way
to manage the injuries when they
occur.
We report on 21 patients who
sustained injury to the bile duct
during a 2-year period and were
referred for management to Univer
sity Hospital, London, Ont., and to
the Hopital Saint-Luc, Montreal,
Que.
510

Patients
Twenty-one patients (18 women,
3 men) underwent LC between June
1991 and June 1993. The mean age
was 37 years (range from 22 to 53
years). All operations were elective.
Dissection was done with elec
trocautery in every instance. None
of the patients was excessively
obese.
The patients were divided into
two groups. In nine patients an
injury to the bile duct was recog
nized during LC (group 1). In the
remaining 12 patients the injury
was diagnosed postoperatively
(group 2). For a classification of the
level of the injury to the common
duct, we adopted the Bismuth clas
sification12 of strictures of the com
mon duct: type I — hepatic duct
stump more than 2 cm long, type II
— hepatic duct stump less than 2
cm long, type III — no hepatic duct
but confluence intact, type IV —
right and left duct separated and
type V — involvement of sectorial
right duct with or without injured
common duct.

Findings
Group 1 (Table I)
In none of these cases was the
LC described as difficult, and there
was no indication that anomalies
were present to confuse the anato
my. In seven patients injury of the
bile duct resulted because the com
mon duct was erroneously identified
as the cystic duct. Only after the
bile duct had been clipped and di
vided or a portion of it had been
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excised was the injury recognized.
A frequent observation was persis
tent bile staining of the operative
field or visualization of a “second
duct” after division of what had
been interpreted as the cystic duct.
In two patients perforation of the
bile duct occurred as a result of the
application of electrocautery with
the dissecting hook. The perfora
tions were recognized when contin
ued bile leakage was noted in the
operative field.
In three patients who had acci
dental resection of a portion of the
common duct, a drain was placed
when the injury was recognized,
and they were transferred the same
day for management of the injury.
Each patient had a laparotomy and
underwent a Roux-en-Y hepaticojejunostomy within 24 hours. Opera
tive identification of the proximal
bile duct was not difficult with
these fresh injuries. The patients
recovered without complication and
were well at follow-up 2, 8 and 23
months later.
Four patients had conversion of
the LC to a laparotomy and a
duct-to-duct anastomosis over a
T tube. The operative notes indicat
ed that the ducts were uniformly
small in calibre, and the anastomo
sis was often described as being
under slight tension. In two of the
four patients, leakage of contrast
material at the site of the anastomo
sis was seen on the initial postoper
ative T-tube cholangiogram. In each
of these four patients the duct-toduct repair tailed, and strictures
developed between 6 weeks and 6
months after the initial repair. The
patients became jaundiced, and per
cutaneous transhepatic cholangiog-

INJURIES IN LAPAROSCOPIC CHOLECYSTECTOMY

raphy (PTC) demonstrated type III
strictures in two patients and ty
pe IV strictures in two patients. In
each patient the duct-to-duct repair
was revised with a hepaticojejunostomy, and they were well at follow
up 3, 4, 16 and 22 months after
reconstruction.
The two patients with electrocau
tery injuries had the LC converted
to a laparotomy, and a T tube was
inserted in the common duct. One
patient (Table I, no. 5) was well 11
months later, and the other patient
(Table I, no. 7) had a type I stric
ture 6 weeks after LC and required
a hepaticojejunostomy. He was well
4 months after repair.
Eight of the nine patients in this
group either initially or ultimately
had a hepaticojejunostomy to repair
the bile duct injury.
Group 2 (Table II)

Ten of the 12 patients in whom
the bile duct injury was diagnosed
after LC presented within the 1st
postoperative week. Jaundice was
present in seven of them, upper
abdominal pain in five, bile collec
tions in five and fever in three. Of

ed in all patients; it was successful
in nine patients. It showed complete
biliary obstruction with visualiza
tion of the distal bile duct only in
seven patients and partial obstruc
tion of the common duct with some
filling of the proximal duct in two
patients. In 11 patients PTC dem
onstrated the proximal biliary tree
and the level of obstruction. Extra
vasation of contrast medium into
the subhepatic space was noted in
three patients.
Eight of the 12 patients had a
Roux-en-Y hepaticojejunostomy as
primary repair of the injuries, and
the procedure was successful in 7
of them. One patient (Table II,
no. 17) subsequently required resec
tion of the right hepatic lobe for a
recurrent intrahepatic stricture of
the right hepatic duct. The biliary
reconstructions were performed
from 4 days to 5.5 months after LC.
When the reconstruction was per
formed within 1 or 2 weeks of LC,
the operative findings were usually
clear enough to determine what
mishap had occurred during LC. It
was evident that there had been
extensive dissection both on and to
the left of the common duct, and in

the two patients who presented
after the 1st postoperative week,
one presented with jaundice 2
weeks after LC and the other with
pruritus and jaundice 3 months
after LC.
In 7 of the 12 patients, the
operative notes revealed nothing of
concern noted by the surgeon dur
ing LC to suggest that an injury to
the bile duct had occurred. The
operations were considered to have
been straightforward. In four pa
tients, however, troublesome bleed
ing had been encountered during
LC; the bleeding was controlled by
the application of between one and
two dozen hemoclips. In two of the
four, the surgeon noted that severe
inflammation of the gallbladder had
made the LC difficult. In the re
maining patient (Table II, no. 19),
bile was noted in the right upper
quadrant at the end of LC, and for
that reason a drain was left in place.
The patients were referred as
early as 3 days after LC, when it
was evident there was a problem,
and as late as 3 weeks after the
onset of signs or symptoms. Endo
scopic retrograde cholangiopan
creatography (ERCP) was attempt

T a b le 1. B ile D uct In ju rie s R e co g n iz e d in G rou p 1 P a tie n ts (D uring L a p a ro s c o p ic C h o le c y s te c to m y [L C ])
T r e a tm e n t
P atien t
no.

Age,
V

S ex

1

30

F

2

32

F

3

36

F

4

25

F

5

35

F

6

22

F

7

52

M

8

26

F

9

46

F

In ju ry (le v e l)
Segm ent o f co m m on
d u c t e x c is e d (II)
Segm ent of co m m on
d u c t e x c is e d (III)
D iv is io n o f c o m m o n
d u c t (III)
Segm ent o f co m m on
d u c t e x c is e d (IV )
P e rfo ra tio n o f rig h t
h e p a tic d u c t (V )
E xcisio n o f c o m m o n
d u c t c o n flu e n c e (IV )
Burn and p e rfo ra tio n
o f c o m m o n d u c t (I)
Segm ent o f co m m on
d u c t e x c is e d (I)
D iv is io n o f p ro x im a l
c o m m o n d u c t (IV )

F irs t re p a ir

C ause of injury
M is in te rp re ta tio n
a n a to m y
M is in te rp re ta tio n
a n a to m y
M is in te rp re ta tio n
a n a to m y
M is in te rp re ta tio n
a n a to m y
E le c tro c a u te ry
a p p lic a tio n
M is in te rp re ta tio n
a n a to m y
E le c tro c a u te ry
a p p lic a tio n
M is in te rp re ta tio n
a n a to m y
M is in te rp re ta tio n
a n a to m y

of
of
of
of

of

of
of

Sam e day
h e p a tic o je ju n o s to m y
D - D a n a s to m o s is o v e r
T tu b e
D - D a n a s to m o s is o v e r
T tu b e
D - D a n a s to m o s is o v e r
T tu b e
T -tu b e in s e rtio n
Sam e day
h e p a tic o je ju n o s to m y
T -tu b e in s e rtio n
S am e day
h e p a tic o je ju n o s to m y
D - D a n a s to m o s is o v e r
T tu b e

S eco n d re p a ir
(m o a fte r LC)

O u tc o m e (m o )

N o t re q u ire d

W e ll (2 3 )

F le p a tic o je ju n o s to m y

W e ll (4 )

(4 )
H e p a tic o je ju n o s to m y
(1 .5 )
H e p a tic o je ju n o s to m y

W e ll (1 6 )

(6 )
N o t re q u ire d

W e ll (1 1 )

N o t re q u ire d

W e ll (8 )

H e p a tic o je ju n o s to m y
(1 .5 )
N o t re q u ire d

W e ll (4 )

H e p a tic o je ju n o s to m y

W e ll (3 )

W e ll (2 2 )

W e ll (2 )

(6 )

D - D = d u c t-to -d u c t-re p a ir
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two patients the lateral aspect of
the portal vein had been exposed.
Segments of the common duct were
missing or, especially when bleed
ing had been encountered during
LC, many hemoclips had been ap
plied to the common duct and peri
ductal tissues. When reconstruction
was not performed until several
weeks after LC, considerable in
flammation and scarring were al
ways present, with hemoclips em
bedded in the scar and in strictured
segments of the common duct.
Patient no. 13 (Table II) had a
laparotomy 5 days after LC when
an ERCP showed complete obstruc
tion of the common duct by two
hemoclips. The two clips intended
for the cystic duct were found en
croaching on the common duct near
the junction of the two ducts. The
clips were removed, and the patient
T a b le II.
P ro b lem
e n c o u n te re d
during LC

was referred for hepaticojejunostomy 7 months later when a stricture
developed at the site. Presumably,
the clips had produced enough of a
crush injury that healing of the
duct by fibrosis was the result. Two
patients (Table II, nos. 14 and 19)
had bilomas drained externally
without further investigation. The
bile drainage ceased, but both pa
tients had common duct strictures
3.5 and 5.5 months later requiring
hepaticojejunostomy. One patient
(Table II, no. 15) underwent explo
ration of the common duct, and a
T tube was inserted for a type II
stricture that was evident 3 months
after LC. The stricture recurred,
and revision to a hepaticojejunosto
my was necessary at 13 months.
All 12 patients in this group
required a hepaticojejunostomy ei
ther as the primary method of re

Illustrative Cases
Patient 1. Group 1

During LC on this 30-year-old
woman the surgeon clipped and
divided what was believed to be the
cystic duct. As the dissection pro
gressed additional tissue in the area
of Calot's triangle was clipped and
divided, and the gallbladder was
removed. Gross inspection of the
gallbladder showed that a segment
of common duct was attached to
the cystic duct. The surgeon real
ized that a portion of the common
bile duct had been resected, and the
operation was terminated. After
awaking from the anesthetic, the

Bile Duct Injuries Recognized in Group 2 Patients (After LC)
T yp e of
o b stru ctio n /
s tric tu re *

P a tie n t
no.

Age,
yr

Sex

10

23

F

11

37

F

12

36

M

13

40

F

Many clips for
bleeding
Many clips for
bleeding
Many clips for
bleeding —
difficult
procedure
Nothing noted

14

40

F

Nothing noted

15

41

F

Nothing noted

16

45

F

17

53

F

Many clips for
bleeding —
difficult
procedure
Nothing noted

18

30

F

Nothing noted

Fever, pain,
peritonitis,
biloma (3)
Biloma (7)

19

36

F

27

M

Biloma, fever,
jaundice (7)
Pain, jaundice (3)

IV

20

Bile noted, drain
placed
Nothing noted

21

22

F

Nothing noted

Jaundice, biloma
(3)

III

P ostoperative
co m p licatio n s (d)

Jaundice (5)

III

Pain, jaundice (4)

II

Jaundice (3)

I

Pain, jaundice (3)

I

Pain, fever, biloma
(3)
Pruritus, jaundice
(90)
Jaundice (14)

III

'Bism uth classification'2
ECBD = exploration of common bile duct
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pair or for revision of a failed initial
treatment.
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II
IV

T re a ,m e n t
F irst re p a ir
(d a fte r LC)

Hepaticojejunostomy
(42)
Hepaticojejunostomy
(35)
Hepaticojejunostomy
(4)

Well (19)

Not required

Well (15)

Not required

Well (13)

Hepaticojejunostomy
(7)
Hepaticojejunostomy
(5.5)
ECBD, T-tube insertion Hepaticojejunostomy
(3)
(13)
Hepaticojejunostomy
Not required
(14)
Hepaticojejunostomy
(14)

V

Hepaticojejunostomy
to left duct, right
lobectomy (84)
External drainage
Hepaticojejunostomy
(17)
Hepaticojejunostomy
(11)

O u tco m e (m o )

Not required

Laparotomy, removal
of clips (5)
External drainage (12)

V

II

Second rep air
(m o a lte r LC)

Well (15)
Well (13)
Well (2)
Transient bile
leak, well (9)

Right lobectomy and
Well (6)
hepaticojejunostomy
to left duct (14.5)
Not required
Well (2)
Hepaticojejunostomy
(3.5)
Not required

Well (2)

Not required

Well (2)

Well (1)

IN JU R IE S IN LA PA R O SC O PIC C H O L E C Y ST E C T O M Y

patient was immediately transferred
for repair of the injury. At laparoto
my about 4 hours later, the proxi
mal bile duct was identified, disclos
ing a type II injury. A Roux-en-Y
hepaticojejunostomy was per
formed. The postoperative course
was uncomplicated, and the results
of liver function tests 23 months
postoperatively were normal.

Patient 2, Group 1
A 32-year-old woman underwent
LC for symptomatic gallstones.
During the surgery, what was be
lieved to be the cystic duct was
clipped and divided. After the cystic
artery was divided, a third structure

became jaundiced, and ERCP and
PTC disclosed a type IV stricture. A
hepaticojejunostomy was performed
and she was well 4 months after
repair.

was identified as the cystic duct.
The surgeon realized that the com
mon bile duct had been divided, and
a laparotomy was performed. A ty
pe III injury was found with a gap
of about 1 cm in the common duct.
Duct-to-duct reconstruction over a
T tube was performed, and the
anastomosis was described as being
under slight tension. An intraopera
tive T-tube cholangiogram showed
good passage of dye into the duode
num and a leak of contrast material
at the anastomosis (Fig. 1). The
patient was referred postoperatively
for continued management. The bile
leak closed after 2 weeks, and the T
tube was removed 3 months later.
Four months after LC the patient

Patient 10, Group 2
During LC on a 23-year old wom
an, bleeding was encountered and
controlled by the application of ap
proximately 15 hemoclips. Progres
sive, painless jaundice and itch de
veloped postoperatively. Five days
after LC, the serum alkaline phos
phatase level was elevated at
488 U/L (normal 18 to 113 U/L)
and the serum bilirubin level was
also elevated at 186 /umol/L (nor
mal 3.4 to 17.1 pm o\/L). Ul
trasonography revealed dilated intrahepatic bile ducts. The patient
was referred 3 weeks postoperative
ly at which time an ERCP disclosed
complete bile duct obstruction by
numerous hemoclips (Fig. 2). PTC
demonstrated a type III injury
(Fig. 3). She underwent a Rouxen-Y hepaticojejunostomy 6 weeks
after the LC. The patient remained
asymptomatic, with normal results
of liver function tests 19 months
after surgery.

Patient 14, Group 2

FIG. 1. Patient no. 2, group 1. Operative T-tube cholangiogram shows leak of dye
from anastomosis (white arrow). Because proximal limb is in left hepatic duct (black
arrow), there is no opacification of right hepatic duct.

A 40-year old woman with symp
tomatic gallstones had LC. An in
traoperative cholangiogram ap
peared normal. Three days later,
right upper quadrant pain and fever
developed. Ultrasonography showed
a fluid collection, and a biloma was
drained percutaneously 12 days
after the LC. This resulted in clini
cal improvement. ERCP and PTC
were attempted without success. A
laparotomy was performed 2 weeks
after the drainage procedure when
the patient’s clinical condition wors
ened. Bile peritonitis with dense
adhesions was found. The leak was
coming from a divided common
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duct. Because of the local inflam
mation and the instability of the
patient, a catheter was inserted into
the proximal bile duct to create a
controlled external biliary fistula.
Cholangiography through the cath
eter demonstrated a type III injury.
A Roux-en-Y hepaticojejunostomy
with separate anastomoses to the
right and left hepatic ducts was
performed 5.5 months after the LC.
The postoperative course was com
plicated by thrombosis of the right
subclavian vein and spontaneous
hemopericardium after anticoagula

tion. She recovered after 7 weeks in
hospital and was well, with normal
liver function, at follow-up 7
months after biliary reconstruction.

Discussion
The danger of injury to the com
mon duct during cholecystectomy
can never be eliminated, whether
the gallbladder is removed by the
laparoscopic or the open technique.
The training of surgeons in the
Halstedian tradition plus a century

FIG. 2. Patient no. 10, group 2. Endoscopic retrograde cholangiography shows
complete occlusion of common bile duct by multiple hemoclips (large white arrow).
Air bubbles are seen in lower bile duct (small white arrow).
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of experience in biliary tract sur
gery established OC as a technically
safe operation. As OC is replaced by
LC, injury of the common duct has
emerged as a serious problem. Al
though some series record a very
low incidence of common duct inju
ry during LC, others report an
incidence ranging from 0.6% to 1%,
several times higher than that ex
pected with OC.13-16 The tendency
for accidents to be frequent early in
a surgeon’s experience with LC is
best exemplified by the study of
Davidoff and associates.10 In that
report, 10 of 12 bile duct injuries
during LC occurred within the re
ferring surgeon’s first dozen laparo
scopic procedures. A similar finding
was reported by the Southern Sur
geons Club.1
The injuries in our series demon
strated several characteristic fea
tures. When the injury was recog
nized during LC, the error that was
most commonly responsible was
misinterpretation of the common
duct for the cystic duct. This mis
take was the most frequent cause of
injury in other reports too.1017 Hun
ter18 has emphasized the impor
tance of proper orientation of Calot’s triangle in setting up the oper
ative field to avoid this error. Later
al and inferior rather than upward
retraction on Hartmann’s pouch
opens up Calot’s triangle and in
creases the angle between the cystic
and common ducts. This manoeuvre
avoids cephalad tenting of the com
mon bile duct, making it less likely
to be mistaken for the cystic duct.
The use of the 30° angle scope also
permits a more en face view of
Calot’s triangle and provides better
distinction between the relative po
sitions of the cystic duct and the
common duct. Only after the cystic
duct and artery have been both
dissected should either structure be
clipped and divided. Precise adher
ence to the surgical principle of
correct identification of the anato-

INJURIES IN LAPAROSCOPIC CHOLECYSTECTOMY

my would have avoided injury in
most of these cases. Persistent bile
staining of the operative field and
visualization of a “second duct”
after division of what was identified
initially as the cystic duct were
common operative findings during
LC that pointed to an injury of the
bile duct.
The second commonest cause of
injury during LC was dissection on
and around the common duct that
included the application of hemoclips to the common duct and the
tissues surrounding it. The position
of the common duct relative to the
other structures should be con
stantly used as a reference point,
but it is neither necessary nor desir
able to actually dissect out the
common duct. It was evident in this
series of patients that extensive
dissections had frequently occurred

along the right side of the hepato
duodenal ligament, a manoeuvre
that immediately puts the common
duct at risk. Dissection in this area
also increases the risk of bleeding
by trauma to the hepatic artery or
its right branch. This invites the
next commonest mechanism of in
jury, namely the application of
many hemoclips near the common
duct to stop bleeding. The danger
of applying many hemoclips has
been reported recently, with a rec
ommendation that only six hemo
clips be used during LC and that
more clips be applied only with
caution and justification.19 If
enough hemorrhage occurs that the
position of the common duct is
obscured, the repeated application
of hemoclips to stop the bleeding is
hazardous. The bleeding may result
from direct injury to a specific

FIG. 3. Patient no. 10, group 2. Percutaneous transhepatic cholangiography
shows Bismuth type III stricture with intact confluence but absence of
hepatic duct (arrow).

vessel or it may be due to a severely
inflamed or scarred gallbladder. Re
gardless of the cause, such a situa
tion calls for a critical assessment
of the need to convert the LC to an
OC to avoid a bile duct injury.
Electrocautery injury of the bile
duct was the least common mecha
nism of injury in this series. Vigor
ous use of electrocautery anywhere
close to the common duct must be
avoided. Thermal injury may create
a hole that is immediately apparent,
or the area of burn may heal by
fibrosis and ultimately result in a
stricture weeks or months later.10
When the common duct is inad
vertently divided or a portion of it is
resected, and the injury is recog
nized during LC, a duct-to-duct
anastomosis over a T tube may
seem the easiest, most expeditious
solution. This type of repair is re
ported to have a high failure rate,20
however, and this was demonstrat
ed in our patients. Circumferential
loss of length of the common bile
duct or common hepatic duct, or
both, is common, limiting the feasi
bility of a good duct-to-duct anasto
mosis without tension. In addition,
the dissection during LC and burn
from the electrocautery may have
impaired the blood supply to the
ends of the bile duct. The duct is
usually nondiseased and small, per
mitting only a narrow calibre anas
tomosis that is predisposed to ste
nosis. Our preference for primary
repair of a divided bile duct recog
nized during LC would be an imme
diate Roux-en-Y hepaticojejunostomy. The loop always has a good
blood supply, the anastomosis is
without tension and the long-term
results with this type of reconstruc
tion are good.21 Although years of
follow-up are necessary before de
claring success with any type of
biliary reconstruction, none of the
patients in this series who under
went a hepaticojej unostomy either
for immediate primary repair or for
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secondary reconstruction has so far
needed a revision. If the surgeon
performing the LC is not prepared
to perform a reconstruction with a
Roux-en-Y loop, immediate referral
should be made to a centre where a
hepaticojejunostomy can be per
formed within 24 hours of injury. A
catheter may be left for interim
drainage of bile to the exterior
during the transfer. Insertion of a T
tube may be appropriate treatment
if there has been just a partial
laceration of the bile duct.
Right upper quadrant pain, jaun
dice and a bile collection within
days of an LC are a suggestive
triad. Patients presenting with this
symptom complex demand immedi
ate investigation to exclude a bile
duct injury. It is not adequate to
drain a postoperative bile collection
and await events. As shown in this
series, patients with an injured bile
duct will have serious signs and
symptoms within several days after
LC. A prompt diagnosis would
allow reconstructive surgery soon
after the injury, before sepsis and
infected bile collections create ad
verse systemic and local conditions.
Abdominal ultrasonography will
often show dilatation of the intrahepatic biliary tree, but the most
important test is a contrast study of
the ducts. Our preference is an
ERCP, because it will be diagnostic
for a bile duct injury and it may be
therapeutic if jaundice is due to a
retained stone or if a nasobiliary
catheter is required to control leak
age of bile from a cystic duct
stump. When the ERCP shows ob
struction to the common duct the
precise anatomy of the proximal
duct is essential in planning recon
structive surgery. An ERCP may
detail the proximal anatomy when
the obstruction is incomplete, but a
PTC is usually necessary to deter
mine the exact level of injury and in
particular whether the confluence
of the right and left hepatic ducts is
516
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intact. This information is needed
to ensure that all obstructed ducts
will be adequately drained at the
time of reconstruction. Placement
of a percutaneous transhepatic
catheter in the proximal bile duct
immediately before reconstruction
may make identification of the duct
easier at the time of surgery.22 The
best chance at repair of an injured
duct is the first attempt, and factors
that are important in the ultimate
outcome after biliary reconstruction
include the level of the stricture and
prior attempts at reconstruction.23
More than half the patients in
this series were in their third or
fourth decade of life, and in more
than half of them the injury or
stricture was high (type III or
above). Collectively, they will have
many decades to test the effective
ness and durability of their biliary
repairs. This underscores the key
message, namely, that prevention
has to be regarded as the real
solution to bile duct injuries during
LC.
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U s e of the External Fixation Apparatus
for Percutaneous Insertion of Pins
in the Distal One-Third of the Radius:
an Anatomic Study
Ronald Vandersluis, MD;* Robert S. Richards, MD, FRCSC;t James H. Roth, MD, FRCSC, FACS*t
Objective: To assess the risk of soft-tissue injury during percutaneous placement of external fixation
pins in the proximal radius.
Design: An anatomic study with embalmed cadaver limbs.
Setting: Hand and upper limb centre at a university-affiliated hospital.
Interventions: Two 4-mm Hoffman half pins were percutaneously placed along the dorsoradial ridge of
the radius, four finger breadths proximal to the radial styloid process.
Main Outcome Measures: Injuries to soft tissues including tendons, nerves and vessels were noted.
Results: Nerve or tendon injuries occurred in 7 of 26 forearms. Three pins transfixed either the
superficial branch of the radial nerve or lateral antebrachial cutaneous nerves. Tendon injuries
included the brachioradialis in two forearms, the extensor carpi radialis brevis in three forearms, and
the extensor carpi radialis longus an "he abductor pollicis longus in one forearm each.
Conclusions: Percutaneous pin placement in the distal radius is unsafe. The authors recommend open
pin placement for fractures of the distal radius.

Objectif: Evaluer le risque de blessure des tissus mous durant l’insertion percutanee d’une tige de
fixation externe du radius proximal.
Conception : Une etude anatomique utilisant des membres embaumes de cadavres.
Contexte : Le centre du traitement des mains et les membres superieures, dans un hopital universitaire.
Interventions : Deux demi-tiges Hoffman de 4 mm ont ete inserees par voie percutanee le long de la
Crete dorsoradiale du radius, a quatre largeurs de doigt de l’apophyse styloi'de du radius.
Principaux effets mesures : Les lesions des tissus mous incluant tendons, nerfs et vaisseaux furent
notees.
Resultats : Des lesions des nerfs ou des tendons sont survenues dans 7 avant-bras sur 26. Trois tiges
ont traverse soit la branche superficielle du nerf radial, soit les nerf brachiaux cutanes internes
lateraux. Les blessures tendineuses comprennent des lesions du brachioradialis dans deux avant-bras,
de l’extensor carpi radialis brevis dans trois avant-bras, et de l’extensor carpi radialis longus et de
l’abductor pollicis longus dans un avant-bras chacun.
Conclusions : L’insertion percutanee de tige dans la partie distale du radius n’est pas sure. Les auteurs
proposent la pose ouverte de tiges dans les fractures du radius distal.

of the wrist with liDistraction
gamentotaxis provides a good
method of stabilizing comminuted
or unstable fractures of the distal
radius. This can be accomplished
with pins and plaster12 or with an

external fixator.3'4 Although the
complication rate associated with
the use of an external fixator is
lower than that with pins and plas
ter,13 use of an external fixator can
cause complications. These include

pin infection, loosening, fracture of
the radius, nerve injury, neuroma
and tendon injury.
The purpose of this study was to
assess the risk associated with per
cutaneous pin placement in the ra-
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dius and to determine whether a
safe zone exists.

Methods
Twenty-six forearms (13 right
and 13 left) from different cadavers
were used. Two 4-mm self-tapping
Hoffman (Howmedica Inc., Ruther
ford, NJ) half pins were placed into
the radius with a universal hand
drill. Cooney5 has recommended
placement of the first pin four fin
ger breadths proximal to the radial
styloid process. Therefore, the first
pin was placed 8 cm proximal to the
radial styloid. The second pin was
placed 2 cm proximal to the first.
The pins were placed percutaneously along the dorsoradial ridge of the
radius parallel to the coronal plane
of the forearm. No stab incisions or
predrilling was used. After pin
placement, skin and subcutaneous
tissues were dissected with
3.5-loupe magnification over an
area extending from the midaxial
line of the dorsum of the forearm to
the flexor carpi radialis tendon. The

lateral antebrachial cutaneous nerve
(LACN) and the superficial branch
radial nerve (SBRN) were preserved.
Measurements of the following dis
tances were made: arm length from
the radial styloid to the elbow
flexion crease, the distance from
the radial styloid to the SBRN at its
exit from beneath the brachioradialis tendon, the distance from the
radial styloid to each pin, and the
distance from the SBRN and the
LACN to each pin. Injuries to soft
tissues, including tendons, nerves
and vessels, were noted and photo
graphed. The distance from the
radial styloid to the SBRN was
compared to the arm length from
the radial styloid to the elbow
flexion crease to determine if
there was a safe zone for percuta
neous pin placement that would
protect the SBRN from injury.

Findings
The SBRN was identified within
the dissection field (Fig. 1) in all 26
specimens, and the LACN was simi

larly identified in 8 specimens. The
distance measurements are shown
in Table I. The average distance
from the SBRN to pin 1 was 7 mm
(range from 0 to 18 mm) and to
pin 2 was 9 mm (range from 4 to
14 mm). The average ratio of the
distance from the radial styloid to
the elbow crease and the distance
from the radial styloid to the exit of
the SBRN from under the brachioradialis tendon was 0.35 (range
from 0.28 to 0.44). The SBRN was
transfixed by pin 1 (the distal pin)
twice. The average distance from
the LACN to pin 1 was 6 mm
(range from 3 to 10 mm) and to
pin 2 was 6 mm (range from 0 to
11 mm). The LACN was transfixed
once by pin 2.
Three tendons were transfixed by
the pins. The abductor pollicis longus and the extensor carpi radialis
longus were transfixed by pin 1.
The extensor carpi radialis brevis
(ECRB) was transfixed by pin 2.
Four tendons sustained partial ten
don lacerations. The ECRB was
injured by both pins, and the brachioradialis was injured twice by
pin 1.
The point of nerve emergence
from beneath the brachioradialis
varied in relation to the arm length,
from 28% to 44% of total arm
length. In other words, it could
emerge anywhere from the mid
forearm to the distal one quarter of
the forearm.
Overall, 7 (27%) of 26 arms susTable I. Measurements Made in 26 Cadaver
Forearms
Distance, mm
Measurement

FIG. 1. Cadaver specimen showing anatomic points of interest in placement of pins
for percutaneous external fixation of radial fractures. In this specimen elbow is to
right and wrist to left. Distal external fixation pin is placed 8 cm proximal to radial
styloid (R). Cephalic vein (C) is seen, with branch of lateral antebrachial cutaneous
nerve (large arrow) passing in close proximity to pin. Superficial branch of radial
nerve (small arrow) is seen exiting from beneath brachioradialis tendon (B).
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Pin 1 to SBRN
Pin 1 to LACN
Pin 2 to SBRN
Pin 2 to LACN
Radial styloid to SBRN
Arm length

Average

Range

7
6
9
6
88
251

0-18
3-10
4-14
0-11
70-112
212-285

SBRN = superficial branch of the radial
nerve, LACN = lateral antebrachial cutane
ous nerve

PERCUTANEOUS INSERTION OF PINS

tained soft-tissue injuries. Three
nerve (12%) and seven (27%) tendon
injuries were noted.

Discussion
Complications associated with
use of the external fixator appara
tus can be clinical, equipment relat
ed or multifactorial.6 Clinical com
plications can be from soft-tissue or
osseous damage. Pin complications
include infections and loosening.
Clinical soft-tissue injuries during
pin insertion include damage to
nerves, vessels, muscles and ten
dons. These complications can be
avoided with proper insertion tech
nique, for which intimate knowl
edge of forearm anatomy is essen
tial. Attempts have been made to
make percutaneous pin insertion
safe by delineating safe, hazardous
and unsafe corridors. Safe corridors
without musculotendinous units
and neurovascular structures occur
only in the scapula, ulna and metacarpals in the upper limb. Hazard
ous corridors contain musculotendi
nous units but no important neuro
vascular structures. The radius and
humerus are concentric bones in
which no safe corridors exist. Pin
placement here ideally occurs
through corridors in which mus
culotendinous units are present
without neurovascular structures.6
In regard to external fixation of
the radius, complications involving
tendon and nerve damage range
from 5%5 to 11%7 to 18%.8 Cooney5
believed that the radial sensory
nerve is not at risk if pins are
placed four finger breadths or more
from the radial styloid. He stated
that in the 10% of his cases in
which the radial sensory nerve or
tendons were considered to be at
risk, an open technique was appro
priate. Others9’10 have reported that
proximal pin placement through
small stab incisions avoids sensory

neuromas. Seitz, Putnam and
Dick10 believed that small stab inci
sions with a drill sleeve to protect
the soft tissues can avoid injury.
The use of blunt dissection and drill
sleeves is easily accomplished in
metacarpal pin placement but can
be difficult in radial pin placement.
To date no study has defined risk
factors or external landmarks that
predict the location of the SBRN.
In our anatomic study we showed
that percutaneous pin placement
was associated with soft-tissue in
jury in 27% of forearms studied.
Varying degrees of tendon injury
occurred, but all injuries involved
less than 50% of the tendon sub
stance. Although there were no
complete tendon lacerations, the
subsequent scarring may affect re
habilitation. The incidence of nerve
injury was 12%. This correlates well
with reported clinical complication
rates. Due to the well-established
degree of overlap11 between the
LACN and the SBRN, injury to
either nerve will give similar symp
toms, and in our opinion both these
nerves are at risk. We were unable
to identify external landmarks that
determined a safe zone for percuta
neous pin placement. The anatomy
of the SBRN and the LACN is
highly variable. Our data show that
both these nerves are at risk when
pins are placed anywhere into the
distal half of the radius. Because of
the high rate of nerve and tendon
injuries recorded, we recommend
open pin placement in this region of
the radius. Open pin placement al
lows visualization and protection of
nerves and tendons and will de
crease the number of soft-tissue
complications.

fractures could not be established.
Injury to both nerves and tendons is
common after percutaneous pin
placement in the radius.
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A cute Abdominal Emergencies in Patients
on Long-Term Ambulatory Peritoneal
Dialysis
James L. Wellington, MD, CM, FRCSC, FACS; Kelly Rody, RN
Objective: To review intercurrent abdominal emergencies in patients receiving long-term peritoneal
dialysis on an ambulatory basis.
Design: A chart review.
Setting: Tertiary care referral centre.
Patients: Seven patients receiving long-term peritoneal dialysis, who suffered an acute abdominal
emergency during a 7-year study period.
Interventions: Laparotomy with appropriate management depending on the findings. Antibiotic therapy
and dialysate culture.
Results. In all patients the acute abdominal process involved the colon: five patients had perforated
diverticulitis and two had ischemic colitis. The death rate overall was 57%. Peritonitis in these patients
was difficult to differentiate from the peritonitis that occurs commonly in patients on long-term
peritoneal dialysis. As a result there was a delay in the initiation of therapy ranging from 2 to 27 days.
Conclusions: Coincidental abdominal emergency should be considered when patients receiving
long-term peritoneal dialysis on an ambulatory basis present with peritonitis that does not respond to
established antibiotic protocols and when culture results show evidence of multiple enteric organisms.
Objectif: Etudier les urgences abdominales intercurrentes qui surviennent chez les patients soumis a
une dialyse abdominale de longue duree administree en ambulatoire.
Conception : Une etude retrospective des dossiers d’hopitaux.
Contexte : Un centre d’acheminement pour soins tertiaires.
Patients : Sept patients sous dialyse peritoneale de longue duree qui ont presente une urgence
abdominale aigue au cours d’une periode de 7 ans.
Interventions : Une laparotomie accompagnee des soins appropries aux observations. Antibiotherapie
avec culture du dialysat.
Resultats : Dans tous les cas, l’abdomen aigu etait relie a une atteinte du colon: cinq patients avaient
une diverticule perforee et deux, une colite ischemique. La mortality a ete de 57 %. Chez ces patients, il
etait difficile de differencier ce type de peritonite des peritonites frequemment observees chez les
patients sous dialyse peritoneale de longue duree. En consequence, on compte un delai de 2 a 27 jours
avant de debuter le traitement.
Conclusions : On doit envisager la possibility d’une urgence abdominale intercurrente quand un patient
sous dialyse peritoneale de longue duree administree en ambulatoire presente une peritonite qui ne
cede pas aux protocoles d’antibiotherapie etablis et quand les cultures indiquent la presence de
multiples enterobacteries.

he role of chronic (long-term)
ambulatory peritoneal dialysis
(CAPD) in the treatment of chronic
renal failure is rapidly expanding.
Exogenous infection resulting in

T

peritonitis is the commonest late
complication in most CAPD pro
grams. Such infections are usually
due to a single organism and re
spond to established treatment pro

tocols. However, when peritonitis
develops because of unrelated intra
abdominal disease of the gastroin
testinal tract, the diagnosis may be
uncertain, and this may lead to
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delay in emergency operation and
contribute to a high surgical death
rate. Our experience with seven
such patients on CAPD, who had
coincidental emergency surgical
conditions, is reported.

Patients and Methods
Between May 1984 and October
1991, seven patients (five men, two
women) on CAPD were recognized
as suffering from acute abdominal
surgical conditions (Table I). The
diagnosis was verified at operation
in six and at autopsy in one. Many
patients were elderly (mean age 69
years, range from 57 to 83 years).
They had been on peritoneal dialy
sis for periods ranging from 1 to
106 months. Five of the seven
patients had had peritonitis.

in six of the seven patients. Two of
these specimens gave negative re
sults, but the remainder grew gram
negative bacilli. Cultures of the dialysate from six of the seven pa
tients grew mixed enteric organ
isms, including Bacteroides fragilis
in two and a solitary growth of
Escherichia coli in one.
At operation or autopsy, all pa
tients were noted to have conditions
affecting the large intestine. Five
patients had perforated sigmoid di
verticulitis with either paracolic ab
scess or frank peritonitis, and two
suffered from ischemic infarction of
the large bowel. Six patients under
went some form of colonic resec
tion: primary anastomosis in one
and fecal diversion in five. Four
(57%) of the seven patients died.
The cause of death was myocardial
infarction in two and sepsis in two.

Clinically, the patients with gas
trointestinal complications could
not be differentiated from the usual
patient with CAPD peritonitis. Radi
ologic investigations were not help
ful, most patients showing nonspe
cific bowel distension compatible
with ileus. No patient had evidence
of free intraperitoneal air. When an
acute abdomen developed, treat
ment was initiated with a standard
antibiotic protocol consisting of
cefazolin 1 g, tobramycin 40 mg
and vancomycin 1 g infused intraperitoneally. Antibiotic therapy
was modified depending on the cul
ture results.

Results
In this series, specimens of dialysate were sent for Gram’s staining

T a b le 1. Data on Patients Receiving Chronic Ambulatory Renal Dialysis (CAPD) and S uffering From Acute Gastrointestinal C om plications

D uration
Age, of C APD,
P atien t
mo
no.
Sex yr

P revious
e p is o d e s of
p erito n itis,
no.

R e s u lts of
G ra m ’s
sta in in g

R esults of
culture

D uration
fro m
o n set to
su rg ery,
d

F in d in g s

MEO
(.Bacteroides
fragilis)
MEO

2

Perforated
diverticulitis

5

Negative

Escherichia
coli

3

Perforated
diverticulitis
w ith pericolic
abscess
Infarction right
colon

2

Gram
negative
bacilli

MEO
(Bacteroides
fragilis)

45

2

MEO

5

77

27

2

MEO

No surgery

69

34

6

Gram
negative
bacilli
Gram
negative
bacilli,
gram 
positive
cocci
N /A

MEO

6

1

M

63

106

1

Negative

2

M

83

1

0

Gram
negative
bacilli

3

M

69

3

0

4

M

57

16

5

F

66

6

M

7

F

I
27

Perforated
diverticulitis
w ith pericolic
abscess
Ischem ic colitis
w ith
perforation
Perforated
diverticulitis
w ith pericolic
abscess
(autopsy)
Perforated
diverticulitis
w ith
peritonitis

P ro c e d u re

O u tc o m e

L e n g th of
h o s p ita l
s ta y , d

Local resection
and
anastom osis
Sigmoid
resection,
colostom y

Survived

21

Survived

79

Right
hem i
colectom y,
ileostom y
Sigmoid
resection,
colostom y

Died (M l)

8

Died
(sepsis)

87

Total
colectomy,
ileostom y
No surgery

Died
(sepsis)

46

Died (M l)

4

Sigmoid
resection,
colostom y

Survived

23

N /A = not available, MEO = Multiple enteric organism s, Ml = myocardial infarction
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Three of the six patients who un
derwent surgery died for an opera
tive death rate of 50%.
The delay from the time of pre
sentation to surgery varied from 2
to 27 days. In four of the six
patients treated surgically, the delay
was longer than 5 days. One patient
(no. 6) died on the 4th day after
admission and did not undergo op
eration.
The length of stay from admis
sion to discharge or death varied
from 4 to 87 days (mean 38 days).

Discussion
Since it was introduced in 1976,1
CAPD has been used with increas
ing frequency as the preferred
method of home dialysis in patients
with end-stage renal failure. As ex
perience with the technique has
increased, the incidence of compli
cating peritonitis has fallen. Howev
er, peritonitis remains the main
complication in these patients, with
a reported incidence of approxi
mately 1.3 episodes per patient per
year.2 Our incidence of peritonitis at
the Ottawa General Hospital is low
er, being 0.45 episodes per patient
per year with a current peritoneal
dialysis population of 166 patients.
CAPD peritonitis is usually
caused by normal skin bacteria,
notably coagulase-negative staphy
lococci.3 However, gram-negative
bacteria may be responsible for as
many as one-third of all cases of
peritonitis associated with CAPD.4
The presence of anaerobes or poly
microbial peritonitis should raise
the suspicion of bowel perforation.
In a series of patients reported by
Spence and colleagues,5 no patient
without multiple enteric organisms
required laparotomy. Conversely, 6
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of 10 patients with multiple enteric
organisms recovered without sur
gery.
Peritonitis secondary to bowel
perforation may be difficult to dif
ferentiate clinically from that of
peritonitis associated with CAPD.
Similar findings were reported by
both Spence and colleagues5 and
Moffat, Deitel and Thompson.6 The
presence of severe pain, especially
when initially localized, should raise
the suspicion of an intercurrent
acute abdominal condition. Such
conditions are frequently associated
with muscle guarding and absent
bowel sounds, which are infrequent
features of the type of peritonitis
commonly occurring in CAPD pa
tients. Certainly, pain that persists
after institution of the usual treat
ment protocol should alert the phy
sician to the possibility of peritoni
tis caused by gastrointestinal com
plications.
In our series, all patients suffered
from colonic conditions. Perforated
diverticulitis was the commonest
complication, followed in frequency
by ischemic bowel disease. Delay in
necessary surgery was almost in
variable, inviting a poor outcome
and high mortality. Our operative
death rate of 50% was identical to
that reported by Moffat, Deitel and
Thompson6 who cited nutritional
depletion as a factor contributing to
the poor outcome.
The cause for delayed interven
tion in our series was related to
prolonged medical treatment for
what was interpreted as acute sig
moid diverticulitis without perfora
tion. Surprisingly, patients in the
series of Spence and colleagues5
had an average delay of 7.5 days
before they underwent operation,
and all survived. These authors be
lieved that longer intraperitoneal

administration of antibiotics, by
producing therapeutic serum levels,
might have been responsible for the
increased survival in the treatment
of patients suspected of having
CAPD peritonitis.

Summary and Conclusions
Peritonitis remains the common
est complication of CAPD for pa
tients with chronic renal failure.
When such patients present with
peritonitis that, on culture, demon
strates multiple enteric organisms
and does not respond to standard
treatment protocols, a bowel perfo
ration should be suspected. Delay in
surgery is likely to lead to increased
surgical complications and mortali
ty. Our experience with seven such
patients, all with disease affecting
the large bowel, resulted in an
operative mortality of 50%.
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Pediatric Free Tissue Transfer:
an Evaluation of 99 Cases
Howard M. Clarke, MD, PhD, FRCSC, FACS;* Joseph Upton, MD, FACS;f
Ronald M. Zuker, MD, FRCSC, FACS;* Ralph T. M anktelow, MD, FRCSC*
Objective: To evaluate the results of free tissue transfers in children who undergo reconstructive
surgery.
Design: Case series chart review. Mean follow-up longer than 2 years.
Setting: Two tertiary care pediatric hospitals.
Patients: Consecutive sample of 99 children.
Interventions: Free tissue transfers for reconstruction of a variety of defects.
Main Outcome Measures: Indications, operations, complications, survival.
Results: The most common indications were for restoration of muscle function and for difficulties with
soft-tissue coverage. Multiple donor sites were used, with the gracilis muscle, fibula, latissimus dorsi
and groin flaps predominating. The overall survival rate was 99.0%. Complications were common, with
an overall rate of 59.6%; most were graded as minor or moderate.
Conclusions: Meticulous planning is paramount in achieving a successful outcome. Complications are
common but do not include vascular spasm. Free tissue transfers can be successfully completed in small
children despite the dimensions of the tissues.

Objectif: Evaluer les resultats des transferts de tissu libre chez les enfants qui subissent une chirurgie
de reconstruction.
Conception : Une revue d’une serie de cas. Le suivi moyen depasse 2 ans.
Contexte : Deux hopitaux de soins pediatriques tertiaires.
Patients : Un echantillonnage de 99 patients consecutifs.
Interventions : Les transferts de tissu libre pour la reconstruction de diverses lacunes.
Principaux effets mesures : Indications, operations, complications, survie.
Resultats : Les indications les plus courantes etaient liees au retablissement de la fonction musculaire
ou a des difficultes de recouvrement des tissus mous. On eut recours a de multiples zones de
prelevement de greffons, avec predominance des muscles droit interne de la cuisse, perone et grand
dorsal, de meme qu'a des lambeaux d’aines. La survie fut de 99 %. Les complications etaient frequentes,
leur taux atteignant 59,6 %; la plupart de celles-ci furent considerees benignes ou moderees.
Conclusions : Une planification meticuleuse est de premiere importance pour obtenir de bons resultats.
Les complications sont frequentes mais ne comprennent pas le spasme vasculaire. Le transfert de tissu
libre peut etre realise avec succes chez le petit enfant malgre la faible dimension des tissus.
he ability to transfer viable,
functional units of tissue about
the body has greatly enhanced the
capabilities of reconstructive sur
gery. The techniques are no better

T

applied than in children, a popula
tion in which there is an interesting
array of congenital deformities and
acquired defects.
Harii and Ohmori1 were the first

to report on free tissu e transfer in
children. They used free groin-flap
transfer in two 4-year-old children
to cover open wounds of the ankle.
Free tissue transfer has been under-
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taken in children as young as 3
months.2 To date there are two
large series describing free tissue
transfer in children. Parry, Toth
and Elliott3 reviewed 22 cases in
children ranging from 2 to 14 years
of age. All but one case was for the
coverage of soft-tissue defects, and
15 had massive lower-extremity
trauma with exposed bone. In their
series of 21 patients under 20 years
of age (mean age, 10.6 years) who
underwent free tissue transfer,
Serafin and Barwick4 reported on
22 free flaps used for a variety of
problems. There was one failure.
They felt that there were problems
related to vessel size in small chil
dren. Further, Banic and Wulff3
described injuries to the lower limbs
of 15 children from 3 to 9 years of
age that were treated by immediate
reconstruction with latissimus dorsi
musculocutaneous flaps. Iwaya,
Harii and Yamada6 recommended
the groin flap as the preferred
donor site for coverage of traumatic
defects on the dorsum of the foot
and ankle in seven children. Ex
panded parascapular free skin flaps
were used by Moghari and col
leagues7 in four children, with di
rect closure of the donor wound.
Superior gluteal flaps of fascia lata,
muscle and fat and, in one case,
skin were used to reconstruct hemi
facial microsomia by La Rossa and
associates.8 Other reports have in
cluded a high proportion of children
but in small numbers.9-13
In reviewing the first 99 free
tissue transfers undertaken at two
large pediatric centres we hope to
indicate the breadth of surgery that
can be undertaken and the relative
safety of these procedures.

Patients and Methods
The first 99 consecutive free tis
sue transfers undertaken in children
at the Hospital for Sick Children in
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Toronto (70 cases) and the Chil
dren’s Hospital Medical Center in
Boston (29 cases) were reviewed.
Half of these children were operated
on in the first decade of life (mean
age at operation, 10.8 years, range
from 17 months to 19 years). The
hospital charts were reviewed in all
cases to identify any complications
in the perioperative period. Further
recall visits were not feasible. The
mean follow-up was 25.1 months
with a maximum follow-up of 6.5
years.

Results
Indications for Operation
The most common indication for
operation was restoration of facial
(20 children) or forearm (9 children)
animation (Table I). Facial anima
tion was undertaken in most cases
for congenital facial palsy or Mobius’ syndrome. Forearm animation
was indicated after Volkmann’s
ischemic contracture as a result of a
supracondylar fracture of the hu
merus. Soft-tissue reconstruction
was undertaken in the head and
neck (11 children), the upper limb
(4 children) and the lower limb (13
children). Hand reconstruction with
replacement of congenitally absent

or traumatically damaged structures
was undertaken in 12 children.
Pseudarthrosis of the tibia was
treated with free fibular transfer in
nine cases. There were an additional
nine cases of bony reconstruction
and eight cases of soft-tissue con
tour treatment without a cutaneous
defect.
Planning for Operation
Extensive planning was under
taken in all cases. A two-team ap
proach was usually used, one team
to prepare the donor tissue and the
other to prepare the recipient site.
Both teams reviewed the cases preoperatively in the planning phase.
Angiography was undertaken in
50% of cases to evaluate either the
donor site anatomy, as is commonly
required in tree fibular transfers, or
the recipient vascular anatomy, as
in trauma cases. Models and tem
plates were frequently used.
Variety o f Operations
The gracilis muscle was the most
common donor tissue used (30 chil
dren), in many cases for functioning
muscle transfer (Table II). The fibu
la was used in 17 children and is
the preferred bone for microvascular transfer in children because the

Table 1. In d ic a tio n s f o r Free T is s u e
T ra n s fe r in C h ild re n

T a b le II. D o n o r T is s u e s U sed
Donor tissues

Indication

P atie n ts , no.

Facial re c o n s tru c tio n
S o ft-tis s u e c o v e r
L o w er lim b
Head and n e c k
U pper lim b
D ig ital re c o n s tru c tio n
Forearm a n im a tio n
P se u d a rth ro s is
B o n y re c o n s tru c tio n
S o ft-tis s u e c o n to u r
B urn-sc ar a lo p e cia
C u tis a p lasia c o n g e n ita
S ho tg u n in ju ry
O vary p re s e rv a tio n

20
13
11
4
12
9
9
9
8
1
1
1
1

G ra c ilis
F ibu la r
L a tis s im u s d o rsi
G roin
S eco n d to e
F irs t to e
T e m p o ro p a rie ta l fa s c ia
P o s te rio r ca lf
S ca p u la r
F orearm
R e ctu s a b d o m in u s
D o rs a lis p e d is
S ca lp
O varian
O m e n tu m

T o ta l

99

T otal

P atien ts , no.
30
17
16
11
7
5
3
2
2
1
1
1
1
1
1
99

PEDIATRIC FREE TISSUE TRANSFER

dissection is straightforward, can be
done under tourniquet control and
provides a long segment of bone for
reconstruction. It was extremely
well suited for microsurgical recon
struction of pseudarthrosis of the
tibia (nine children). The latissimus
dorsi was used to cover large de
fects (16 children). The groin flap,
known to be a difficult dissection,
was used less commonly (11 chil
dren). It is reserved for selected
cases of soft-tissue contour defor
mities. First and second toes were
used in hand reconstruction with
the second toe often used for con
genital deformities of the ulnar side
of the hand.
All patients received increased in
travenous fluid infusions intraoperatively, and one and one-half their
normal maintenance requirements
postoperatively. The fluids were ta
pered gradually over 5 to 7 days.
The transfusion rate was 60% and
included packed red cells, plasma,
albumin and coagulation factors.
Postoperative anticoagulation
was not routine, being used in only
13 of the 70 children in Toronto
and 20 of the 29 in Boston.
Complications (Table III)

Complete necrosis of the trans
ferred flap was documented in only
one case, giving an overall flap
survival rate of 99%. There were
Table III. Complications
Complication
Bulk or scar
necessitating revision
Recipient wound problems
Infection
Systemic
Donor wound problems
Partial or complete flap
necrosis
Vascular compromise
necessitating
re-exploration
Hypertrophic scar
Poor function
Total

Patients, no.
23
17
14
10
9
5
4
2
2
86

three late deaths, all of which were
related to recurrence of the original
condition (rhabdomyosarcoma), and
there were no operative deaths.
Complications were classified as
minor, moderate or severe. Minor
complications (in 28% of the pa
tients) were those that did not re
quire reoperation, such as infection
or delayed healing, and did not
prolong the hospital stay. Moderate
complications were seen in 38% of
cases; more than one-half of these
were revisions to the flap to correct
contour or bulk. In some cases it
was not possible to provide a defini
tive sizing for the flap at the origi
nal surgery, thus necessitating this
reoperation. Severe complications,
all occurring in groin flap transfers,
were seen in 3% of patients and
consisted of loss of a significant
portion, but not all, of the flap.
Major systemic complications,
such as pulmonary embolism or
respiratory failure, were not seen.
Lesser systemic complications in
cluded pulmonary problems related
to prolonged procedures, antibiotic
sensitivity and fluid and electrolyte
problems, which were seen in 10
patients. In total 86 complications
were seen in 59 patients, an overall
complication rate of 60%.

Discussion
The indications for free tissue
transfer in children differ from
those in adults in that congenital
anomalies and the specific diseases
of childhood account for a large
group of cases. They include the
reconstruction of congenital hand
deformities,14 congenital pseudar
throsis of the tibia,15 hypospadias16
and tumours such as rhab
domyosarcoma. The vascular anato
my may also vary in congenital
anomalies. The normal arches of
the .hand may not be present in cleft
hands or radial ray deformities. Ab

normal vascular anatomy has been
noted by Fisher and Jackson9 in
patients with hemifacial microso
mia, in whom the carotid bifurca
tion may be low and the external
carotid system abnormal.
More delicate technique is re
quired in small children because the
structures are smaller than those in
adults.2-410 The vessels may not be
smaller in proportion to the child’s
size but are often more delicate.
Masquelet and colleagues10 dissect
ed the vascular pedicle in posterior
arm flaps without difficulty but
found that it was less than 1 mm in
diameter in the two youngest chil
dren (aged 3 and 6 years) in their
series. In their opinion the size of
the vascular pedicle is directly relat
ed to the age of the patient. Parry,
Toth and Elliott3 noted that the
vessels were slightly smaller than in
comparable flaps in adults. Serafin
and Barwick4 recommended that
elective microsurgical procedures
should be performed after the child
has reached 3 to 4 years of age
since the histologic appearance of
the blood vessels becomes more like
that of the adult. The vessels may
be particularly small in hypoplastic
tissues.8'943 Vascular spasm was not
a problem in our series or those of
others.3
The common features of adult
and pediatric free tissue transfer
bear emphasis because a successful
outcome depends on them. The
planning required in carrying out
these procedures cannot be overem
phasized. All the details of the
procedure should be worked out in
advance by a microvascular team.
Anesthetists who are familiar with
the requirements of children under
going extended procedures should
be involved in the planning process.
Small vessels require appropriately
fine instruments and sutures. Post
operative monitoring of fluid status
and flap perfusion must be under
taken by experienced nursing and
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medical personnel. Shapiro, Akbarnia and Hanel17 recommended
hydration with twice the usual
maintenance fluids for 12 hours
before and 5 days after surgery. We
recommend one and one-half times
the usual maintenance fluids.
Complication rates were high in
our series as in other pediatric17 and
adult experiences. Morrison, O’Bri
en and MacLeod18 reported a com
plication rate of 38% and noted that
thrombosis was the most serious
problem.
Given the possible complications
of transfusion therapy, the transfu
sion rate of 60% in our series raises
concern. The risk of giving albumin
may be extremely small but is con
sidered none the less.
The postoperative need for an
ticoagulation. including heparin,
dextran or acetylsalicylic acid, re
mains extremely controversial.
Banic and Wulff5 used anticoagu
lants in 2 of 15 cases after revision
of the arterial anastomosis. Parry,
Toth and Elliott3 related their two
complications (bleeding into the
donor site) to the use of lowmolecular-weight dextran, and they
used dextran only if there was a
technical problem with the anasto
moses. Acetylsalicylic acid was used
by Shapiro, Akbarnia and Hanel17 in
all cases for 2 weeks, but they
acknowledged that there are no
data to support this practice. Our
approach is to consider anticoagula
tion if there are problems with the
vascular anastomoses or perfusion
of the flap. The intra-arterial infu
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sion of streptokinase and heparin
has been suggested for the salvage
of vascular repairs in children,19 but
we have no experience with these
agents.

Conclusions
Both pediatric and adult microsurgical procedures must be
carefully planned and meticulously
executed. In children, the vessels,
although smaller, are still of ade
quate size for reliable anastomosis.
There is no lower age limit for these
procedures. Vascular spasm is not a
problem. Intraoperative complica
tions have been reduced with the
establishment of appropriate anes
thetic protocols. Anomalies of the
recipient vasculature are often
found to be critical at surgery.
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B lun t Traumatic Liver Injury Associated
With Clostridial Infection of Early Onset
Alan W. Hemming, MD;* Charles H. Scudamore, MD, FRCSC;* Gregor I. McGregor, MD, FRCSC;*
David Owen, MD, FRCPath, FRCPCf
Hepatic clostridial infections associated with blunt abdominal trauma are rare. Generally they occur
from 2 weeks to 3 months after injury and are thought to result from the growth of normal enteric
organisms, which are carried to the liver by the portal venous system and infect devitalized tissue. The
authors describe two patients in whom the hepatic infection became established in less than 24 hours
after injury and was due to Clostridium spp. The patients were successfully treated by hepatic resection
and combination antimicrobial therapy. Hyperbaric oxygen was used as an adjunct in one case.

Les infections hepatiques a clostridies liees aux traumatismes abdominaux fermes sont rares. Elies
surviennent generalement de 2 semaines a 3 mois apres la blessure et l’on croit qu’elles resultent de la
multiplication de bacteries intestinales normales, lesquelles migreraient vers le foie par le systeme
porte pour aller infecter le tissu devitalise. Les auteurs decrivent deux patients chez qui une infection
hepatique a Clostridium spp s’est etablie moins de 24 heures apres la blessure. Les patients ont bien
repondu a une resection hepatique et a une antibiotherapie dissociation. L’oxygene hyperbare fut
utilise comme traitement d’appoint dans un des cas.

yogenic liver abscess is uncom
mon. It is reported to occur in
approximately 0.03% of all hospital
admissions.1 Blunt trauma to the
abdomen and lower chest is the
third most common cause after pri
mary biliary tract infection and di
rect contiguous infection.2 In recent
years anaerobic organisms have
been more frequently implicated as
causative organisms, although
Clostridium spp. have been isolated.
We present two cases of rapidly
occuring clostridial hepatic infec
tion after blunt abdominal trauma
seen at the Vancouver General Hos
pital between August 1990 and No
vember 1991. The limited experi
ence with clostridial hepatic infec
tion after blunt abdominal trauma is

P

reviewed, and the principles of ther
apy are discussed.

Case Reports
Case 1
A 29-year-old man was involved
in a roll-over motor vehicle accident
in a remote area of the province. He
was not wearing a seat belt. At the
scene of the accident his blood
pressure and heart rate were report
ed to be 80 mm Hg systolic and 110
beats/min respectively. The patient
was awake and alert. Transfer to
the nearest hospital took approxi
mately 3 hours during which time
the patient received 5 L of crystal

loid solution. Upon admission the
patient was in respiratory distress
with a blood pressure of
110 mm Hg systolic and a heart
rate of 100 beats/min. A flail seg
ment of ribs four to seven was
noted on the right side. Right tube
thoracostomy was performed, and
the patient was intubated. A chest
film revealed a large right pulmo
nary contusion. The findings on
abdominal examination with the pa
tient awake and apparently nonobtunded was considered to be nor
mal; however, a contusion measur
ing 10 cm in diameter was noted
over the right upper quadrant. Al
though the patient appeared to be
in stable condition, he was trans
ferred to the Vancouver General
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Hospital, which is the level I trauma
centre for British Columbia.
The patient arrived at the Van
couver General Hospital approxi
mately 10 hours after injury. He
had been intubated, and paralysed
and sedated for transfer. His blood
pressure was 100 mm Hg systolic,
and he had a tachycardia of
125 beats/min. His body tempera
ture was 38°C. On admission the
patient had received 8 L of crystal
loid solution. A right chest tube
was in place. A large right pulmo
nary contusion with fractures of
ribs four to seven on the right side
was confirmed by chest radiogra
phy. Abdominal examination re
vealed a contusion of the right
upper quadrant. Diagnostic perito
neal lavage was grossly positive for
blood. The hemoglobin value was
94 g /L (140 g /L before transfer).
The leukocyte count was depressed
at 3.3 X 109/L (normal 4.5 to 11 X
109/L ), with a shift to the left.
Prothrombin time was prolonged at
16.5 s (normal 12 to 14 s), with a
plasma fibrinogen level of 0.77 g /L
(normal 2 to 4 g/L). The serum
aspartate aminotransferase level
was elevated at 1448 U /L (normal
7 to 40 U/L) and the total serum
bilirubin elevated at 106 /rmol/L
(normal 0 to 22 /umol/L.
After receiving 2 g of ceftizoxime, the patient underwent a mid
line laparotomy, which revealed a
splenic hilar laceration, requiring
splenectomy. There was a foul
odour from the liver, and explora
tion revealed a large laceration
(10 cm in dimension) extending to
the portal hilum. The majority of
the right lobe was soft, yellowish
and necrotic and was the source of
the foul odour. No obvious gas was
present. Intraoperative Gram’s
staining revealed gram-positive ba
cilli. A formal right hepatic lobecto
my, with an inflow occlusion time
of 47 minutes, was performed. Re
section margins were negative for
530

bacteria. A no. 32 French chest
tube connected to closed suction
was used as a subdiaphragmatic
drain along with two smaller flat
Jackson-Pratt drains. The patient
was given penicillin G, 30 million
units/d and imipenem, 500 mg
every 6 hours. Microscopic exami
nation of the liver showed extensive
areas of coagulative necrosis with
large numbers of gram-positive,
spore-bearing rods (Fig. 1). Tissue
cultures identified a Clostridium sp.
that could not be grown out for
subtyping.
Six hours postoperatively the pa
tient remained tachycardic and fe
brile, so hyperbaric oxygen therapy
was instituted. Five dives at 2.5
atmospheres for 90 minutes each
were undertaken over the next 3
days. The patient was returned to
the operating room on the 2nd
postoperative day for evacuation of
a right subdiagphragmatic hemato
ma. Cultures of this material
showed no bacterial growth. Antibi
otics were continued for 12 days at
which time the patient was afebrile

and had a normal leukocyte count.
He suffered no further compli
cations and was discharged from
the hospital 21 days after his acci
dent.
Case 2
A pedestrian, a 31-year-old man
who was intoxicated, was struck by
a motor vehicle in a remote area of
the province. About 4 hours after
the accident he was seen in the
emergency department of the local
hospital, complaining of abdominal
pain. The blood pressure was
120/50 mm Hg, the heart rate was
98 beats/min and the body temper
ature was 38.2°C. Physical exami
nation revealed a markedly tender
abdomen especially in the right
upper quadrant. A chest film
showed a right pulmonary contu
sion, fractures of the eighth rib on
the left side and fractured trans
verse processes of lumbar vertebrae
2 and 3. His transfer to the Vancou
ver General Hospital was delayed
for 10 hours because of adverse

FIG. 1. Case 1. Excised necrotic liver showing preservation of architecture with
pyknotic nuclei (arrowheads) (hematoxylin-eosin, original magnification X 100).
Insert shows gram-positive rods typical of Clostridium organisms (Gram’s stain,
original magnification X 400).
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weather conditions. On arrival, his
body temperature was 38.5°C, his
heart rate was 117beats/min and
his blood pressure 110/60 mm Hg.
He .was awake and alert. A chest
film confirmed the right pulmonary
contusion but also showed some
consolidation of the lower lobe of
the right lung with mild loss of
volume. The presence of the previ
ously noted fractures was also con
firmed. Abdominal examination elic
ited marked tenderness in the right
upper quadrant. There was frank
hematuria. The hemoglobin level
was 146 g /L and the leukocyte
count was 16 X 109/ L with a
marked shift to the left. The serum
aspartate aminotransferase level
was 417 U/L with an elevated total
serum bilirubin level of 50 mmol/L.
Triple-contrast computed tomogra
phy and retrograde cystography
were carried out. The retrograde
cystogram revealed an intact blad
der with mild, right, renal contu
sion. There was no evidence of
pedicle injury. A large amount of
intraperitoneal fluid, and a hepatic
contusion and laceration corre
sponding to hepatic segments six

and seven were noted (Fig. 2). Con
solidation of the lower lobe of the
right lung was again noted. Preoperatively, blood samples were drawn
for culture.
After receiving a loading dose of
2 m g /k g of gentamicin and
750 mg of clindamycin the patient
underwent laparotomy. A right sub
costal incision with midline exten
sion to xiphisternum revealed a
frank hemoperitoneum with a foul
odour from the right lobe of the
liver. There was a minimal right
retroperitoneal hematoma, but the
retroperitoneal portion of the duo
denum appeared normal. Mobiliza
tion of the right lobe of the liver
revealed a laceration 6 to 8 cm long
in hepatic segments 6 and 7. The
surrounding liver tissue was soft,
yellowish and malodorous. Gas was
present in the tissue along with
some pus and a marked bile leak.
Nonanatomic resectional debride
ment was carried out until unin
volved hepatic parenchyma was
reached. A visible lacerated segmen
tal bile duct was ligated. An in
traoperative dose of 6 million units
of penicillin G was given. A no. 32

FIG. 2. Case 2. Computed tomography scan demonstrating laceration in hepatic
segments 6 and 7, with gas.

French chest tube connected to
closed suction was used in addition
to the standard Jackson-Pratt
drains to provide maximal drainage
of the subdiagphragmatic space.
Postoperatively, the patient was
given penicillin G 20 million
units/d, clindamycin 750 mg four
times daily and gentamicin 80 mg
three times daily. Cultures of both
blood and resection tissue grew
Clostridium sp., but as in case 1 the
culture could not be successfully
grown out for subtyping. A moder
ate bile leak resolved spontaneously
after 3 days, at which time the
drains were removed. The hematu
ria resolved spontaneously. Antibi
otics were discontinued on postop
erative day 8 after the patient had
shown no signs of sepsis for 72
hours. The patient was discharged
from hospital 11 days after opera
tion.

Discussion
Blunt abdominal trauma with he
patic infection has been reported,
but in most instances the temporal
relationship of the trauma to the
development of the infection has
ranged from 2 weeks to 3 months
after the inciting event.3 In our
cases hepatic infection with Clos
tridium sp. was well established
within 16 hours of injury. The
pathogenesis of hepatic infection
after trauma has yet to be delineat
ed. Eng, Tecson-Tumang and Corrado3 have postulated that in nor
mal circumstances organisms from
the gastrointestinal tract are carried
through the portal circulation and
cleared by the Kuppfer cells of the
liver. When hepatic trauma occurs
these organisms multiply in the
hepatic hematoma or devitalized tis
sue. They may then elaborate cytotoxins that produce further necrosis
and extending infection.
The only other reported case of
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clostridial hepatic infection after
blunt abdominal trauma is that de
scribed by Nachman and col
leagues.4 A 6-year-old child with
abdominal trauma and hepatic lac
eration of the right lobe was ma
naged conservatively, an approach
that is often successful in children.
A hepatic infection with Clostridium
bifermentans developed on the 3rd
day after injury. The infection was
successfully treated by resection
and combination antimicrobial ther
apy.
Standard surgical treatment of
clostridial infections includes
debridement of involved tissue and
appropriate antibiotics. This may be
combined with hyperbaric oxygen
therapy. This protocol also appears
applicable to traumatic clostridial
liver infection as well. Mixed anaer
obic bacteria have been the causa
tive organisms cultured from many
hepatic infections, although in
some instances no organisms could

be demonstrated or cultured.5 Be
cause of the possibility of a mixed
infection in our cases we elected to
use antibiotic coverage appropriate
for this eventuality. If the mecha
nism of hepatic infection is via the
portal venous drainage system, then
antibiotic coverage of enteric anaer
obes appears prudent in every in
stance.
Although the use of hyperbaric
oxygen therapy remains controver
sial, its use in all cases of clostridial
infection following full debridement
and appropriate antibiotic coverage
is favoured.6 The cases we have
described illustrate that hepatic
clostridal infection after blunt ab
dominal trauma can be early in
onset and difficult to diagnose preoperatively. On the basis of our
experience and the few reports in
the literature we suggest that trau
matic hepatic clostridial infection be
diagnosed by the operative findings
of foul odour and liver necrosis,

confirmed by Gram’s staining of
tissue and fluid and treated by re
sectional debridement or formal re
section to eliminate nonviable tissue
along with combination antimicrobi
al therapy. Hyperbaric oxygen ther
apy may be a useful adjunct.
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SESAP VII Question / Question SESAP VII
Item 241

Iatrogenic vascular injuries that result in permanent disability are chiefly related to
(A) the location of the injury
(B) delayed surgical intervention
(C) preexisting atherosclerotic disease
(D) the type of instrument causing the injury
(E) extravasation of material around the injury site
For the incomplete statement above select the one completion that is best of the five given.
For the critique of Item 241 see page 550.
(Reproduced by permission from SESAP '92-'93 Syllabus; Surgical Education and Self-Assessment Program
No. 7. For enrolment in the Surgical Education and Self-Assessment No. 7. please apply to the American College
of Surgeons, 55 E Erie St., Chicago, IL 60611.)

532

JCC, VOL. 36, NO 6, DECEMBRE 1993

ORIGINAL ARTICLES

U nusual Isolated Common Bile Duct Injury
After Blunt Trauma
Peter C.W. Kim, MD, PhD; Thomas Gilas, MD, FRCSC; Michele F.M. Brule, MD
Isolated injury to the extrahepatic biliary tree after blunt trauma is rare. The authors describe the case
of a 17-year-old boy who suffered such an injury after falling over the handlebar of his motocycle.
Ultrasonography, computed tomography and abdominal paracentesis were used to make the diagnosis.
At laparotomy there was a partial tear of the common bile duct at its junction with the cystic duct. A
cholecystectomy was performed and a T tube inserted. The patient recovered without complication. The
authors emphasize that only awareness of the condition and diagnostic confirmation by computed
tomography and abdominal paracentesis can expedite the diagnosis and treatment. The choice of
surgical repair must be individualized according to the clinical findings and the nature of the injury.

Suite a un traumatisme fem e, il est rare d’observer une lesion isolee des voies biliaires
extrahepatiques. Les auteurs decrivent le cas d’un garfon de 17 ans qui subit une blessure de ce type
apres avoir ete projete contre le guidon de sa motocyclette. L’echographie, la tomographie par
ordinateur et la parencentese abdominale furent toutes utilisees pour le diagnostic. On decouvrit a la
laparotomie une dechirure du choledoque a sa jonction avec le canal cystique. Une cholecystectomie fut
pratiquee avec insertion d’un tube en T. Le patient se retablit sans complication. Les auteurs
soulignent que ce n’est qu’en gardant cette possibility a l’esprit et en recherchant une confirmation
diagnostique au moyen de la tomographie par ordinateur et par paracentese abdominale que Ton peut
hater le diagnostic et le traitement. Le traitement chirurgical doit etre choisi en fonction du tableau
clinique individuel et de la nature de la lesion.

I

solated injury to the extrahepatic
biliary tree by blunt trauma is
rare.1' 5 The diagnosis is usually
made when the injury is found
incidentally during an urgent ab
dominal exploration or as a late
presentation in the form of obstruc
tive jaundice, resulting from stric
ture formation.12 The following
case report illustrates an early diag
nosis, an unusual site of injury and
a rational plan for surgical manage
ment.

Case Report
A 17-year-old boy presented to

our emergency room with moder
ately severe, vague, epigastric dis
comfort of less than 2 hours’ dura
tion, after falling over the handlebar
of a motorcycle. His body tempera
ture was 38.2°C, the pulse rate was
92beats/m in, the respiratory rate
was 35/min, and the blood pres
sure was 157/55 mm Hg. Findings
on initial physical examination were
unremarkable except for a moderate
degree of tenderness to deep palpa
tion in the epigastrium. The hemo
globin level was 147 g/L, leuko
cyte count was 12.4 X 109/ L with
the differential of lymphocytes 73%
and granulocytes 21%; the serum
amylase level was 135 U/L, serum

aspartate aminotransferase level
400 U /L, serum alkaline phospha
tase level 172 U/L, serum creatine
phosphokinase level 209 U /L and
serum bilirubin (direct/total) level
2 /6 jumol/L. The initial chest x-ray
film and a flat plate of abdomen
were normal.
Repeat examination of the patient
6 hours after initial presentation
demonstrated persistent tenderness
in the epigastrium without any
signs of peritoneal irritation. Repeat
laboratory evaluation revealed a leu
kocyte count of 15.7 X 109/ L with
the differential of lymphocytes 12%
and granulocytes 83%. Ultrasonog
raphy of the abdomen demonstrated
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a significant amount of free fluid in
the abdomen. The computed to
mography scan of the abdomen
demonstrated a moderate amount of
free fluid in subhepatic, pericholecystic and right paracolic gut
ter spaces (25.5 Housefield units)
(Fig. 1). Abdominocentesis was per
formed, and a bilious fluid with a
bilirubin (direct/total) content of
119/473 /zmol/L and an amylase
content of 38 U /L was obtained.
Laparotomy through an upper
abdominal midline incision 18 hours
after the initial injury revealed
500 mL of free bilious fluid in the
abdomen. There was a substantial
retroperitoneal collection of bilestained fluid. The only injury dis
covered after a careful laparotomy
with special attention to duodenum
was an isolated partial tear involv
ing about 25% of the circumference
of the common bile duct at its

junction with the cystic duct
(Fig. 2). A cholecystectomy was
performed, and a no. 10 French T
tube was inserted into the common
bile duct at the site of the injury by
extending the laceration distally.
Intraoperative cholangiography was
performed (Fig. 3). The abdomen
was closed, and a closed drain
was left at the operative site.
The patient's postoperative
course was uncomplicated. T-tube
cholangiography on the 7th postop
erative day (Fig. 4) gave essentially
normal results with good flow into
the duodenum. At the time of dis
charge on postoperative day 7, the
patient's leukocyte count was 5.6 X
109/ L with the differential of lym
phocytes 30% and granulocytes
60%, the serum aspartate amino
transferase level was 130 U/L, the
serum alkaline phosphatase level
was 133 U/L, the serum amylase

FIG. 1. Preoperative computed tomography scan of abdomen demonstrating
significant subhepatic and pericholecystic free fluid.
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level was 114 U/L and the serum
bilirubin (direct/total) level was
3 /1 0 nmo\/L. At the time of dis
charge the patient’s T tube was
clamped.

Discussion
Injury to gallbladder and extrahepatic bile duct is uncommon.
In a recent multicentre review. Cogbill and associates6 reported that an
associated injury to the gallbladder
and to extrahepatic bile duct after
blunt trauma was found in only 5%
and 3% of cases respectively. Isolat
ed injury to the extrahepatic biliary
tree after blunt trauma is rare. Only
126 cases have been reported in the
literature since 1 7 9 9 . The low
incidence has been attributed to the
location and relative size of the
extrahepatic biliary tree.2-3
The usual site of injury in these
cases is at the superior border of
the pancreas, and the injury usually
results in a complete transection of
the common bile duct.2-3 The trans
mission of maximum stress from a
lateral shearing force of blunt trau
ma is thought to occur at the
superior border of the pancreas due
to the relative fixity of the intrapancreatic portion of common bile
duct.2-3 In addition, traumatic de
compression of the gallbladder into
the common bile duct and the resul
tant ductal distension may render
the biliary tree more susceptible to
a lateral shearing force.1-3 Only four
cases have been reported in the

FIG. 2. Schematic diagram of ex
trahepatic biliary system, demonstrat
ing site and extent of injury.

ISOLATED BILIARY-TRACT INJURY

literature involving disruption of
the common bile duct occurring at
its junction with the cystic duct.3’8
We suspect that the injury in our
patient resulted from an avulsion
shearing type of force applied cranially and medially to the distended
common bile duct at its junction
with the cystic duct, when the liver
was displaced by the motorcycle
handlebar.
Isolated injury of the extrahepatic biliary tree from blunt trauma
presents a unique diagnostic chal
lenge. The delay between clinical
presentation and surgical interven
tion in the literature averaged 18 to
24 days.1-3 The lack of overt perito
neal irritation by noninfected bile,
the rarity of the injury and the
insufficient indications all have been
thought to contribute to the de
lay.1' 3 Several radiologic modalities,
including intravenous cholangiogra
phy, HIDA scanning and angiogra
phy have been suggested to aid in
early diagnosis.23'8 Although suffi

cient reports do not yet exist to
document that, we agree with the
suggestion by Michelassi and Ranson3 that ultrasonography and com
puted tomography of the abdomen
followed by a radiologically guided
abdominal paracentesis may be the
most valuable diagnostic proce
dures in making an early diagnosis.
Elevated serum amylase levels in
the paracentesis fluid may represent
a confounding variable. However, in
the hands of those experienced in
ultrasonography or computed to
mography, the diagnostic confusion
should be minimized.
The literature on isolated injury
to the extrahepatic biliary tree by
blunt trauma is scarce and provides
no data on which to make a general
recommendation for surgical treat
ment.1' 5 Therefore, the choice of
surgical repair must be individual
ized according to the clinical sce
nario and the nature of the injury.
There appears to be a consensus on
the treatment of a completely tran

FIG. 3. Intraoperative cholangiogram through T tube immediately after repair.

sected common bile duct.1' 3 Choledochoenteric reconstructions have
provided the best long-term results
by significantly reducing morbidity
and mortality associated with stric
ture formation.1-3-8 Simple axial or
lateral tear, or common bile duct
disruption less than 25% of its
circumference as in our patient can
be successfully repaired primarily,
without significant morbidity and
mortality, with placement of a T
tube and external drainage of the
subhepatic area.38 Given the high
incidence of stricture formation (up
to 55%) and mortality (up to 40%)
attributed to primary end-to-end
anastomosis, any significant bile
duct disruption after blunt trauma
should be repaired with choledochoenteric reconstruction.1-3

FIG. 4. T-tube cholangiogram on post
operative day 7, demonstrating intact
extrahepatic biliary tree with good
flow into duodenum.
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The development of a benign cys
tic lesion in the thymus after radio
therapy for Hodgkin’s disease has
also been reported.9 The lesion is
usually well-circumscribed with an
attenuation value close to that of
water, and gallium scanning is usu
ally negative. The cyst seems to
originate from successful radiother
apy to a thymus previously involved
with lymphoma. With these find
ings most patients can be followed
up without lymphoma therapy or
biopsy.
Recent studies to evaluate the
frequency of thymic changes after
chemotherapy indicated that the
problem is more common than pre
viously thought.4'10 With modern
imaging techniques in the follow-up
of cancer patients, the clinician will
face more cases of thymic changes.
If thymic hyperplasia and benign
thymic cysts are considered in the
differential diagnosis of a mediasti
nal mass recurring after the suc
cessful treatment of a malignant
lesion by chemotherapy or radio
therapy, some patients could be
saved unnecessary suffering. More
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Prognostic Factors in Metastatic
Nonseminomatous Germ Cell Tumours
Paul R. Hanson, MD; Philip Belitsky, MD, FRCSC; Oliver H. Millard, MD, FRCSC; Stan G. Lannon, MD
Objective: To determine predictors of prognostic significance for patients with nonseminomatous
testicular cancer (NSTC) who have advanced disease at the time of presentation.
Design: A chart review with a mean patient follow-up of 5.5 years (range from 0.75 to 13 years).
Setting: University hospitals in Halifax.
Patients: All patients with NSTC, stages II-B, II-C and III. Patients were excluded if the follow-up
status at the time the study closed could not be determined. Thirty-three patients were included in the
study. Current patient status was determined from the clinical charts and personal communication with
the patients or their physicians.
Interventions: All patients received cisplatinum-based chemotherapy. The extent of the disease was
assessed by chest radiography or lung tomography, bone scanning, abdominal computed tomography
or lymphangiography.
Main Outcome Measures: Correlation between levels of /3-human chorionic gonadotropin (BHCG) and
a-fetoprotein (AFP), comparison of duration of symptoms before initial treatment, response to
treatment and survival, and relationship between stage, tumour volume and survival.
Results: The 3-year overall survival rate was 76%. Seven of 18 patients with symptoms for more than
16 weeks died of disease (p < 0.01). Overall complete response was seen in 27 of 33 patients. All initial
nonresponders died. A survival rate of 93% was seen among initial complete responders (p < 0.01). All
seven patients with persistent elevation of BHCG levels (p < 0.001) and the two patients with
persistent elevation of AFP levels (p < 0.01) after the second course of chemotherapy died.
Conclusions: A symptomatic interval of more than 16 weeks, poor response to initial treatment, bulky
retroperitoneal disease, larger volume lung disease and persistently elevated levels of BHCG and AFP
were all indicators of poor prognosis.

Objectif: Etablir quels sont les indicateurs previsionnels possedant une signification pronostique pour
les patients atteints d’un carcinome testiculaire non seminomateux (CTNS) dont la maladie est deja a
un stade avance lorsqu’ils consultent pour la premiere fois.
Conception : Une etude des dossiers de patients avec une periode de surveillance moyenne de 5,5
annees (ecart de 0,75 a 13 ans).
Contexte: Les hopitaux universitaires d’Halifax.
Patients : Tous les patients porteurs de CTNS de stades II-B, II-C et III. Furent exclus de l’etude, les
patients dont 1’evolution de la maladie n’avait pu etre etablie a la fermeture de l’etude. Trente-trois
patients furent inclus. L’etat actuel des malades fut determine a partir des dossiers medicaux et d’une
communication personnels des medecins avec leurs malades.
Interventions : Tous les patients avaient re?u une chimiotherapie comprenant du cisplatine. L’etendue
de la maladie fut evaluee par radiographie thoracique ou tomographie des poumons, scintigraphie
osseuse, tomographie abdominale par ordinateur ou lymphangiographie.
Principaux effets mesures : La correlation entre les taux de /3-gonadotrophine chorionique humaine
(BGCH) et ceux d’a-foetoproteine (AFP), la comparaison entre la duree des symptomes precedant le
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traitement initial, la reponse au traitement et la duree de la survie, et le rapport entre le stade
devolution, le volume de la tumeur et la survie.
Resultats : Le taux de survie global a 3 ans a ete de 76 %. Sept des 18 patients ayant eu un intervalle
symptomatique de plus de 16 semaines sont morts de la maladie (p < 0,01). Pour l’ensemble, une
reponse fut obtenue chez 27 des 33 patients. Tous les patients qui n’ont pas repondu initialement au
traitement sont decedes. On a observe un taux de survie de 93 %chez les patients qui ont eu une
reponse initiate complete (p < 0,01). Les sept patients qui ont presente des taux eleves de BGCH
(p < 0,001) et les deux patients qui ont eu des taux eleves persistants d’AFP apres un second cycle de
chimiotherapie sont decedes.
Conclusions : Un intervalle symptomatique de plus de 16 semaines, une reponse insatisfaisante au
traitement initial, une masse retroperitoneale importante, des atteintes pulmonaires de volume
important et la persistance de taux eleves de BGCH et d’AFP sont tous indicateurs d’un mauvais
pronostic.

atient survival after treatment
for advanced nonseminomatous
testicular cancer (NSTC) has im
proved greatly with recent advances
in treatment.12 The mortality, how
ever, remains at 25% to 30%.1'2 The
extent of the disease is universally
accepted as being the single most
important prognostic factor.1-5
There is no consensus as to which
other factors may identify a patient
as having a poor prognosis. In an
effort to determine if other predic
tors of survival could be found, we
reviewed the charts of all patients
with advanced NSTC treated be
tween 1980 and 1990 at Dalhousie
University hospitals in Halifax. The
following factors were considered:
duration of symptoms before initial
treatment, response to treatment,
retroperitoneal tumour volume, ex
tent of pulmonary metastases, and
/3-human chorionic gonadotropin
(BHCG) and a-fetoprotein (AFP)
levels at the time of diagnosis and
after treatment.

P

tients was 29.7 years (range from
19 to 57 years). The mean duration
of symptoms was the time from the
day that a patient became aware of
symptoms to the day of presenta
tion to a physician, rounded off to
the nearest week. The extent of the
disease was assessed by physical
examination, chest radiography or
lung tomography, or both, bone
scanning and abdominal computed
tomography or lymphangiography,
or both. The mean duration of
follow-up was 5.5 years (range from
0.75 to 13 years). Table I shows the
histologic type of the tumours.
Serum AFP and BHCG levels were
measured at the time of initial pre
sentation and at the start of each
treatment cycle. All patients re
ceived chemotherapy (Table II) with
cisplatin-based drug regimens in
standard 3-week cycles until tu
mour-marker levels had normalized
and there was radiologic evidence
that the tumour had regressed or
disappeared or until the degree of
regression plateaued. The response

to chemotherapy was graded as
follows: complete (disappearance of
all clinical, radiologic and biochemi
cal evidence of disease for at least 1
year), partial (a 50% decrease in
tumour volume and normal AFP
and BHCG levels for at least 6
months) and no response (all other
types of response).
Student’s t-test was used for sta
tistical analysis.

Results
The overall 3-year survival rate
was 76%. Initially, 27 (82%) pa
tients had a complete response to
chemotherapy (Table III), and 6
(18%) patients had no response or a
partial response; all 6 died of dis
ease within 2 years. Nine (33%) of
the 27 patients with initial complete
response had a subsequent relapse
T a b le II. C h e m o th e ra p y R e g im e n s U sed on
3 3 P a tie n ts W ith NSTC B etw e e n 1 9 8 0 and
1990
C h e m o th e ra p y reg im en

Patients and Methods
The charts of the 33 patients
with NSTC, stages II-B (dimension
of retroperitoneal tumour involve
ment of 2 to 10 cm), II-C (dimen
sion of retroperitoneal tumour in
volvement greater than 10 cm) and
III (tumour spread beyond retroperi
toneal lymph nodes),6 were re
viewed. The mean age of the pa
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Table 1. H is to lo g ic T y p e s o f A d v a n ce d
N o n s e m in o m a to u s T e s tic u la r C a n ce r
(N S T C ) in 3 3 P atie n ts

E m b ry o n a l ca n c e r
E m b ry o n a l c a n c e r +
c h o rio c a rc in o m a
T e ra to m a
T e ra to m a + c h o rio c a rc in o m a
P ure c h o rio c a rc in o m a

1 0 (3 0 )
5 (1 5 )
3 (9 )
3 (9 )

C is p la tin , v in b la s tin e ,
b le o m y c in
C is p la tin , c y c lo p h o s p h a m id e ,
v in b la s tin e , b le o m y c in
C is p la tin , v in c ris tin e ,
m e th o tre x a te , b le o m y c in ,
a c tin o m y c in D,
c y c lo p h o s p h a m id e ,
e to p o s id e
C is p la tin , c y c lo p h o s p h a m id e ,
v in b la s tin e , a c tin o m y c in D,
b le o m y c in

T o ta l

3 3 (1 0 0 )

T o ta l

H istologic ty p e

P atien ts ,
no. (% )
1 2 (3 6 )

P atien ts,
no. (% )

2 4 (7 3 )
6 (1 8 )

2 (6 )

1 (3 )
3 3 (1 0 0 )

METASTATIC NONSEMINOMATOUS GERM CELL TUMOURS

after 1 year. Of these, seven (78%)
had a complete response to salvage
chemotherapy or surgery, or both,
and at the closing date of this study
had not had a relapse. A survival
rate of 93% (25 of 27 patients) was
observed in those with a complete
response to initial chemotherapy.
A comparison of mean duration
of symptoms, treatment response
and survival revealed that 7 (39%)
of 18 patients with symptoms for
longer than 16 weeks died com
pared with 1 (7%) of 15 patients
with symptoms for less than 16
weeks (p < 0.01).
The relationship between stage,

metastatic tumour volume and sur
vival is shown in Table IV. Three
deaths (27%) occurred in 11 stage
II patients with aggregate retroperi
toneal disease of 5 cm or more in
diameter; in contrast, no deaths
occurred in the nine stage II pa
tients with an aggregate retroperi
toneal tumour diameter of less than
5 cm (p < 0.01). A 3-year survival
rate of 100% was seen in patients
with unilateral lung metastases less
than 2 cm in diameter, whereas
only one (17%) of six patients with
bilateral lung metastases less than 2
cm survived (p < 0.01).
No significant correlation be

Table III. Response to Treatment and Survival of 33 Patients With NSTC
Initial
response

Relapse

Response to
salvage chemotherapy
and surgery

3-year
survival

Response

No.

%

No.

%

No.

°/o

No.

%

Complete
Partial
None

27
2
4

82
6
12

9/27

33

—

—

7/9
0/2
0/4

78
0
0

25/27
0/2
0/4

93
0
0

Total

33

100

9/27

33

7/15

47

25/33

76

—

—

Table IV. Factors Influencing Survival at 3 Years
Patient survival
Factor
Clinical stage
IIB
IIC
III
Retroperitoneal tumour bulk, cm
Stage II < 5
> 5
Pulmonary metastases, cm
Unilateral < 2
Bilateral < 2
> 2

Patients, no.

No.

%

15
5
13

15
4
6

100
80
46

9
11

9
8

100
73

3
4
6

3
1
1

100
25
17

Table V. Three-Year Survival According to Pretreatment Levels of Serum Tumour Markers
Patient survival
Tumour marker levels
a-fetoprotein, ng/mL
5 -1 0 0
1 0 1 -9 9 9
>1000
/3-human chorionic gonadotropin, ng/mL
2 -1 0 0
101 - 9 9 9
1 0 0 0 -9 9 9 9
> 10 000

Patients, no.

No.

°/o

16
4
5

12
4
4

75
100
80

11
6
5
2

10
4
4
1

91
67
80
50

tween the degree of initially elevat
ed AFP or BHCG levels and survival
was noted (Table V). However, 6
(21%) of 28 patients with persis
tently elevated AFP levels after one
cycle of chemotherapy died of dis
ease. All patients with elevated AFP
or BHCG levels, or both, after two
cycles of chemotherapy died
(p < 0.001). No patient with normal
levels of AFP or BHCG after two
cycles of chemotherapy died of dis
ease (p < 0.05).

Discussion
Several authors have identified
prognostic factors in advanced
NSTC that may identify a patient as
a poor risk.1-2-5 All agree on the
importance of tumour bulk at the
time of diagnosis. However, there is
no general agreement as to which
other prognostic factors are truly
significant.
Among the factors found signifi
cant in our patients was the correla
tion between duration of symptoms
and survival. This has been demon
strated for advanced NSTC patients
in other studies.7-12 The increased
mortality seen with delays in diag
nosis reinforces the importance of
self-examination programs.
Several authors13-16 have studied
the effect of different chemotherapy
regimens on “ poor-risk” groups.
There was no consensus on the
constituents of a “poor-risk” group
in these studies; therefore, it is
impossible to compare the results
accurately. No agreement on the
chemotherapeutic treatm ent of
“ poor-risk” groups has emerged
from these and other studies.
Other factors such as retroperito
neal tumour volume, AFP levels,
number of pulmonary metastases
and visceral organ involvement have
been suggested as characteristics
defining poor-risk patients. Initial
complete response rates of up to
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94% have been found in patients
considered to be “ poor risk” by one
set of criteria but “good risk” by
another.17 Retroperitoneal tumour
volume, number of pulmonary metastases and AFP and BHCG levels
have all been demonstrated to be
significant in other studies.3’41318-22
We found that persistently elevated
AFP and BHCG levels after two
courses of chemotherapy were pre
dictive of a worse prognosis than
when the levels normalized.
Large prospective studies using
multivariate analysis of prognostic
factors are needed to spare goodrisk patients from potentially toxic
chemotherapy and to identify a de
finitive poor-risk group. This study
has helped to provide the basis for
eligibility criteria for such groups.
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T h e Cardiac Surgery Program at the Royal
Columbian Hospital: Review of the First
Fiscal Year
Lynn M. Fedoruk, MD; Keir M. Stewart, MD, FRCSC; Robert I. Hayden, MD, CM, FACS, FRCSC
From a budgetary viewpoint, the authors summarize the operative experience of the cardiac surgery
program at the Royal Columbian Hospital during its first fiscal year of operation. The program was
funded for 250 cardiopulmonary bypass (CPB) procedures: $16 800 per CPB procedure ($4.2 million
for the program). The 250 CPB procedures were performed on 248 patients. The 30-day operative
mortality was 2%. Thirty patients (12.1%) underwent a second operation for complications or delayed
primary closure of the sternum, or both; the complications included aortic prosthetic perivalvular leaks
in 2 patients. Eight patients (3.2%) required insertion of an intra-aortic balloon pump preoperatively to
stabilize their condition; 10 others (4.0%) required intra-aortic balloon pump insertion at surgery to
correct low-cardiac-output syndrome. Blood products were needed for 149 (59.6%) of the 250 CPB
procedures. The average hospital stay was 10.4 days for noncoronary procedures and 9.0 days for
coronary procedures.
Les auteurs resument au plan budgetaire les resultats d’exploitation du programme de chirurgie
cardiaque du Royal Columbian Hospital durant son premier exercice financier. Le programme a refu
des fonds pour 250 pontages aortocoronariens (PAC): 16 800 $ par malade ou 4,2 millions de dollars
pour l’ensemble du programme. Les 250 PAC furent effectues chez 248 patients. La mortalite
operatoire a 30 jours fut de 2 %. Trente patients (12,1 %) subirent une seconde operation pour des
complications ou pour defaut de soudure primaire du sternum, ou pour les deux; parmi les
complications, on a constate des fuites perivalvulaires de la prothese aortique chez deux patients. Huit
patients (3,2 %) ont necessite l’insertion d’une pompe a ballonnet intra-aortique (PBIA) en
preoperatoire pour stabiliser leur etat; 10 autres (4,0 %) ont necessite la PBIA durant l’intervention
pour corriger un syndrome de faible debit cardiaque. Des derives sanguins furent requis pour 149
(59,6 %) des 250 PAC. Le sejour hospitalier moyen fut de 10,4 jours pour les interventions non
coronariennes et de 9,0 jours pour les interventions coronariennes.

ecause of increasing demand,
three new cardiac surgery units
were established in Canada in 1990
and 1991. One of these, at the
Royal Columbian Hospital in New
Westminster, BC, was established
to provide community service rather
than a new teaching program.
In conjunction with the increas
ing demand for cardiac surgical
services there is a demand for great
er fiscal responsibility by all levels
of health care personnel. The goal
for the new heart unit set by the

B

Ministry of Health of British Co
lumbia was to provide 250 cardi
opulmonary bypass (CPB) proce
dures in the first fiscal year, with an
operating budget of $16 800 per
procedure (including bridge fund
ing) — a total of $4.2 million. The
goal of the Royal Columbian Hospi
tal was to provide this care with a
mortality of less than 2%, in a way
that would have minimal impact on
the function of other services in the
institution.
We report on the 250 CPB proce

dures completed between Apr. 1,
1991 and Mar. 31, 1992 — the first
fiscal year of the new cardiac unit.

Background
A number of factors affected the
provincial government’s decision to
open a heart unit at the Royal
Columbian Hospital. An apparent
increase in the elective waiting list
for open heart surgery was of in
creasing concern.1 For several
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months before the government’s de
cision, the medical staff had worked
zealously to draw attention to the
particular needs of the patients at
the Royal Columbian Hospital and
the advantages to government in
locating the heart surgery unit
there. The provincial government
had carried out an independent re
view of the needs for open heart
surgery in the province of British
Columbia; this review identified the
establishment of a cardiac unit at
the Royal Columbian Hospital as an
ideal solution to the need for fur
ther cardiac service in the province.
A nursing strike and severe short
age of perfusion personnel thwarted
the provincial ministry of health’s
efforts to increase the caseload
through additional funding in the
province’s existing heart units. The
increased expenditures did not re
duce the waiting list or increase the
number of procedures performed.
These factors created a climate of
scepticism on the part of both the
Ministry of Health of British Co
lumbia and the medical community
and led to the requirement that the
1st year’s operation of the new unit
must provide evidence of the ability
to achieve mutually acceptable
goals.
The inaugural year was also ex
pected to attract intense scrutiny
from the medical staff of the Royal
Columbian Hospital. They had
given unanimous approval to the
hospital’s medical administration to
establish an open heart surgery
program that would function within
an established budget and not
create demands on the underfunded
critical care areas of the hospital.
The medical community in the
greater referral area was also ex
pected to monitor the surgical out
come of the inaugural caseload out
of genuine concern for the patients.
For these reasons, and to provide
reassuring statistics to the general
community, it was decided to apply
542
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stringent case exclusion criteria for
the inaugural period.

died within 30 days of operation
(Table IV).

Exclusion Criteria

Complications

These criteria essentially exclud
ed patients with known risk factors
that would adversely affect their
surgical outcome. They included
patients requiring heart transplants,
procedures on the thoracic aorta,
repeat cardiac procedures, proce
dures for major congenital cardiac
deformities, emergency procedures
other than cardiac catheterization
and patients who had associated
critical systemic, pulmonary, renal,
cerebrovascular or hemopoietic dis
orders. Verbal agreements made
with established cardiac units in
British Columbia allowed easy refer
ral of these higher-risk patients.
Results
Between Apr. 1, 1991, and Mar.
31, 1992, 250 CPB procedures
were performed on 248 patients
(Table I); 2 required a repeat proce
dure with cardiopulmonary bypass
before discharge from hospital after
the initial operation. Patients were
categorized by age, sex and admis
sion status (Tables II and III).
Times spent by the patients on the
various nursing units and mean
hospital stays were also recorded.
Fifteen patients underwent multi
ple or miscellaneous operations.
Death Rate

Five (2.0%) of the 248 patients

Patients were returned to the
operating room on 30 occasions
because of complications or for fur
ther management. In 16 cases re
opening of a recent sternotomy was
required because of bleeding or
tamponade. Thirteen patients were
returned to the operating room for
delayed primary closure of an open
sternotomy in the management of
low-output syndrome. One patient
was returned to the operating room
for removal of a foreign body (a
piece of chest tube). In two patients
who underwent aortic valve replace
ment, suture line disruption at the
site of the first valve insertion ne
cessitated repeat valve replacement
with CPB. One of these patients
was the recipient of a double valve
implant at the first procedure.
Intra-aortic balloon pumps were
used on 18 patients (7.2%) to en
hance myocardial and systemic per
fusion. In eight cases (3.2%), the
patient arrived in the operating
room with the intra-aortic balloon
pump in situ after it was inserted in
the catheterization laboratory to
stabilize the patient’s condition for
emergency coronary artery bypass
grafting. This practice provided a
smooth transition for the patient
from the catheterization laboratory
to the operating room, allowing for
organized operative intervention.
The remainder of the intra-aortic
balloon pumps were placed intraop-

Table I. Summary of Cardiopulmonary Bypass Procedures Performed During the First Fiscal Year
____________
at the Royal Columbian Hospital, New Westminster, BC
Type of procedure

No.

%

Coronary artery bypass grafting
Aortic valve
Mitral valve
Atrial septal defect
Combined and miscellaneous

196
25
10
4
15

78 4
10 0
40
16
6.0

Total

250

100.0

NEW CARDIAC SURGERY PROGRAM

eratively to manage low-output syn
drome and facilitate weaning from
cardiopulmonary bypass.
One patient had a prolonged hos
pitalization because of dehiscence
of a leg incision. Two patients were
readmitted for sternal wound infec
tion, which required open sternoto
my, operative debridement and pro
longed hospitalization with healing
by secondary intention (0.8% infec
tion); neither of these patients had
delayed primary closure of the ster
num.

149 (59.6%) of the 250 CBP proce
dures (Table V). Overall, 160
(64.5%) patients required two or
less units of blood (99 [39.9%] of
them required no transfusion at all).
Hospital Stay
The average length of hospital
stay was 10.4 days for noncoronary
procedures and 9.0 days for CBP
procedures. This compared with a
national average of 14 days (HMRI
data).

Blood Bank Use

Discussion
During the fiscal year, blood
transfusions were required during

Our cardiac unit consists of two

fully equipped operating rooms,
which were used on alternate days
to complete these procedures and
ensure that the new equipment was
functional in both theatres, a car
diac surgery intensive care unit
(CSICU) with four beds and a ward
component consisting of six patient
beds. The national average of 14
days from HMRI data was used to
budget for length of stay. We
planned for an operative death rate
of 2% or less in our 1st year, based
on our case exclusion criteria. The
30-day death rate was precisely 2%.
Funds were made available for
the open heart surgery program at
the Royal Columbian Hospital in its
first fiscal year from the Ministry of

T a b le II. Results in Patients Who Underwent Coronary Artery Bypass Grafting

S ex
No. of
g rafts
1

2
3
4
5
6
7
8
Total/mean

No. of
p a tie n ts

M ean
age, yr

Adm ission
category

M ean
s ta y

M ean
s ta y

M ean

in
C S IC U , d

on
w a rd , d

h o s p ita l
s ta y , d

M

F

E

U

El

8
26
50
55
37
17
2
1

60.7
60.7
63.3
65.6
65.5
63.1
64.5
68.0

4
20
38
38
29
16
2
1

4
6
12
17
8
1
0
0

2
2
2
3
3
2
0
0

4
15
44
48
31
14
1
1

2
9
4
4
3
1
1
0

3.87
3.07
3.48
3.38
3.62
3.64
3.50
3.00

5.37
5.42
5.38
5.63
5.43
5.70
5.50
6.00

9.42
8.49
8.76
9.01
9.05
9.34
9.00
9.00

196

63.9

148

48

14

158

24

3.45

5.56

9.01

M = male, F = female, E = emergency, U = Urgent, El = elective, Csicu cardiac surgery intensive care unit

T a b le III. Results in Patients Who Required Procedures Other Than Coronary Artery Bypass Grafting
Adm ission
category

S ex
P rin cip al
p rocedure

Mitral valve
Repair
Tissue
replacement
Mechanical
replacement
Aortic valve
Tissue
replacement
Mechanical
replacement
Repair of
atrial septal
defect
Removal of
myxoma
Total/mean

No. of
p a tie n ts

M ean
ag e, yr

M

F

E

U

El

M ean
s ta y
in
C S IC U , d

M ean
s ta y

M ean

on
w a rd , d

h o s p ita l
s ta y , d

3

45.0

0

3

0

0

3

2.33

7.33

9.66

2

80.5

1

1

1

1

0

11.50

3.00

14.50

13

57.6

3

10

1

11

1

5.69

5.84

11.53

3

74.6

1

2

0

3

0

4.00

8.33

12.33

26

66.5

21

5

1

18

7

4.07

6.23

10.30

4

50.0

2

2

0

0

4

2.25

4.20

6.45

1

67.0

0

1

0

0

1

3.00

5.00

8.00

5.70

10.39

52

63.0

28

24

3

34

15

4.69
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Health of British Columbia
($15 077 per CPB procedure) and
from bridge funding provided by the
Royal Columbian Hospital ($1800
per CPB procedure). The total of
$16 800 per procedure was the
total program budget available for
the 1st year of operation and
amounted to $4.2 million. Careful
cost-centre analysis of the actual
money spent during the first fiscal
year indicated that the program had
an operating surplus of $164 887
or $659 per procedure. (Cost cen
tres had been established within
each hospital department to evalu
ate the inaugural year of open heart
surgery experience.) The program
was managed on a month-to-month
basis by a program management
committee, representing key areas
of the hospital administration, and
by the open heart surgery team.
The program management commit
tee was concerned that as case

exclusion criteria were withdrawn,
the narrow operating surplus would
likely preclude a balanced operating
budget for the program. From a
hospital accounting viewpoint, how
ever, the first year’s results were
obtained with the expenditure of
$16 141 per procedure of the
$16 800 funded for each CPB
procedure.
Review of our findings invites a
discussion of the principles of case
selection. It had been our intention
to provide emergency surgery only
to patients who encountered misad
venture during angioplasty proce
dures and that other patients identi
fied for urgent or emergent surgery
would be transferred to the other
institutions that had supported the
catheterization laboratory at the
Royal Columbian Hospital. Within a
few months of the program’s initia
tion, however, the scope of emer
gency support was broadened to

include any patients resident in the
Royal Columbian Hospital whose
anatomy had been defined and who
did not have multisystem disease.
Our intention to avoid repeat sur
gery similarly had to be disregard
ed. Four repeat procedures were,
for various reasons, undertaken in
the 1st year. As the program gained
momentum, the intention to avoid
combined procedures was also dis
regarded, and complicated multipleprocedure cases were included, ac
counting for 6% of the total.
Nevertheless, patient selection
was quite strictly applied to the
candidates for surgery through the
1st fiscal year. The cooperation of
the referring cardiologists at the
Royal Columbian Hospital and the
surgeons working in established
programs at other centres, which
permitted this case selection, must
have acted favourably on the overall
results in terms of morbidity and
mortality. The relatively low use of
intra-aortic balloon pump support
(4.0%) in patients not identified as
candidates for surgery from the
catheterization laboratory also indi
cates the favourable effect of case
selection. This effect is reflected in
the overall length of patient stay in
the unit, and also in the CS1CU, the
costs for which were well below the
budgeted target for the program
that had been based on HMRI stan
dards.
Review of the complications re-

Table IV. Details of Operative Deaths
Patient no.
1

Diagnosis
Critical aortic and mitral
stenosis, ischemic heart
disease
Rheumatic valvular heart
disease
Severe mitral insufficiency
Aortic root aneurysm with
aortic insufficiency
Severe aortic stenosis and
mitral regurgitation,
ischemic heart disease

2
3
4
5

Procedures performed

Postop.
survival, d

AVR, MVR, CABG X 3

11

AVR, MVR
MVR

15
2

Bentail procedure

20

AVR, MVR, CABG X 3

18

AVR = aortic valve replacement, MVR = mitral valve replacement

Table V. Blood Transfusion Requirements
No. of
patients

No. (%) of
procedures with
blood products

RBCs

Platelets

FFP

Cryo.

CABG
AVR
MVR
Atrial septal
defect repair
Combined and
miscellaneous
procedures

196
25
10

112(57.1)
15(60.0)
6 (60.0)

2.22
4.64
4.20

0.23
2.24
2.80

0.62
1.92
2.40

0.21

_

Total/mean

250

Procedure

2.60

4

1 (25.0)

0.25

_

15

15(100.0)

6.00

2.00

9.60

1.00

2.74

0.63

1.34

0.32

149 (59.6)

RBCs = red blood cells, FFP = fresh frozen plasma, Cryo. = cryoprecipitate
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quiring repeat operative interven
tion revealed that of the 30 occa
sions on which this was required,
13 procedures were for delayed pri
mary closure of the sternotomy,
which had been electively packed
open either at the time of the initial
procedure due to low-output syn
drome or at the time of emergency
sternotomy for hemorrhage or for
management of diffuse nonspecific
bleeding. It has been our experience
in many patients requiring intra
aortic balloon counterpulsation for
low-output syndrome that hemody
namics are markedly improved by a
decision to delay sternal closure. It
has also been our experience that
patients returned to the operating
room because of hemorrhage or
tamponade in whom the bleeding
site is not identified are best treated
by packing the sternal incision and
delaying sternal closure for 24 to
36 hours. This technique has not
been associated with an increased
incidence of infection, and we be
lieve it helped to keep our operative
mortality at the expected 2%.
In the two patients who did have
deep sternal wound infection, the
sternum was closed primarily in one
instance. The other patient had
been treated by delayed closure.
Surgical treatment of both cases
was accomplished by immediate re
opening of the entire sternotomy
wound allowing debridement, irriga
tion and packing in the operating
room. Over the following 2 to 3
weeks’ stay in the Royal Columbian
Hospital, these patients were ma
naged by repeated replacment of
the packing three times a day with
sponges soaked in quarter-strength
Dakin’s solution. The patients were
then transferred to another institu
tion for long-term sternal wound
care before being discharged home
to allow healing by secondary inten
tion.
Reoperation for periprosthetic
aortic valve leak was required in

two patients, both of whom had
rheumatic valvular heart disease
with severe annular calcification.
The leaks occurred despite the use
of pledgeted sutures and care taken
to control decalcification of the
heavily calcified annulus.
Sixty-four percent of our patients
could have been managed without
the use of any blood bank products
if there had been a mechanism in
place for preoperative personal
blood donation and storage of two
units. The overall effect of such a
mechanism would have been a net
donation to the blood bank. It is
hoped that such a procedure can be
provided in the future at our hospi
tal.
During the 1st fiscal year of
operation of the new cardiac sur
gery program, approximately twothirds of the patients identified by
the cardiac catheterization laborato
ry at the Royal Columbian Hospital
as candidates for open heart sur
gery were referred to other institu
tions. Some of these referrals were
arranged as we attempted to meet
our case exclusion criteria, but the
bulk of referrals were required be
cause of the overall ceiling on the
program of 250 funded CPB proce
dures. The strains created in the
Department of Cardiac Sciences by
referring two-thirds of the surgical
caseload were considerable, and the
members of the Department will
continue to work with the hospital
administration to expand the pro
gram as additional ministry of
health funding is secured.

Conclusions
The inaugural fiscal year of the
open heart surgery program has
been viewed as successful by the
Ministry of Health of British Co
lumbia, the hospital administration
and the medical staff both within
and referring to the Royal Columbi
an Hospital. The new unit demon

strated that it could function within
a budget (250 procedures budgeted,
250 procedures completed). The
staff in the program were able to
control the demands for emergency
procedures and function within the
program budget. The program op
erated without interfering with
scheduled cases on the main operat
ing room slate and with little impact
on the medical and surgical inten
sive care units or the coronary care
unit. The professional staff directly
involved with the program were
able to work together as a team and
provide morbidity and mortality re
sults that would inspire the confi
dence of colleagues and the com
munity.
Reflection on the principles in
volved in planning for a new open
heart unit at the Royal Columbian
Hospital reinforces that case exclu
sion criteria, even if not 100% appli
cable, were important in achieving
the program’s goals. Other deci
sions, including recruitment and
employment of experienced person
nel responsible for the initial phase
of the program, must be viewed as
another factor responsible for suc
cess. The decision to manage the
funding as a separate program out
side the hospital global budget
gives the opportunity to measure
success in financial terms, namely a
balanced budget. As daunting as
the prospect may be for the person
nel handling the initial caseload, the
anxiety felt by patients having sur
gery in an untested unit must be
even greater. If the experience at
the Royal Columbian Hospital were
to be followed in opening other new
units, the patients should be reas
sured of a satisfactory outcome.
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IM
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IM
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MEAN
MEAN
MEAN
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Gastrointestinal Effects: Close m e d ic a l supervision is re c o m m e n d e d in p a tie n ts
prone to gastrointestinal tract irritation, particularly those with a history of peptic ulcer, diverticulosis or other inflammatory disease of the gastrointestinal tract, In these cases, the physician
must weigh the benefits of treatment against the possible hazards. Patients ta k in g any
NSAID in c lu d in g k e to ro la c tro m e th a m in e should b e instructed to contact a physician
immediately if they experience symptoms or signs suggestive of peptic ulceration or gastroin
testinal bleeding. These reactions can occur a t any time during the treatment. If peptic ulcer
ation is suspected or confirmed, or if gastrointestinal bleeding occurs, ketorolac tromethamine
should be discontinued and appropriate treatment instituted with close patient monitoring.
Renal Effects: As w ith oth er drugs th a t in h ib it p ro sta g la n d in biosynthesis, elevations
of blood urea nitrogen (BUN) and creatinine have been reported in clinical trials with (ketoro
lac tromethamine), Since ketorolac tromethamine and its metabolites are excreted primarily
by the kidney, the following precautions are indicated for patients with: Severely impaired
renal function (serum creatinine values greater than 5 mg/dL, 442 pmol/L): Toradol is not rec
ommended; Moderately impaired renal function (serum creatinine values ranging from 1.9 to
5.0 mg/dL, 168 to 442 pmol/L) - The total daily dose of ketorolac tromethamine should be
reduced by half. In these patients the rate o f ketorolac tromethamine clearance was reduced
to approximately half of normal. Patients who are volume depleted may be dependent on
renal prostaglandin production to maintain renal perfusion and, therefore, glomerular filtration
rate. In such patients, the use of drugs which inhibit prostaglandin synthesis has been associa
ted with further decreases in renal blood flow. Predisposing factors include sepsis, impaired
renal function, heart failure, liver dysfunction, diuretic therapy, and advanced age. Caution is
advised if ketorolac tromethamine is used in such circumstances. Close monitoring of urine out
put, serum urea and serum creatinine is recommended until renal function recovers.
Hepatic Effects: Meaningful elevations (greater than 3 times normal) of serumtransaminases (glutamate pyruvate (SGPT or ALT) and glutamic oxalacetic (SGOT or AST)), occurred in
controlled clinical trials in less than 1% of patients. If clinical signs and symptoms consistent with
liver disease develop, or if systemic manifestations occur (e.g., eosinophilia, rash, etc.), ketoro
lac tromethamine should be discontinued. Patients with impaired hepatic function from cirrho
sis do not have any clinically important changes in ketorolac tromethamine clearance. Studies
in patients with active hepatitis or cholestasis have not been performed.
Fluid and Electrolyte Balance: Fluid retention and edema have been observed in patients
treated with Toradol. Therefore, as with many other NSAIDs, the possibility of precipitating con
gestive heart failure in elderly patients or those with compromised cardiac function should be
considered. Toradol should be used with caution in patients with cardiac decompensation,
hypertension or other conditions which cause a predisposition to fluid retention.
Hematologic Effects: Ketorolac trom etham ine inhibits platelet function and may prolong
bleeding time. It does not affect platelet count, prothrombin time (Pi) or partial thromboplas
tin time (PIT). Unlike the prolonged effects from ASA the inhibition of platelet function by
ketorolac tromethamine is normalized within 24 to 48 hours after the drug is discontinued.
Patients on full anti-coagulation therapy (e.g. heparin or dicumarol derivatives) may be at
increased risk of bleeding if given Toradol concurrently. Thus, the benefit should be weighed
against this risk. The concomitant use of Toradol and heparin (5000 U s.c. BID) appears to be
associated with less risk (see DRUG INTERACTIONS), In patients receiving anticoagulants, the risk
of intramuscular haematoma formation from Toradol IM injections may be increased. In post
marketing experience, postoperative wound haemorrhage has been reported with the use of
Toradol. Therefore, caution should be exercised when strict haemostasis is critical. Toradol IM is

► not recommended as a pre-operative or intra-operative medication because of the risk of
excessive bleeding. Blood dyscrasias associated w ith the use o f NSAIDs are rare,
but could occur with severe consequences.
. Infection: In comm on with other non-steroidal anti-inflam m atory drugs, ketorolac
' tromethamlne may mask the usual signs of infection.
DRUG INTERACTIONS:
Protein Binding: Toradol (ketorolac tromethamine) is highly bound to human plasma
protein (mean 99.2%) and binding is independent of concentration. As ketorolac
tromethamine is a highly potent drug and present in low concentrations in plasma, it would not
be expected to displace other protein-bound drugs significantly. Therapeutic concentrations
► of digoxin, warfarin, acetaminophen, phenytoin, and tolbutamide did not alter ketorolac
tromethamine protein binding.
Anticoagulant Therapy: Prothrombin time should be carefully monitored in all patients
► receiving oral anticoagulant therapy concomitantly with ketorolac tromethamine. Torado! IM
given with two doses of 5000 U of heparin to 11 healthy volunteers resulted in a mean tem
plate bleeding time of 6.4 min (3.2-11.4 min) compared to a mean of 6.0 min (3.4-7.5 min) for
heparin alone and 5,1 min (3.5-8.5 min) for placebo. The in vitro binding of warfarin to plasma
proteins is only slightly reduced by k e to ro la c tromethamine (99.5% control vs. 99.3%)
at plasma concentrations of 5 to 10 pg/mL.
Digoxin: Ketorolac tromethamine does not alter digoxin protein binding.
►
Salicylates: in vitro studies indicated that, at therapeutic concentrations of salicylates
(300 ug/mL), the binding of ketorolac tromethamine was reduced from approximately 99.2% to
97.5% representing a potential two-fold increase in unbound Toradol plasma levels,
>
Enzyme Induction: There is no evidence, in anima! or human studies, th at ketorolac
tromethamine induces or inhibits the hepatic enzymes capable of metabolizing itself or other
drugs. Hence, it would not be expected to alter the pharmacokinetics of other drugs due to
► enzyme induction or inhibition mechanisms.
Probenecid: Concomitant administration of ketorolac tromethamine and probenecid
results in the decreased clearance of ketorolac and a significant increase in ketorolac plasma
► levels (approximately three-fold increase) and terminal half-life (approximately two-fold
increase).
Furosemide: Ketorolac trometham ine reduces the diuretic response to furosemide
► by approxim ately 20% in normovolemic subjects.
Lithium: Some NSAIDs have been reported to inhibit renal lithium clearance, leading to
an increase in plasma lithium concentrations and potential lithium toxicity. The effect of
► ketorolac tromethamine on lithium plasma levels has not been studied.
Methotrexate: The concom itant administration of methotrexate and some NSAIDs has
been reported to reduce the clearance of methotrexate, thus enhancing its toxicity. The
effect of ketorolac tromethamine on methotrexate clearance has not been studied.
Morphine: Intramuscular Toradol has been administered concurrently with morphine
in several clinical trials of postoperative pain without evidence of adverse interactions,
ADVERSE EVENTS:
, ,,,
TORADOL TABLETS: Short-Term Patient Studies - The incidence of adverse reactions in 371
patients receiving multiple 10 mg doses of Toradol (ketorolac tromethamine) for pain resulting
from surgery or dental extraction during the post-operative period (less than 2 weeks) is listed
below, These reactions may or may not be drug related. Incidence between 4 and 9/«:
Nervous system - somnolence, insomnia, Digestive system - nausea. Incidence between 2 and
3%: Nervous system - nervousness, headache, dizziness: Digestive system - diarrhea, dyspep
sia gastrointestinal pain, constipation. Body as a whole - fever. Incidence 1% or Less: Nervous
system - abnormal dreams, anxiety, dry mouth, hyperkinesia, paresthesia, increased sweating,
euphoria, hallucinations; Digestive system - anorexia, flatulence, vomiting, stomatitis, gastritis,
gastrointestinal disorder, sore throat; Body as a whole - asthenia, pain, back pain;
Cardiovascular system: vasodilatation, palpitation, migraine, hypertension; Respiratory system cough increased, rhinitis, dry nose; Musculo-skeletal system - myalgia, arthralgia; Skin and
appendages - rash, urticaria; Special senses - blurred vision, ear pain; Urogenital system:
dysuria,
Long-Term Patient Study - The adverse reactions listed below were reported to be probably
k related to study drug in 553 patients receiving long-term oral therapy (approximately 1 year)
,
with Toradol. Incidence between 10 and 12%: Digestive system - dyspepsia, gastrointestinal
pain.
k
Incidence Between 4 and 9%: Digestive system - nausea, constipation; Nervous system headache. Incidence Between 2 and 3%: Digestive system - diarrhea, flatulence, gastrointesti
nal fullness, peptic ulcers; Nervous system - Dizziness, somnolence; Metabolic/Nutritional disor
der - edema. Incidence 1% or Less: Digestive system - eructation, stomatitis, vomiting, anorex► ia, duodenal ulcer, gastritis, gastrointestinal haemorrhage, increased appetite, melena, mouth
ulceration, rectal bleeding, sore mouth; Nervous system - abnormal dreams, anxiety, depres
sion, dry mouth, insomnia, nervousness, paresthesia; Special senses - tinnitus, taste perversion,
t
abnormal vision, blurred vision, deafness, lacrimation disorder; Metabolic/Nutritional disorder F
Weight gain, alkaline phosphatase increase, BUN increased, excessive thirst, generalized
edema, hyperuricemia; Skin and appendages - pruritus, rash, burning sensation skin; Body as
t
a whole - asthenia, pain, back pain, face edema, hernia; Musculo-skeletal system - arthrai► gia, myalgia, joint disorder; Cardiovascular system: chest pain, chest pain substernal,
migraine; Respiratory system - dyspnea, asthma, epistaxis; Urogenital system - hematuria,
increased urinary frequency, oliguria, polyuria; Hemic and lymphatic - Anemia, purpura,
► TORADOL IM: The adverse reactions listed below were reported in Toradol IM clinical effica
cy trials. In these trials patients (n=660) received either single 30 mg doses (n=151) or multiple
30 mg doses (n=509) over a time period of 5 days or less for pain resulting from surgery.
^
These reactions may or may not be drug related Incidence Between 10 and 13%: Nervous
System - somnolence; Digestive system - Nausea. Incidence Between 4 and 9%: Nervous sys
tem - headache; Digestive system - vomiting; Injection site - injection site pain. Incidence
t
Between 2 and 3%: Nervous System - sweating, dizziness; Cardiovascular system - vasodilata
tion. Incidence 1% or Less: Nervous system - insomnia, increased dry mouth, abnormal
dreams, anxiety, depression, paraesthesia, nervousness, paranoid reaction, speech disorder,
euphoria, libido increased, excessive thirst, inability to concentrate, stimulation; Digestive sys*
tern - flatulence, anorexia, constipation, diarrhea, dyspepsia gastrointestinal fullness, gastroin
testinal haemorrhage, gastrointestinal pain, melena, sore throat, liver function abnormalities,
'
rectal bleeding, stomatitis; Cardiovascular system - hypertension, chest pain, tachycardia,
► haemorrhage, palpitation, pulmonary embolus, syncope, ventricular tachycardia, pallor, flush
ing; Injection site - injection site reaction; Body as a whole - asthenia, fever, back pain, chills,
pain, neck pain; Special senses - taste perversion, tinnitus, blurred vision, diplopia, retinal
w
haemorrhage; Musco-skeletal system - myalgia, twitching; Respiratory system - asthma,
*
cough increased, dyspnea, epistaxis, hiccup, rhinitis; Skin and appendages - pruritus, rash, sub
cutaneous hematoma, skin disorder; Urogenital system - dysuria, urinary retention, oliguria,
increased urinary frequency, vaginitis; Metabolic/nutritional disorders - edema, hypokalemia,
► hypovolemia Hemic and lymphatic system - anemia, coagulation disorder, purpura.
Post-Marketing Experience: The following post-marketing adverse experiences, although
rare (1% or less), have been reported for patients who have received either formulation of Toradol.

t

Renal events - acute renal failure, flank pain with or without haematuria and/or azotemia
Hypersensitivity reactions: bronchospasm, laryngeal edema, hypotension, flushing, rash, and
anaphylactoid reactions, such reactions have occurred in patients with no prior history of
hypersensitivity. Gastrointestinal events - gastrointestinal hemorrhage, peptic ulceration, gas
trointestinal perforation; Hematologic events - postoperative wound haemorrhage, rarely
requiring blood transfusion (see PRECAUTIONS), thrombocytopenia; Central nervous systemconvulsions, abnormal dreams, hallucinations, hyperkinesia, hearing loss; Cardiovascular pulmonary edema; Dermatology - Lyell's syndrome, Stevens - Johnson syndrome, exfoliative
dermatitis, maculopapular rash.
OVERDOSAGE: The absence of experience with acute overdosage precludes characteriza
tion of sequelae and assessment of antidotal efficacy at this time. In a gastroscopic study of
healthy subjects, daily doses of 360 mg given over an 8-hour interval for each of five consecu
tive days (3 times the highest recommended dose) caused pain and peptic ulcers which
resolved after discontinuation of dosing.
DOSAGE AND ADMINISTRATION:
Adults: Dosage should be adjusted according to the severity of the pain and the response
of the patient. Oral: The usual oral dose of Toradol (ketorolac tromethamine) is 10 mg every
4 to 6 hours for pain as required. Doses exceeding 40 mg per day are not recommended.
Toradol is recommended for short-term use only, i.e„ for a maximum of a few weeks.
Parenteral: The recommended usual initial dose is 30 mg. Subsequent dosing may be 10 mg
to 30 mg every 4-6 hours as needed to control pain. It is recommended that the administration
of Toradol IM be limited to short-term therapy (not over 5 days) and the total daily dose should
not exceed 120 mg.
This is because the risk of toxicity appears to increase with longer use at recommended doses
(see WARNINGS and PRECAUTIONS). The administration of continuous multiple daily doses of
Toradol IM has not been extensively studied. There has been limited experience with intramus
cular dosing for more than 3 days since the vast majority of patients have transferred to oral
medication or no longer required analgesic therapy after this time, In the initial post-operative
period, more frequent dosing (e.g. every 2 hours) may be employed but the total daily dosing
should not exceed 120 mg/day, If supplementary analgesia is required, a concomitant low
dose of opiate can be used.
Patients under 50 kg, over age 65 years, or with less severe pain at baseline: the lower end
of the dosage range (10-15 mg 4 times a day) is recommended.
Impaired Renal Function - Moderate - In patients with impaired renal function (serum
creatinine values ranging from 1.9 to 5.0 mg/dL or 168 to 442 pmol/L), the total daily dose of
Toradol should be reduced by half;
Severe - In patients with severely impaired renal function (serum creatinine values greater than
5 mg/dL, or 442 pmol/L) Toradol is not recommended,
Conversion from Parenteral to Oral Therapy: Toradol tablets may be used either as monothera
py or as follow-on therapy to parenteral ketorolac. Toradol IM should be replaced by an oral
analgesic as soon as feasible. When Toradol tablets are used as a follow-on therapy to par
enteral ketorolac, the total combined daily dose of ketoroloc (oral + parenteral) should not
exceed 120 mg on the day the change of formulation is made. Subsequent oral dosing should
not exceed the recommended daily maximum of 40 mg.
Directions for Use of the Prefilled Syringes: Insert the plunger into the syringe barrel and thread
it onto the screw. WITHOUT REMOVING THE NEEDLE GUARD, apply quick, firm pressure to the
plunger to break the inner seal. (You will feel it let go). Pull back on the plunger slightly to
relieve pressure. Remove the needle guard by twisting as you pull. Use the unit as you would a
normal syringe. Dispose of properly. Single use only. Discard Unused Portions. Parenteral drug
products should be inspected visually for particulate material and discoloration prior to use.
Toradol (ketorolac tromethamine) is a Schedule F drug.
Stability and Storage Recommendations:
Toradol Tablets: Store at room temperature with protection from light.
Toradol IM: Store at room temperature with protection from light.
Availability of Dosage Forms: Toradol (ketorolac tromethamine) is available as 10 mg white
round film coated tablets containing ketorolac tromethamine, microcrystalline cellulose, lac
tose and magnesium stearate with one side printed in red with TORADOL inside bold T and
other side with Syntex, Toradol (ketorolac tromethamine) 10 mg tablets are available in bottles
of 100 and 500 tablets,
Toradol IM is available in 1 mL ampoules (trays of 10) containing 10 or 30 mg/mt.
Torado! IM is also available in 1 mL syringes (1 / box) containing 15 or 30 mg/mL.
Product Monograph available on request,
References: 2. TORADOL Product Monograph, Syntex ln c„ Dec. 1992. 3. Rooks WH II.
Pharmacother 1990; 10(6 Pt 2):30S-32S. 4. Yee JP et ai. Pharmacother 1986; 6(5):253-61.5. Brown
CR et al. Pharmacother 1990; 10(6 Pt 2):45S-50S. 6. O'Hara DA et al. Clin Pharmacol Ther 1987;
41:556-61.7. Fragen RJ. Data on File, Syntex Inc., Document CL3837,1987.8. Cherry C et al. Data
on File, Syntex Inc., Document CL3835, 1987. 9. Stanski DR et al. Pharmacother 1990; 10(6
Pt 2Y40S-44S. 10. Data on File, Syntex lnc„ Document #90027-1, 1989, 13. Stahlgren L. Data on
File, Syntex Inc., Document RS-37619, 1991. 16. Data on File, Syntex, Document #90027-2,1989.
17 Forbes JA et al. Pharmacother 1990:10(6 Pt 2);77S-93S. 18. Forbes JA et al. Pharmacother
1990; 10(6 Pt 2):94S-105S. 21. Data on File, Syntex Inc., Document #90027-3, May 1990,
22 Mehlisch D et al. Data on File, Syntex lnc„ Document CL3686, 1986. 23. Oosterlinck W et al,
J Clin Pharmacol 1990; 30: 336-41. 24. Cutting CJ et al. Data on File, Syntex Inc., Document
CL4740, 1989.25. Diebschlag W and Nocker W. Data on File, Syntex Inc., Document CL5468,
1990 26 Molinie J et al. Data on File, Syntex Inc., Document CL4624,1988.27, Herrera JMC et al.
Data on File, Syntex Inc., Document CL4886, 1989. 30. American Pain Society, Principles of
Analgesic Use in the Treatment o f Acute Pain and Cancer Pain, 3ra edition, 1992, 36. Hutteman
W et al Data on File, Syntex Inc., Document CL4882,1989.38. Bloomfield S et al. Pharmacother
1986 6(5)'247-52. 39. Sunshine A et al. Data on File, Syntex Inc., Document CL3674, 1986.
46 Vanqen 0 et al. J Int Med Res 1988;16:443-51. 48. Brown J. Clin Pharmacol Ther 1993:53:222.
52 Cataldo PA et al. Surg Gynecol Otos/e# 1993; 176:435-8. 54. Inklaar H et al. Data on File, Syntex
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ORIGINAL ARTICLES

Thoracoscopic Intracavitary Drainage
for Pneumothorax Secondary to Bullous
Emphysema
John D. Urschel, MD, FRCSC; William J. Dickout, MD, FRCPC
Most patients with spontaneous pneumothorax secondary to bullous emphysema are successfully
managed by chest-tube drainage. Occasionally a very large air leak prevents full lung expansion. The
authors report on a patient in whom thoracoscopic intracavitary drainage of a leaking bulla led to rapid
resolution of the pneumothorax and obliteration of the bulla. A large bronchopleural fistula was
converted to a controlled bronchocutaneous fistula. The authors conclude that when conventional
management fails to provide full lung expansion in cases of pneumothorax secondary to bullous
emphysema, thoracoscopic intracavitary drainage is useful.

La plupart des patients qui subissent un pneumothorax spontane secondaire a un emphyseme bulleux
sont traites avec succes par drainage thoracique. Occasionnellement, une fuite d’air tres importante va
empecher l’expansion complete du poumon. Les auteurs decrivent un cas de ce genre oil un drainage
intracavitaire par thoracoscopie de la bulle responsable de la fuite a resulte en une resolution rapide du
pneumothorax et en l’elimination de la bulle. Une importante fistule bronchopleurale fut transformee
en une fistule bronchocutanee controlee. Les auteurs concluent que, quand le traitement traditionnel
ne suffit pas a permettre l’expansion complete du poumon dans les cas de pneumothorax secondaire a
un emphyseme bulleux, le drainage intracavitaire par thoracoscopie est utile.

losed chest-tube drainage is the
treatment of choice for patients
with pneumothorax secondary to
bullous emphysema. We describe a
patient in whom we used a thoraco
scopic modification of an old tech
nique to manage the pneumotho
rax. We discuss the place of this
modified technique, intracavitary
drainage, in the management of
pneumothoraces that do not re
spond to conservative treatment.

C

Case Report
An 84-year-old man with a histo

ry of smoking and chronic obstruc
tive pulmonary disease presented
with chest pain and dyspnea. Chest
radiography showed a left pneumo
thorax and a bulla in the lower lobe
of the left lung (Fig. 1). Insertion of
a chest tube resulted in only tran
sient lung expansion. A massive air
leak, subcutaneous emphysema and
collapse of the lung required inser
tion of a second chest tube. Pleurodesis with tetracycline was unsuc
cessful. After 12 days of chest-tube
drainage, the pneumothorax and air
leak persisted.
Left thoracoscopy was performed
under general anesthesia. A rup

tured bulla was found in the lower
lobe of the left lung. Because of the
size of the bulla, intracavitary drain
age was favoured over endoscopic
stapling. The bulla was “ pursestringed" with an absorbable su
ture, and a large Foley catheter was
inserted. Two pleural chest tubes
were inserted, and the bulla was
brought up to the chest wall by
gentle traction on the inflated Foley
catheter. Air leak from the pleural
tubes ceased within 24 hours, and a
postoperative radiograph showed
lung expansion. A large air leak
was noted from the intracavitary
Foley catheter. The pleural tubes
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were removed after several days
(Fig. 2). Despite the presence of a
persistent small air leak from the

sumed to be present. The bronchocutaneous fistula quickly closed,
and the pneumothorax did not re
cur.

intracavitary tube, it was removed
on the 10th postoperative day be
cause pleural symphysis was as-

Discussion

F1G. 2. On 7th postoperative day pneumothorax has resolved. Position of
intracavitary drainage tube is shown by balloon filled with contrast material.

Most pneumothoraces secondary
to bullous emphysema resolve with
a combination of chest-tube drain
age and patience. If the lung cannot
be expanded by pleural drainage,
surgical intervention is necessary.
Many of these patients are elderly
and have poor pulmonary function
so they are not candidates for tho
racotomy and excision of the bullae.
Minimally invasive thoracoscopic
techniques are preferred. These
techniques include ligation of the
bullae,1 laser or cautery ablation of
the bullae23 and endoscopic sta
pling. Thoracoscopic approaches to
pleural symphysis, such as pleural
abrasion, pleural cautery or laser
pleurodesis,4 pleurectomy1 and talc
poudrage,5 are useful if the lung
can be expanded.
T horacoscopic intracavitary
drainage is a modification of Monaldi’s two-stage procedure for tuber
culous cavities.6 Intracavitary drain
age has proved successful in the
elective treatment of selected symp
tomatic patients with bullous lung
disease.7 In the case we have de
scribed, intracavitary drainage re
sulted in prompt resolution of the
pneumothorax and obliteration of
the bulla. A large bronchopleural
fistula was converted to a controlled
bronchocutaneous fistula. This al
lowed lung expansion and facilitat
ed the development of pleural sym
physis. The bronchocutaneous fis
tula closed spontaneously after re
moval of the intracavitary tube.
When conventional methods of
management fail, thoracoscopic in
tracavitary drainage is a useful op
tion in the treatment of selected
patients with pneumothorax sec-
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ondary to bullous emphysema.
Large bullae are particularly suit
able for intracavitary intubation.
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SESAP VII Critique / Critique SESAP VII
Item 241
Iatrogenic vascular injuries are an increasingly common event in hospital practice. Invasive diagnostic and
therapeutic interventions create situations in which vascular disruption or thrombosis can create acute ischemia,
hemorrhage, or neurologic deficit. Although the location of the vascular injury and the presence of preexisting
atherosclerotic disease may complicate the repair, a delay in surgical intervention is the dominant factor in
predicting permanent disability. That permanent disability is usually a result of the peripheral ischemic
neurologic deficit. Prompt reversal of the peripheral ischemia lessens the likelihood of permanent neurologic
damage.

B
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P ica in the Mentally Handicapped: a 15 -Year
Surgical Perspective
Chris J. Decker, MD, FRCSC
Objective: To review the general surgical management of mentally handicapped persons with pica.
Design: A study of hospital records and a review of the current literature.
Setting: A community hospital.
Patients: Thirty-five patients from a large institution for the mentally handicapped were treated for
well-documented pica on 56 occasions at the Orillia Soldiers Memorial Hospital between 1976 and
1991.
Interventions: Endoscopy and laparotomy for the removal of foreign bodies or to close perforations.
Results: Fourteen (25%) cases of pica were managed by observation only, but 42 (75%) cases required
surgical intervention. There were 34 laparotomies. The complication rate was 30% and the death rate
11%.

Conclusions: Pica is a serious health risk for mentally handicapped patients. Diagnosis and
postoperative care can be difficult. Pica should be suspected in mentally handicapped patients with
gastrointestinal symptoms.

Objectif: Revoir le traitement chirurgical des handicapes mentaux souffrant de pica.
Conception : Une etude des dossiers d’hopitaux et une revue de la litterature actuelle.
Contexte : Un hopital communautaire.
Patients : Trente-cinq patients d’un important etablissement pour handicapes mentaux furent traites
pour une pica bien etablie, en 56 occasions, au Orillia Soldiers Memorial Hospital, entre 1976 et 1991.
Interventions : Des endoscopies et des laparotomies effectives pour retirer des corps etrangers ou pour
refermer des perforations.
Resultats : Quatorze cas (25 %) de pica furent traites par simple observation mais 42 cas (75 %)
necessiterent une intervention chirurgicale. II y eut 34 laparotomies. Le taux de complications fut de
30 % et la mortality, de 11 %.
Conclusions : La pica represente une menace serieuse pour la sante des handicapes mentaux. Le
diagnostic et les soins postoperatoires peuvent presenter de grandes difficultes. La pica doit etre
soupconnee chez les handicapes mentaux qui presentent des symptomes gastro-intestinaux.
ica is a pathologic craving for
normal food constituents or for
substances not commonly regarded
as food. First defined by Ambrose
Pare in the 16th century, pica is the
Latin word for magpie, a bird
known for its proclivity to pick up
multiple things to satisfy its hunger
or curiosity.1

P

Pica may be seen in four sets of
circumstances: nutritional disor
ders, social or cultural mores, men
tal illness and mental handicap. The
major nutritional disorder is iron
deficiency anemia, which results in
the ingestion of many unusual sub
stances such as ice, clay, starch or
lead.2 Cultural practices may in

volve geophagia (darth eating),
which is endemic throughout the
world and is valued as an adjunct to
religious or magical beliefs in some
areas.3 Among mentally ill people,
long-term schizophrenics or those
with marked personality disorders
may indulge in pica.4
Pica is said to be the m ost fre-
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quently seen eating dysfunction in
the mentally handicapped. Danford
and Huber5 studied 991 institution
alized patients over a 2-year period
and found a 25% incidence of pica.
It became less frequent as age in
creased and the level of retardation
decreased. Food pica was most fre
quently found in borderline retarded
patients, whereas non-food pica in
creased with the severity of retarda
tion.
The practice of pica was deliber
ate in every case, and in 56% specif
ic items such as cigarette butts
were preferentially sought. Some
researchers believe that pica is re
lated to a patient’s inability to dis
criminate between edible and inedi
ble items, with an infantile hand to
mouth response.6 A small group of
patients may suffer from specific
brain disorders in the left temporal
lobe or amygdala, and this can
cause faulty eating patterns.1
Patients confined to large institu
tions for the mentally handicapped
provide an opportunity to study this
behaviour. Nearby community gen
eral hospitals are called upon to
provide surgical care. Orillia Sol
diers Memorial Hospital (OSMH)
provides surgical services to the
Huronia Regional Centre (HRC), a
large institution for the mentally
and physically handicapped. In this
paper we report our experience with
pica in patients from HRC.

Patients and Methods
A retrospective study of OSMH
records from Jan. 1, 1976, to Dec.
31, 1991, identified those patients
who presented from HRC with doc
umented pica, foreign bodies in the
gastrointestinal tract, bowel ob
struction, peritonitis or perforation
with transfer from another institu
tion. Patients who underwent lapa
rotomy after transfer from another
institution were also reviewed. Ex
552

cluded from analysis were patients
who presented with aspiration of
foreign bodies and normal pediatric
patients with foreign bodies. The
HRC records of patients with pica
transferred to OSMH were also
analysed.
Numerous patients from HRC
presented to the emergency depart
ment of OSMH with an acute abdo
men. Although many were suspect
ed of pica they were excluded from
the study if the pica was not clearly
documented radiographically, if for
eign bodies were not recovered or if
ingestion was not witnessed. The
data assessed included sex, age,
clinical presentation, hemoglobin
level and leukocyte count, radiolog
ic findings, operative findings, type
of operation, postoperative compli
cations or death, other diagnoses,
time from clinical onset to surgery
and time of year treated.

Findings
From 184 cases identified, 56
cases of documented pica in 35
different patients (31 male, 4 fe
male) were treated at OSMH; 21
patients had repeat incidents. The
patients ranged in age from 15 to
48 years (median 23 years). All
patients were moderately to severely
retarded and were usually physically
handicapped also. Sixteen patients
(46%) were epileptic and were tak
ing antiepileptic medications. Two
had Down’s syndrome, and one
each had microcephaly, tuberous
sclerosis, Prader-Willi syndrome
and congenital rubella. None was
anemic. In eight cases (14%) the
patient presented with impaction in
the oropharynx or esophagus. The
presenting signs were excessive sal
ivation with choking or agitation.
In 5 cases (9%) there was gastric
outlet obstruction and in 22 cases
(39%) there was small-bowel ob
struction.
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In nine cases (16%) the patient
had peritonitis from acute perfora
tion of the gastrointestinal tract:
five in the small bowel, three in the
large bowel and one in the stomach
(Table 1).
Five patients had asymptomatic
large foreign bodies in the stomach.
These were removed when the for
eign body failed to pass after a
minimum of 5 to 7 days’ observa
tion or if the foreign bodies were
too large to be removed endoscopically.
Twenty (36%) of the 56 cases of
pica occurred in August and Sep
tember.
Fourteen (25%) cases were treat
ed nonoperatively. In nine cases
there was incomplete small-bowel
obstruction. In two cases, the pa
tients were seen to ingest foreign
bodies but had no symptoms, and in
two other cases, asymptomatic pa
tients were found to have foreign
bodies on the x-ray film. One pa
tient presented in septic shock and
died.
In three cases foreign bodies
were removed from the posterior
oropharynx or hypopharynx laryngoscopically. In another five cases
esophagoscopy was required for re
moval of foreign bodies.
Thirty-four laparotomies were
carried out: 9 involved simple gastrotomy and removal of foreign bo
dies and 12 involved enterotomy or
colotomy, or both. In three cases,
T a b le 1. C lin ic a l P re se n ta tio n o f P ica
( / V = 56)
D iagnosis
Im p a c tio n in e so p h a g u s
o r h y p o p h a ry n x
G a s tric o u tle t o r s m a ll-b o w e l
o b s tru c tio n
P e rfo ra tio n
A s y m p to m a tic , fa ilu re o f
fo re ig n -b o d y passage
O b serve d pica, a s y m p to m a tic
G a s tro in te s tin a l h e m o rrha g e
In te s tin a l m a s s
T o ta l

C ases, no.
(»/o)

9 (1 6 )
2 7 (4 8 )
9 (1 6 )
5 (9 )
4 (7 )
1 (2 )
1 (2 )
5 6 (1 0 0 )

PICA IN MENTALLY HANDICAPPED

foreign-body perforation of the in
testine was treated by simple clo
sure. In seven (21%) of the laparot
omies the patient required bowel
resection for removal of long-stand
ing foreign bodies that could not be
removed by simple enterotomy, for
gross perforation of the intestine
and, in one case, for removal of a
mass of unknown nature, proven on
later pathological examination to be
a foreign body. In two cases, the
patient required partial gastrecto
my, for bleeding in one case and for
perforation in the other. In one
case, the patient had lysis of adhe
sions and milking of a foreign body
into the large bowel. The foreign
body then passed with no further
complication.
The types of foreign bodies re
moved were variable, but plastic
was the most common, being recov
ered in 26 cases (46%) (Table II).
There were 17 in-hospital compli
cations or deaths (30%). Four pa
tient died (11%). One sustained a
massive upper gastrointestinal he
morrhage after endoscopic removal
of a piece of leather. Autopsy re
vealed erosion of a pulmonary ar
tery causing exsanguination. Two
patients died of septic shock after
free perforations and generalized
peritonitis. The fourth patient who
died was moribund on arrival in the
Emergency Department and died
there. Autopsy revealed acute bowel
obstruction and acute tubular ne
crosis of the kidneys. There were
four cases of prolonged ileus be
yond 7 days. There were four in
T a b le II. F o re ign B o d ie s R e co ve re d
B ranches
C anvas
G loves
H air ro lle rs
Hard p la s tic
J a r to p s
K eys
M a rb le s
M eta l fo il
P la stic bags

P ieces o f c lo th
R aw p o ta to e s
R ings
S h o e la c e s
S to n e s
S ty ro fo a m
T o o th p ic k s
T o w e ls
W o o d e n b a lls
W o o d e n s p a tu la

hospital wound infections, two
cases of postoperative urinary tract
infection, two cases of pneumonia
and one seizure. Four cases of
small-bowel obstruction developed
from 7 days to 4 months postoperatively.

Discussion

The gastrointestinal tract has a
remarkable ability to pass most ob
jects that enter it: 80% to 90% of all
foreign bodies will pass, given
time.7 Although the HRC has 668
patients, over a 15-year period only
56 cases of documented pica re
quired assessment or treatment at
OSMH. If estimates of 25% inci
dence are correct, then far more
pica takes place at chronic care
institutions than is encountered at
acute care hospitals. Since foreign
bodies were recovered endoscopically in only 9 (16%) of the 56 cases,
the other objects, some of which
were very large (towels, gloves,
plastic bags), passed uneventfully
through the esophagus and in some
cases the pylorus also.
The gastroesophageal junction,
pylorus, distal ileum and rectosig
moid are the narrowest areas in the
gastrointestinal tract,8 but these
were not the only areas of obstruc
tion noted, probably because of the
size or sharpness of some of the
objects.
In addition to mental handicap,
the patients in this study, exhibited
multiple skeletal deformities and
motor and sensory impairment, and
were taking numerous medications,
so history taking and physical ex
amination could be extremely diffi
cult. Illness is suspected when
symptoms of vomiting, distension,
prolonged constipation, irritability
and fever are noted. Attendants
who know the patient are crucial to
the assessment. Patients can be
combative, irritable or show no re

sponse to stimuli that would make
normal patients extremely uncom
fortable. Symptomatology does not
always correlate with the advanced
condition sometimes encountered.
The physician must rely on labora
tory and radiologic data for diagno
sis. However, of the 34 cases in
which laparotomy was performed,
foreign bodies could be seen in only
12 (35%) of the plain x-ray films. In
19 patients the development of
symptoms preceded laparotomy by
more than 24 hours. Although in
five cases the patient was observed
to see if the foreign body would
pass, 14 (41%) laparotomies were
delayed because of some doubt
about diagnosis. Aerophagy is com
mon in the mentally handicapped,
hence presentation of patients in
the emergency department with ab
dominal distension, vomiting and
air fluid levels demonstrated radiologically is encountered relatively
frequently.
The complication and death rate
was 30%. Most complications were
relatively minor but did point out
the difficulties with these patients
in the postoperative period. Their
lack of cooperation resulted in na
sogastric tubes and intravenous
catheters being removed by the pa
tient. Chest physiotherapy can be
impossible. Most of our patients
were young and did recover, but
the death rates of 11% in this
series, 25% reported by Voitk9
and 33% reported by Teimourian,
Cigtay and Sm yth10 em phasize
that pica is a significant compli
cation in this population.
Although anemia is a known
causal factor in pica, no evidence of
this was found in the HRC patients,
the mean hemoglobin level being
144 g /L (range from 122 to
191 g/L ). Sixty percent of patients
were on antiepileptic medication,
but this has never been implicated
as a cause of pica in patients of
normal intelligence.
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Although institutional staff at
tempt to prevent pica by placing
high-risk patients in special wards,
it is virtually impossible to prevent
all cases.
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Noncemented Stem Tibial Component
in Total Knee Replacement: the 2- to 6-Year
Results
Hugh U. Cameron, MB, ChB, FRCSC;* Young B. Jung, MDt
Objective: To determine if the addition of a stem to the tibial component in noncemented total knee
replacement affects sinkage of that component or micromotion.
Design: A cohort of 176 consecutive cases with no exclusions. Follow-up ranged from 2 to 6 years.
Setting: A university-affiliated institution specializing in elective orthopedic surgery.
Participants: All 176 patients had arthritis of the knee, mainly osteoarthritis. All agreed preoperatively
to prolonged postoperative follow-up.
Intervention: Noncemented total knee replacement with the Tricon M long-stem tibial component.
Main Outcome Measures: Hospital for Special Surgery rating system for clinical results and degree of
tibial sinkage and stem lucency seen radiologically.
Results: Eight (4.5%) of the 176 prostheses required revision, none for sinkage. Of the remaining 168
knees, 156 (92.9%) scored good or excellent, 6% fair and 1.2% poor. Sinkage occurred in 3%, but was
not of sufficient severity to require revision. No lucency was visible in 33.8% of stems, partial lucency
in 62%, complete lucency with the lines being parallel to the stem in 3.5% and complete lucency with
divergent lines, indicating a loose implant, in 1.7%. Lucency, when present, was seen mainly in the
lateral view, seldom in the anteroposterior view. There was no correlation between radiologic results
and clinical results.
Conclusions: The addition of a metaphyseal stem reduces the incidence of sinkage of the tibial
component in total knee replacement. The stem largely solves the problem of mediolateral micromotion
but does not completely prevent anteroposterior micromotion.

Objectif: Determiner si 1’addition d’une tige a la partie tibiale d’une prothese totale non cimentee du
genou affecte l’affaissement de la partie tibiale de la prothese ou les micromouvements du tibia.
Conception : Une cohorte de 176 cas, sans exclusions. La periode de surveillance s’etend sur 2 a 6 ans.
Contexte : Un etablissement universitaire specialise en chirurgie orthopedique non urgente.
Participants : Les 176 patients souffraient tous d’une atteinte arthritique du genou, principalement
d’arthrose. Tous avaient accepte avant l’operation de participer a un suivi prolonge.
Intervention : Arthroplastie totale non cimentee du genou avec la composante tibiale Tricon M a
longue tige.
Principaux effets mesures : Evaluation des resultats cliniques a l’aide du systeme «Hospital for Special
Surgery# et degre d’affaissement du tibia et d’espacement de la tige visible a la radiographie.
Resultats : Huit (4,5 %) des 176 protheses ont necessite une revision, aucune pour affaissement. Des
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168 autres genoux, 156 (92,9 %) ont donne des resultats bons ou excellents, 6 %des resultats moyens
et 1,2 /&, de mauvais resultats. Un affaissement est survenu dans 3 % des cas mais il ne fut jamais assez
important pour necessiter une revision. Aucun espacement n’est apparu pour 33,8 %des tiges, un
espacement partiel a ete vu dans 62 %des cas, un espacement complet avec parallelisme des lignes avec
la tige dans 3,5 %des cas, et un espacement complet avec divergence des lignes indiquant une prothese
flottante dans 1,7 %des cas. L’espacement pouvait etre visualise surtout en vue laterale, rarement en
vue anteroposterieure. On n’a note aucune correlation entre les resutats radiologiques et cliniques.
Conclusions : L’addition d’une tige metaphysaire reduit la frequence de l’affaissement de la partie
tibiale d’une prothese totale du genou. La tige resolut en grande partie le probleme des
micromouvements mediolateraux mais ne previent pas totalement les micromouvements
anteroposterieurs.

oncemented total knee replace
ment is now well established,
although the majority of reported
studies have a short follow-up.1-5
Some concern exists about fixation
of the noncemented tibial compo
nent.6-7 It has been shown experi
mentally with micromotion studies8
and pressure-sensitive-plate film
studies9 and clinically in one roent
gen stereophotogrametric analysis
of a small number of cases10 that
the addition of a stem to the tibial
component significantly increases
initial stability. This in turn may
reduce the incidence of tibial sinkage and the extent of micromotion,
which is a potent cause of failure of
bone ingrowth into porous metal
components.1
Tibial sinkage in noncemented
total knee replacement usually oc
curs within 2 years and most often
in the first 6 months to 1 year.11
We believed that there were enough
cases of a noncemented ingrowth
stem tibial component with a fol
low-up longer than 2 years to allow
meaningful examination of tibial
sinkage.
Micromotion is difficult to study
on clinical x-ray films. Unless an
image intensifier is used to ensure
an edge-on shot of the tibial base
plate, radiolucency, which is an
indicator of micromotion, is always
underestimated: a variation in the
beam angle of only 3° will obscure
a radiolucent line.12 Radiolucency
surrounding a stem prosthesis, as
for example a hip stem, is not
nearly as sensitive to minor changes

N
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in beam angle and rotation. Mi
cromotion of the stem of the tibial
component can occur in three
planes: rotation, anteroposterior
toggle and medial lateral toggle. By
a comparison of anteroposterior and
lateral x-ray films of the stem tibial
component we felt useful informa
tion could be obtained about the
relative incidence of anteroposterior
and medial lateral micromotion.
Therefore, all Tricon M (Richards
Manufacturing Co., Memphis,
Tenn.) long-stem total knee replace
ments carried out by the senior
author (H.U.C.) were studied pro
spectively. We believed that this
approach would eliminate variables
in surgical technique and postoper
ative management.

Patients, Materials and
Methods
The 202 patients ranged in age
from 47 to 83 years (mean, 69.5
years). Eight patients had rheuma
toid arthritis, two had post-traumat
ic arthritis, three had Paget’s dis
ease13 and one had avascular necro
sis. The remainder had primary os
teoarthritis.
There were 212 knees: bilateral
replacements were done with an
identical knee (Tricon M prosthesis)
in 10 patients and with another
type of knee in 56 patients. All
numbers will refer to knees with
Tricon M replacements only and bi
laterality will be ignored.
Thirty-six knees (17.0%) were
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lost to follow-up: 10 (27.8%) of
them were placed in patients who
died within 2 years of replacement.
Of the remaining 176 knees, 134
were replaced in women and 42 in
men. Thirty-seven knees (21.0%)
had been operated on previously
(22 high tibial osteotomies, 6 total
knee revisions, 2 unicompartmental
knee replacements, 2 Girdlestone
procedures, 2 fusions, 1 procedure
for supracondylar fracture, 1 for
supracondylar osteotomy and 1 Maquet procedure (elevation of tibial
tubercle). The replaced knees were
evaluated at 3 months and 6
months after placement and annual
ly thereafter. They were rated ac
cording to the Hospital for Special
Surgery rating system.14 Patients
were examined radiographically by
1-m standing anteroposterior, later
al and skyline views of the knee.
The follow-up ranged from 2 to 6
years (mean, 3.5 years).
The Prosthesis
The Tricon M prosthesis, a po
rous coated total knee replacement,
is designed for use without bone
cement. The stem design chosen
was wide in the sagittal plane to
resist medial lateral loads. It was
cut in the shape of an I-beam to
minimize bone resection. It was
designed to approach the posterior
tibial endosteal cortex to prevent
anterior sinkage of the tibial com
ponent. It was highly polished to
prevent osseointegration.
Initially, the stem was straight

TOTAL KNEE REPLACEMENT

posteriorly, but five crack fractures
of the posterior tibial cortex oc
curred in the 1st year of use. (These
cases have been included in this
study.) Thereafter, the stem was
bevelled to slide down the posterior
cortex, and no further fractures
have occurred (Fig. 1).

Insertion Technique
The tibial plateau was cut at
right angles to the long axis of the
tibia and the distal femur in 7° of
valgus. The ligaments were careful
ly balanced, releasing the structures
in the concave side of the deformi
ty. The tibial components trials
were sized and positioned to give
maximum tibial coverage, and when
trial reductions were complete, the
hole for the central tibial stem was
punched out.
Most patients were allowed imme
diate, full weight bearing. Those
with tibial crack fractures or bone
grafts larger than 2 cm2 were re
stricted to touch weight bearing for
4 to 6 weeks.
All patellae were resurfaced.

was parallel to or divergent from
the stem. The lucent line was grad
ed after the fashion of Engh15 as
modified by Dorr for noncemented
total hip replacement:16 type IA rep
resents no lucency; type IB repre
sents partial lucency (Fig. 2); type 11
represents complete lucency with
the lucent lines parallel to the stem;
and type III represents complete lu
cency with the lucent lines diver
gent from the stem (i.e., the tibial
component exhibits macromotion
and is therefore loose [Fig. 3]).

Evaluation of the Prosthesis
Sinkage was measured on serial
anteroposterior x-ray films. A verti
cal line was drawn on the long axis
of the tibia and a horizonal line to
some recognizable feature, usually
the top of the fibular head. Another
line was drawn along the base of
the metal tibial tray, and the differ
ence between these two lines mea
sured. After several measurement
sessions on serial x-ray films, we
decided that only sinkage of more
than 3 mm could be measured reli
ably.
The stem was examined radiologically in anteroposterior and lateral
views. Any bone change, a visible
lucent line or a linear increase in
bone density adjacent to the stem
was counted as lucency, except for
changes at the absolute stem tip.
Lucency was divided into partial
lucency, when the lucent line was
only seen around part of the stem,
and complete lucency, when the
lucent line extended around the
whole stem. Note was made of
whether the complete lucent line

Results

FIG. 1. Stem on this tibial component is bevelled to slide down posterior tibial
cortex, giving added resistance to anterior sinkage of tibial component. Stem is
wide in sagittal plane to give medial lateral resistance.

Of the 176 knees available for
2-year follow-up, 8 (4.5%) were re
vised. The reasons for revision were
as follows: sepsis in four knees
(three early and one late), lost skin
and subcutaneous tissue over the
anterior aspect of the knee and
subsequent dislocation of the knee
in one patient, sticking of the origi
nal stem of the prosthesis before
complete seating in one knee, patel
lar wear in one knee and patellar
and tibial wear in one knee.
Of the remaining 168 knees, 127
(75.6%) knees scored excellent, 29
(17.3%) scored good, 10 (6%)
scored fair and 2 (1.2%) scored
poor. There were no femoral loosenings. Tibial sinkage occurred in
five (3.0%) knees. Sinkage was less
than 5 mm in all cases and none
was of sufficient severity to require
revision. Sinkage of the patella oc
curred in two (1.2%) cases and
reflex sympathetic dystrophy in
four (2.4%) cases. With use of the
original stem, there were five crack
fractures of the tibial cortex at the
time of stem insertion. Screws were
inserted in two cases, but the others
were simply ignored, and the pa
tient was limited to touch weight
bearing for 6 weeks. All fractures
healed without complication. This
problem did not occur with the
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bevelled stem. Wear of the tibial
component occurred in two knees,
one of which was revised, and in
three patellae, two of which were
revised. In one case the patellar
tendon was reinforced with wires at
the time of the initial replacement.
The wires were removed later. A
stress fracture of the tibia of one
knee was treated conservatively.
One patient had early sepsis and the
knee was treated with debridement.
Although this knee continued to
function 2 years later, both tibial
sinkage and patellar sinkage were
demonstrated, suggesting an ongo
ing low-grade infection.
According to the modified EnghDorr classification, 33.8% of tibial
components were type IA, 62% were
type IB, 3.5% were type II and 1.7%
were type III. Stem lucency in the
anteroposterior x-ray film appeared

complete in 5.2% of cases, partial in
6.5% and absent in 88.3%. On the
lateral x-ray film, lucency was com
plete in 14.3%, partial in 51.9% and
absent in 33.8%.

Discussion
It has been pointed out11 that
wear of the plastic component is
unlikely to be noted before 3 to 4
years of follow-up and revision is
unlikely to be needed before 6 years
from the time of placement. Be
cause the mean follow-up in this
study was 3.5 years, no reliable
conclusions could be drawn regard
ing wear other than to point out
that it does exist in both the patel
lar and tibial components.
Sinkage associated with noncemented components usually occurs

FIG. 2. Arrows on stem indicate radiolucent line, which does not extend completely
around stem. Small arrow indicates radiolucency under base plate anteriorly.
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in the first 6 months after place
ment of the prosthesis and is non
progressive.11 Sinkage of the noncemented tibial component of such
severity as to require revision is
uncommon in the short term.1-5
Sinkage occurred in five knees
(2.8%) in this series, and one of
them was probably infected. In no
case was sinkage of sufficient sever
ity as to require revision, even
though 5% of cases had tibial bone
grafting to some degree. These
sinkage rates are superior to those
obtained with the flat-plate version
of this knee prosthesis, suggesting
that the stem does indeed aid in
initial stability.
There seem to be few disadvan
tages to the use of a stiff meta
physeal stem. Undoubtedly more
bone is sacrificed, but this is mostly
poor-quality subsurface bone. Use
of a bevelled stem has resolved the

FIG. 3. If undersurface of tibial compo
nent only is examined, no lucency will
be seen because beam angle is couple
of degrees off. This implant might,
therefore, be regarded as stable. If
stem is examined, however, radiolucent lines surrounding it are found to
be divergent (i.e., Type III). This stem
is toggling, indicating that implant is
loose.
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problem of crack fractures of the
posterior cortex, which occurred
with the original stem in five cases.
No case of end-of-stem pain was
encountered.
Although the task of seeking
radiolucency under the tibial plate
is difficult, radiolucency of the stem
is easy to identify. In our series
1.7% of knees could be classified as
radiologically loose, although there
was no clinical correlation and x-ray
films of the base plate did not
reflect this. Of more significance
was that the plane of micromotion
could be identified. In the an
teroposterior x-ray film, 88.3% of
knees showed no lucency, indicat
ing that tibial fixation with beads,
pegs and stem is sufficient to stop
micromotion in that plane. Howev
er, lucency was absent in only
33.8% in the lateral x-rays, indicat
ing that micromotion was still oc
curring in the anteroposterior
plane. The most likely reason for
this is that the bone of the anterior
tibial plateau is very soft.
It could be argued that symptom
less micromotion is of little signifi
cance. However, micromotion may
prevent bone ingrowth into porous
materials since the acceptable level
of micromotion is very low, less
than 100 nm.17 If bone ingrowth is

the goal, research into design
changes should be done to further
decrease micromotion at the im
plant-bone interface.
9.
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Noncemented, Porous Ingrowth Knee
Prosthesis: the 3- to 8-Year Results
Hugh U. Cameron, MB, ChB, FRCSC;* Young B. Jung, MDf
Objective: To determine the principal long-term problems encountered in noncemented total knee
replacement.
Design: A cohort of 252 consecutive cases of total knee replacement with no exclusions. Follow-up
ranged from 3 to 8 years.
Setting: A university-affiliated institution specializing in orthopedic surgery.
Participants: All 252 patients had arthritis of the knee, mainly osteoarthritis. All agreed preoperatively
to prolonged postoperative follow-up.
Intervention: Noncemented total knee replacement with the Tricon M prosthesis, which has a
metal-backed patella.
Main Outcome Measures: The Hospital for Special Surgery rating system for clinical results and the
radiologic results, including reasons for revision surgery.
Results: Thirty-five prostheses were revised: 11 prostheses because of patellar wear only; in 13
prostheses the tibial component (mainly a 6-mm unit) and patella were revised because of wear; 6
prostheses were revised for sepsis, 4 for reflex sympathetic dystrophy and 1 only for sinkage of the
tibial component. Of the remaining 217 prostheses, 88% scored good or excellent, 6% fair and 6% poor.
Conclusions: The single most common cause of failure was polyethylene wear. This was associated with
the metal backing of the patella and the use of thin, polyethylene tibial components.

Objectif: Identifier les principaux problemes rencontres a long terme dans les arthroplasties totales
non cimentees du genou.
Conception : Une cohorte de 252 cas consecutifs d’arthroplastie totale du genou, sans exclusions. Le
suivi va de 3 a 8 ans.
Contexte : Un etablissement universitaire specialise en chirurgie orthopedique.
Participants : Les 252 patients souffraient tous d’arthrite du genou, principalement d’arthrose. Tous
avaient accepte avant l’operation de participer a un suivi de longue duree.
Intervention : Arthroplastie totale non cimentee du genou avec la prothese Tricon M qui possede une
rotule avec armature de metal.
Principaux effets mesures : L’evaluation des resultats cliniques a l’aide du systeme "Hospital for
Special Surgery» et resultats radiologiques, incluant les raisons des revisions chirurgicales.
Resultats : Trente-cinq protheses durent etre revisees : 11 pour usure de la rotule seulement, 13 pour
usure de la partie tibiale (principalement une partie de 6 mm) et de la rotule, 6 pour infection de
prothese, 4 pour dystrophie sympathique reflexe et 1 seulement pour affaissement de la partie tibiale.
Des 217 autres protheses, 88 % donnerent de bons ou excellents resutats, 6 % des resultats moyens et
6 %, de mauvais resultats.
Conclusions : La cause la plus frequente d’echec a ete l’usure du polyethylene. Celle-ci est reliee a
l’armature metallique de la rotule et a l’utilisation d’une partie tibiale de polyethylene mince.
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he noncemented ingrowth type
of total knee replacement pros
thesis was introduced about a de
cade ago.1-2 The clinical results,
although short-term, have been rea
sonably good.3-6 However, there is
concern about fixation of the tibial
component7'8 and wear of the patel
lar component.9-10 Sinkage of
noncemented components may be
an early phenomenon, wear is not.
There are two main components to
plastic wear: abrasive wear due to
cement particles and bony impinge
ment, which may occur at a rela
tively early stage; and delamination,
which is the main producer of wear
debris particles and seldom occurs
within the first few years.11
Knee replacement is done mainly
in elderly patients. Thus, it is diffi
cult to obtain sufficient numbers of
long-term survivors for study. How
ever, we believed that a sufficient
number of 3- to 8-year survivors
existed for a meaningful study. Re
placements done by a single sur
geon only were followed so that
variations in technique and manage
ment could be eliminated.
The objective of this study was to
evaluate sinkage and wear in pa
tients who received a Tricon M
(Richards Manufacturing Co., Mem
phis, Tenn.) noncemented total
knee prosthesis. This is a porous
coated ingrowth knee prosthesis.
Initial fixation of the components is
by ridged plastic pegs driven into
undersized holes in the bone.5
Long-term fixation comes from tis
sue ingrowth into the implant.

T

Patients and Methods
Two hundred and fifty-two knees
(85 in men and 167 in women)
replaced with the Tricon M prosthe
sis by one surgeon (H.U.C.) had a
minimal follow-up of 3 years. The
patients ranged in age from 36 to
87 years (mean, 68.5 years). Most

knees were osteoarthritic: 8 (3%)
had rheumatoid arthritis, 3 (1%)
had post-traumatic arthritis and 1
(0.4%) had avascular necrosis. Thir
ty-nine knees (16%) had previously
been operated on: tibial osteotomy
in 29 (12%), unicompartmental
knee replacement in 6 (2%), total
knee replacement in 3 (1%) and a
Maquet procedure (elevation of the
tibial tubercle) in 1 (0.4%).
The tibial cut was made at right
angles to the long axis of the tibia
and the distal femoral cut in 7° of
valgus with respect to the femur.
Ligament balancing was carefully
carried out, with release of the soft
tissues on the concave side of the
knee until equal tension was
achieved. All patellae were resur
faced with an ingrowth metalbacked component (Fig. 1). All pa
tients were allowed to bear weight
immediately.
Follow-up was at 3 months, 6
months and annually, and the knees
were rated clinically according to
the Hospital for Special Surgery
(HSS) rating system.12 They were
examined radiographically from a
1-m, standing, anteroposterior x-ray
film, a lateral view and a skyline
view. Serial x-ray films were com
pared to assess sinkage and wear.
After several trials, it was concluded
that sinkage of less than 3 mm
could not be measured reliably.
No attempt was made to look for
radiolucency. Variation in the beam
angle of 3° obscures lucency. Un
less an image intensifier is used to
ensure an edge-on shot, an impossi
ble task in the review of a sizeable
number of patients, radiolucency is
always so underestimated that the
findings are useless.

Findings
Revision was required for 35
(14%) knees. Of the remaining 216
knees, 75% scored excellent, 13%

good, 6% fair and 6% poor (i.e.,
88% good or excellent according to
the HSS rating system).
The reasons for revision included
pain and chronic effusion due to
patellar wear in 11 knees and patel
lar and tibial wear in 13 knees. This
figure is somewhat inflated because
it has recently become the practice
of H.U.C. to change the tibial com
ponent if there is the slightest sign
of wear when the patella is being
revised. Revision for tibial compo
nent wear was carried out an aver
age of 6.2 years after the initial
replacement. One knee (0.4%) was
revised for tibial sinkage. Six knees
were revised for sepsis, two early,
one intermediate and three late. The
knees requiring late revision for
sepsis showed significant wear of
the tibial component and had a
wear debris synovitis. Four knees
were revised for reflex sympathetic
dystrophy before knowledge that
this condition existed. Three pa
tients required additional surgery
other than revision, two (0.8%) for
patellar subluxation, which was
treated by soft-tissue repair, and
one for patellar tendon rupture,
which was treated by wiring.
Of the 217 knees not revised, 14
(6%) showed evidence of wear of the
tibial component and 10 (5%) had
patellofemoral squeak indicating pa
tellar wear. Twenty (9%) showed
nonprogressive sinkage of the tibial
component (i.e., sinkage was noted
within 2 years but did not change
further) (Fig. 1). Three knees only,
including the revised knee, showed
sinkage of more than 5 mm.
Nine (4%) knees demonstrated
reflex sympathetic dystrophy: revi
sion was done in four of them, as
already noted.
Prior tibial osteotomy is thought
to influence the outcome of total
knee replacement.13 Of 29 such
knees, only 16 (55%) scored good
or excellent and 13 (45%) scored
fair or poor. Seven (24%) of these
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29 knees required revision and four
(14%) had reflex sympathetic dys
trophy.
Most knees were within 3° and
9° of valgus. Even the 10% that fell
outside this range did so only by a
few degrees. Alignment did not cor
relate with clinical scores or with
wear.6

Discussion
The use of standard clinical x-ray

films to measure sinkage is not
ideal. The sinkage rate of 9% refers
only to patients who showed sinkage of more than 3 mm. We could
not reliably measure sinkage of less
than this. In keeping with other
published series,3-6 however, the re
vision rate for sinkage of noncemented tibial components was low,
being only 0.4% in our series. Other
series of porous coated and even
press fit prostheses have had similar
results.14 Indeed, the only series
evaluating noncemented prostheses

FIG. 1. Tricon M (Richards Manufacturing Co., Memphis, Tenn.) tibial component
in this bilateral total knee replacement (right) shows 3 mm of medial sinkage,
which was noted 1 year after replacement and was unchanged thereafter. Knee
continued to be perfectly functional. Newest version of this knee was inserted on
left side. Stiff metaphyseal stem with flexible diaphyseal stem extension appears (in
first 2 years) to have stopped any angular sinkage.
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that showed significant revision for
sinkage was Albrektsson and Herb
erts’ series of press fit in all poly
ethylene components.4
In our series, sinkage occurred
within 6 to 12 months of operation
and was nonprogressive.
The main problem leading to re
vision was pain and swelling due to
polyethylene wear. Wear of metalbacked patellae has been reported
previously, and it is generally rec
ommended that the use of metalbacked patellar components be dis
continued.9’10 Due to the small con
tact area of the patella, the service
loads theoretically exceed the load
capacity of the plastic so that wear
is inevitable. For some reason yet to
be explained, little has appeared in
the literature on wear of non-metalbacked patellae, although this must
occur. The theoretical advantage of
metal backing has in practice
turned out to be a disadvantage,
perhaps by reducing polyethylene
thickness.15
The prosthetic patella in this se
ries was inset into the bone, in
distinction to customary onset pa
tellae (Fig. 2). The fact that the
metal is below the surface of the
patellar bone should have prevented
metal-to-metal contact. Unfortu
nately, the advantage of sinking the
metal backing well below the level
of the bony patella was not recog
nized early in this series. Patellae
that were deeply sunk have not as
yet required revision. In another
study, however, which had a 2-year
longer follow-up, the durability of
an identical inset, snap fit, purely
plastic patella was compared with
that of a metal-backed patella. Only
one knee had to be revised for
patellar wear.16 Because it can be
difficult to sink the metal backing
deeply into an eroded patella and
because the results of the purely
polyethylene component are just as
good, use of the metal-backed patel
la should be discontinued.

TOTAL KNEE REPLACEMENT

Few other noncemented series
have commented on significant tibial component wear. This is almost
certainly a function of time since
delamination is not seen until after
several years of service.11-17 Revision
for tibial component wear in our
series was carried out an average of
6.2 years after the index operation,
and short-term studies therefore are
unlikely to demonstrate significant
wear.
Twenty-seven tibial components
showed evidence of wear, and 13
were revised. This figure is inflated
because many of these tibial compo
nents could have lasted several
more years. Nevertheless, this inci
dence of wear is a cause for con
cern. The location of wear in these
cases was posterior, and significant

cold flow occurred. With one excep
tion all the components were 6 mm
in thickness. Given that the metal
back was 3 mm thick, this means
that the actual thickness of polyeth
ylene at its thinnest was only 3 mm.
This was clearly a design error.
Bartel and colleagues18 and Racherman and colleagues14 have demon
strated that the minimum polyethyl
ene thickness should be 6 mm. In
other words, the minimum total
component thickness should be
9 mm when metal backing is used.
This means that the thickness of
the tibial cut would have to be
increased, and the component
would rest in poorer quality bone,
which in turn may affect sinkage
rates.
One interesting observation is

FIG. 2. Tricon M patella was designed
to be inset into bony patella. Sur
rounding bone protects plastic from
wear-through because there is some
rim contact. Outlines of plastic pegs
that give initial fixation to components
can dimly be seen.

FIG. 3. This knee shows significant
wear of plastic 5 years after initial
placement. There is no tibial sinkage.
Main reason for accelerated wear in
this case was use of small tibial compo
nent, which reduced area contact be
tween femur and tibia. Four years into
this study femoral component was re
placed by component that was wider in
coronal plane and gave increased sur
face area. Patient remained mainly
asymptomatic for 1 year after this film
was obtained, then knee developed an
acute late infection necessitating revi
sion.

that an earlier tibial component
with identical surface geometry had
no cruciate gap and none of these
components have required revision
for wear. Similarly, wear has not
been a major problem with the
original total condylar prosthesis,
which also did not have a cruciate
gap. All the tibial components in
this series had a large cruciate gap,
suggesting that such a gap results
in lack of support of the posterior
part of the tibial component, possi
bly accelerating cold flow. Of
course, the original noncruciate gap
implant was not metal backed and
therefore had 6-mm thick polyethyl
ene, so that the cruciate-gap factor
cannot be seen in isolation.
Polyethylene wear on the tibial
component does not seem to give
rise to pain until the polyethylene is
worn through to expose metal.
Even then, pain may not be a
striking feature.
When significant wear is first
noted on routine x-ray films, the
patient is usually asymptomatic.
Two to 3 years later the knee
becomes chronically swollen. Even
this may not be particularly painful,
and it is difficult to convince a
patient who is largely asymptomatic
to accept a revision. The danger of
delay, however, is that acute late
infection superimposed on a wear
debris synovitis may develop, as in
three knees in this series (Fig. 3).
Another problem is osteolysis. If
this condition is ignored, the wear
debris synovitis may develop into a
granuloma at the metal-bone junc
tion.19 This has been well described
in hips.20 In our series the main
area of erosion was the posterior
femoral condyles. This erosion can
be difficult to see on x-ray films
because a plate of bone usually
remains in place. Fortunately the
grip of the bone to the distal end of
the prosthesis so far has been suffi
cient for implant stabilization and
bone grafting. Bone grafting has
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not been required, and no loosening
of the femoral component has been
seen.
One interesting finding in our
series was the very poor results
following tibial osteotomy. For
some time it has been the senior
author’s practice to reosteotomize
the tibia before total knee arthro
plasty as an interval procedure
when the extra-articular deformity
is greater than 15°.21 In spite of the
ability to gain correction and me
chanical stability, however, the re
sults are much worse than those
reported by Amendola and associ
ates,13 who found reduction in
range of motion to be the main
problem. A large percentage (14%)
of knees subjected to high tibial
osteotomy did develop reflex sym
pathetic dystrophy, which suggests
th at perhaps the reflex sympathetic
dystrophy was unrecognized and
predated the total knee replace
ment.
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will be found and mothers should be apprised to the potential hazards to
the fetus. Ultrasound should be performed to assess fetal development,
well-being and volume of amniotic fluid. If oligohydramnios is observed,
discontinue VASOTEC® unless lifesaving for the mother. A non-stress test
and/or a biophysical profiling may be appropriate however, if concerns
persist, a contraction stress testing should be considered. O ligo
hydramnios may only appear after fetus has sustained irreversible injury.
Closely observe infants exposed in uteroio ACE inhibitors for hypotension,
oliguria and hyperkalemia, and initiate appropriate corrective medical
procedures.
Human Data: Exposure to ACE inhibitors during second and third
trim esters has been associated w ith hypotension, neonatal skull
hypoplasia, anuria, reversible or irreversible renal failure and death of the
fetus. Oligohydram nios, associated w ith fetal lim b contractures,
craniofacial deformation, and hypoplastic lung development also has been
reported. Prematurity and patent ductus arteriosus also reported but
unknown if due to ACE inhibitor use. It is not known whether exposure
limited to the first trimester can adversely affect fetal outcome.

PRECAUTIONS
Im paired renal function: Renal function should be assessed before
initiating therapy w ith enalapril or enalaprilat. Patients w ith renal
insufficiency may require reduced or less frequent doses, and their renal
function must be monitored appropriately (see DOSAGE). Renal failure,
which has been reported mainly in patients with severe congestive heart
failure or underlying renal disease including renal artery stenosis is
usually reversible when treated promptly.
Some hypertensive patients with no apparent renal disease have developed
increases in BUN and creatinine while on concurrent diuretic/ enalapril
therapy. Dosage reduction or discontinuation of one or both drugs may be
required.
^Trademark Merck & Co„ Inc./Merck Frosst Canada Inc., R.U.
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Hyperkalemia: In clinical trials, hyperkalemia (>5.7 mmol/L) was
observed in approximately 1% of hypertensive patients, and caused
discontinuation of therapy in 0.28% of such patients. Risk factors for
hyperkalemia development may include renal insufficiency, diabetes
m ellitus, and concomitant use of agents to treat hypokalemia (see
ADVERSE REACTIONS).
Valvular Stenosis: Theoretically, patients with aortic stenosis, who do
not develop as much afterload reduction, might be at risk of decreased
coronary perfusion when treated with vasodilators.
Surgery/Anaesthesia: During major surgery or anaesthesia with
hypotensive agents, enalapril blocks angiotensin II formation secondary to
compensatory renin release. Hypotension that develops due to this
mechanism can be corrected by volume expansion.

Impaired liver function: Hepatitis, jaundice (hepatocellular and/or
cholestatic),elevation of liver enzymes and/or serum bilirubin, which have
occurred in patients with or without pre-existing liver abnormalities, were
usually reversed on discontinuation of enalapril or enalaprilat. For any
unexplained symptoms, particularly within the first months of treatment, a
full set of liver function tests and other necessary investigations are recom
mended. Consider discontinuation of enalapril or enalaprilat when
appropriate. Use enalapril or enalaprilat with particular caution in patients
with pre-existing liver abnormalities. Obtain baseline liver function tests
before initiating drug and monitor response and metabolic effects closely.
Cough: A dry, persistent cough has been reported, which usually
disappears after withdrawal or lowering the dose of enalapril or enalaprilat.

Nursing mothers: Enalapril and enalaprilat are secreted in human milk in
trace amounts therefore, nursing should be interrupted.
Pediatric use: This use is not recommended because enalapril and
enalaprilat have not been studied in children.

Hemodialysis patients: Anaphylactoid reactions have been reported
with high-flux membranes (eg. polyacrylonitrile [PAN]) and treated
concomitantly with an ACE inhib itor. If symptoms such as nausea,
abdominal cramps, burning, angioedema, shortness of breath and severe
hypotension occur, stop dialysis immediately. The symptoms are not
relieved by antihistamines and the use of a different type of dialysis
membrane or class of antihypertensive agent should be considered.
Drug Interactions
Hypotension - Patients on Diuretic Therapy: Particularly when
diuretics recently initiated, patients occasionally experience hypotension
after initiating therapy with enalapril or enalaprilat. To minimize the
hypotensive effects, discontinue the diuretic or increase the salt intake prior
to starting the drug. If the diuretic cannot be discontinued, patients should
be placed under close medical supervision for at least one hour after the
initial dose of enalaprilat (see WARNINGS).

Agents Increasing Serum Potassium: Since enalapril and enalaprilat
decrease aldosterone production, elevation of serum potassium may occur.
Diuretics such as spironolactone, triamterene or amiloride, or potassium
supplements should be given cautiously for documented hypokalemia only
and should be monitored frequently. Potassium containing salt substitutes
should be used with caution.

Agents Causing Renin Release: Diuretics, for example, augment the

MISCELLANEOUS (cont'd)

—
0.7
Hyperhidrosis
0.3
0.4
Impotence
1.4
3.0
Fatigue
0.3
0.4
Taste disturbance
t Defined as >1 g/24h or >0.5 g/12h on two consecutive measurements,
at least one month apart.

ABNORMAL LABORATORY FINDINGS
Hyperkalemia: (see PRECAUTIONS).
Creatinine, Blood Urea Nitrogen: Increases were reported in about
20% of patients with renovascular hypertension and about 0.2% of patients
with essential hypertension on enalapril alone. Increases, which usually
were reversible upon discontinuation of enalapril or concomitant therapy,
were reported in 9.7% of heart failure patients who were receiving diuretics
and/or digitalis.
Hemoglobin and Hematocrit: Decreases (mean approximately 0.34
g% and 1.0 vol% , respectively) occurred frequently, but were rarely of
clin ic a l im portance. In clin ic a l tria ls, less than 0.1% of patients
discontinued therapy due to anemia.
Hepatic: Elevations of liver enzymes and/or serum bilirubin have occurred
(see PRECAUTIONS).

ADVERSE REACTIONS REPORTED IN UNCONTROLLED TRIALS
AND/OR MARKETING EXPERIENCE
W ith an incidence of 0 .5 to 1%: Insomnia, impotence, renal
dysfunction, renal failure and oliguria.

With an incidence < 0.5%:
Cardiovascular: Myocardial infarction or cerebrovascular accident,
possibly secondary to excessive hypotension in high risk patients (see
WARNINGS); cardiac arrest; pulmonary embolism; rhythm disturbances;
angina pectoris G astrointestinal: Anorexia; ileus; pancreatitis;
dyspepsia; constipation. Hemopoeitic: Neutropenia; thrombocytopenia;
bone marrow depression. Hepatic: Liver function abnormalities; hepatitis;
jaundice (hepatocellular and/or chole static). Nervous System /
Psychiatric: Vertigo; depression; confusion; ataxia. Respiratory:
Bronchospasm/asthma; rhinorrhea. Other: Erythema m ultiform e;
exfoliative dermatitis; Stevens-Johnson syndrome; toxic epidermal
necrosis; urticaria; photosensitivity; alopecia; flushing; tinnitus; hearing
impairment; glossitis; blurred vision. A symptom complex has been
reported w hich may inclu de fever, se ro s itis, vasculitis, m yalgia,
arthralgia/arthritis, a positive ANA, elevated erythrocyte sedimentation rate,
e o sin o p h ilia and leu ko cyto sis. Rash, p h o to se n sitiv ity or other
dermatologic manifestations may occur. These symptoms have disap
peared after discontinuation of therapy.
LABORATORY TEST FINDINGS: Hyponatremia
VASOTEC® I.V .: Since enalapril is converted to enalaprilat, those
adverse reactions associated with VASOTEC® tablets m ight also be
expected to occur with VASOTEC® I.V. The incidence of symptomatic
hypotension is 3.4% with VASOTEC® I.V. Other adverse experiences
occurring in greater than 1% of patients were headache (2.9%) and nausea
(1.1%). Adverse reactions occurring in 0.5 to 1.0% of patients in controlled
clinical trials include myocardial infarct, fatigue, dizziness, fever, rash and
constipation.

When in itia tin g enalapril consider the recent d iure tic therapy and
possibility of severe salt/ volume depletion. Before beginning enalapril
reduce diuretic therapy if possible.
The recom m ended in itia l d a ily dose is 2.5 mg. W hile m anaging
sym ptom atic hypotension, increase dose gradually, depending on
individual response, to the usual maintenance dose of 10-20 mg daily,
given in a single dose or divided in two doses. This dose titration may be
performed over a two- to four-week period, or more rapidly if indicated by
residual signs and symptoms of heart failure. The maximum daily dose is
40 mg.

VASOTEC® I.V. FOR INTRAVENOUS ADMINISTRATION ONLY
VASOTEC® I.V. vials should be inspected visually and should not be used
if particulate matter or discoloration is observed.
VASOTEC® I.V. may be administered intravenously as supplied, or mixed
with up to 50 mL of one of the following diluents:
5% Dextrose Injection
0.9% Sodium Chloride Injection
0.9% Sodium Chloride Injection in 5% Dextrose
5% Dextrose in Lactated Ringer's Injection
Diluted solutions should be used within 24 hours.
The dose is 1.25 mg every 6 hours administered intravenously over at least
5 minutes. A clinical response is usually seen within 15 minutes. Peak
effects after the first dose may not occur for up to four hours after dosing.
The peak effects of the second and subsequent doses may exceed those of
the first.
No dosage regimen for VASOTEC® I.V. has been clearly demonstrated to
be more effective in treating hypertension than 1.25 mg every 6 hours.
However, in controlled clinical studies in hypertension, doses as high as 5
mg every 6 hours were well tolerated for up to 36 hours. There has been
inadequate experience with doses greater than 20 mg per day.
In studies of patients with hypertension, VASOTEC® I.V. has not been
administered for periods longer than 48 hours. In other studies, patients
have received VASOTEC® I.V. for as long as 7 days.
The dose for patients being converted to VASOTEC® I.V. from oral therapy
for hypertension w ith enalapril maleate is 1.25 mg every 6 hours
administered intravenously over at least 5 minutes. For conversion from
intravenous to oral therapy, the recommended initial dose of VASOTEC®
tablets is 5 mg once a day w ith subsequent dosage adjustm ents as
necessary.

Patients on Diuretic Therapy
For patients on diuretic therapy, the recommended starting dose for
hypertension is 0.625 mg adm inistered intravenously over at least
5 minutes. A clinical response is usually seen within 15 minutes. Peak
effects after the first dose may not occur for up to 4 hours after dosing,
although most of the effect is usually apparent within the first hour. If after
1 hour there is an inadequate clinical response, the 0.625 mg dose may
be repeated. Additional doses of 1.25 mg may be administered at 6 hour
intervals.
For conversion from intravenous to oral therapy, the recommended initial
dose of VASOTEC® tablets for patients who have responded to 0.625 mg of
enalaprilat every 6 hours is 2.5 mg once a day with subsequent dosage
adjustment as necessary.

antihypertensive effect of enalapril and enalaprilat.

SYMPTOMS AND TREATMENT OF OVERDOSAGE

Dosage Adjustment in Renal Impairment

Agents Affecting Sympathetic Activity: Ganglionic blocking agents
or adrenergic neuron blocking agents, for example, may be used with
caution. Beta-adrenergic blockers add some further anti hypertensive effect
to enalapril.

Limited human data are available. The m ost likely manifestation of
overdosage would be hypotension, which can be treated by I.V. infusion of
normal saline solution. Enalaprilat may be removed from the general
circulation by hemodialysis.

Lithium Salts: Lithium clearance may be reduced; therefore, monitor
serum lithium levels carefully if they are administered.

VASOTEC® FOR ORAL ADMINISTRATION ONLY

The usual dose of 1.25 mg of enalaprilat every 6 hours is recommended for
patients with a creatinine clearance >30 mL/min [> 0.50 mL/s] (serum
creatinine up to approximately 3 mg/dL [265.2 |m o l/L ]). For patients with
creatinine clearance < 30 m L/m m [< 0 .5 0 m L/s] (serum creatinine
>3 mg/dL [> 265.2 pmol/L]), the initial dose is 0.625 mg (see WARNINGS).
If after 1 hour, there is an adequate clinical response, the 0.625 mg dose
may be repeated. Additional doses of 1.25 mg may be administered at
6 hour intervals.
For dialysis patients, the initial dose should be 0.625 mg every 6 hours,
(see PRECAUTIONS - Hemodialysis patients).
For conversion from intravenous to oral therapy, the recommended initial
dose of VASOTEC® is 5 mg once a day for patients w ith creatinine
clearance >30 mL/min [>0.50 mL/s] and 2.5 mg once daily for patients with
creatinine clearance <30 mL/min [<0.50 mL/s]. Dosage should then be
adjusted according to blood pressure response.

ADVERSE REACTIONS
VASOTEC®: In controlled clinical trials involving 2314 hypertensive
patients and 363 heart failure patients, the most severe adverse reactions
were: angioedema (0.2%), hypotension (2.3%) and renal failure (5 cases).
In hypertensive patients, hypotension occurred in 0.9% and syncope in
0.5%, with a discontinuation rate of 0.1% . In heart failure patients,
hypotension occurred in 4.4% and syncope in 0.8% , w ith a discon
tinuation rate of 2.5%. The most frequent clinical adverse reactions in
controlled clinical trials were: headache (4.8%), dizziness (4.6%) and
fatigue (2.8%). Discontinuation of therapy was required in 6.0% of the
2677 patients.

Hypertension
%

(2314 Patients)
CARDIOVASCULAR
Hypotension
Chest Pain
Palpitations
Myocardial Infarction, Acute
Myocardial Infarction, Recurrent

Heart Failure
%

(3 6 3 Patients)

0.9
0.9
0.6
0.2
—

4.4
1.7
0.3
0.6
0.3

1.4
0.8
0.1
1.4
0.7

1.1
1.7
—
3.0
1.4

0.1
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0.1

0.6
—
—

GASTROINTESTINAL
Nausea
Vomiting
Dysphagia
Diarrhea
Abdominal pain

RENAL
Renal failure
Oliguria
Proteinuriat

1.4
0.4

1.9
1.4

5.2
4.3
0.5
0.6
0.6
0.6

2.2
6.6
0.3
—
—
—

1.3
0.2

1.4
—

0.1
1 case

—
—

0.6
0.6

0.3
1.1

NERVOUS SYSTEM
Headache
Dizziness
Insomnia
Nervousness
Somnolence
Paresthesia

ALLERGIC
Cough
Angioedema

MISCELLANEOUS
Muscle cramps
Dyspnea

HYPERTENSION
Initiation of enalapril requires consideration of extent of blood pressure
elevation, salt restriction and recently used antihypertensive agents, the
dosage of which may need to be adjusted.
The recommended initial dose of enalapril maleate in patients not on
diuretics is 5 mg once a day. Adjust dosage according to blood pressure
response; the usual range is 10 to 40 mg daily, in a single dose or divided
in two doses. Some patients on once-daily dosage may have diminished
anti hypertensive effect toward the end of dosing interval and require an
increase in dosage, or twice daily administration. If blood pressure is not
controlled, a diuretic may be added. Raising the daily dose above 40 mg is
not recommended because adverse reactions may be increased.
Occasionally symptomatic hypotension may occur following the initial
dose, more likely in patients currently taking a diuretic. Therefore, if
possible, discontinue the diuretic two to three days before initiating
enalapril therapy (see WARNINGS). If the diuretic cannot be discontinued,
use an initial dose of 2.5 mg.
In the absence of sufficient experience in the treatment of accelerated or
malignant hypertension, enalapril is not recommended in such situations.
Dosage in the Elderly (over 65 years): Start at 2.5 mg daily. Some
elderly patients may be more responsive than younger patients.
Dosage Adjustment in Renal Impairment: (see PRECAUTIONS Hemodialysis patients)
Guidelines for reducing doses in hypertensive patients:

Normal renal
function
Mild impairment
Moderate to
severe impairment
Dialysis patients

Creatinine
Clearance
mL/min(mL/s)
>80 mL/min
(>1.33 mL/s)
< 8 0 >30 mL/min
(<1.33 >0.50 mL/s)
£ 3 0 mL/min
(£0.50 mL/s)

Initial Dose
mg/day
5 mg

AVAILABILITY OF DOSAGE FORMS
Barrel-shaped, biconvex tablets, engraved with code number on one side
and VASOTEC on other.
VASOTEC® 2.5 mg - yellow, scored, engraved 14.
VASOTEC® 5 mg - white, scored, engraved 712.
VASOTEC® 10 mg - rust-red, engraved 713.
VASOTEC® 20 mg - peach, engraved 714.
All strengths available in bottles of 100 tablets.
VASOTEC® I.V. 1.25 mg per mL, is a clear, colourless solution and is
supplied in vials containing 2 mL.

PRODUCT MONOGRAPH AVAILABLE ON REQUEST
(490iv-a.11.92)
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CONGESTIVE HEART FAILURE

HEMATOLOGIC
Anemia
Leukopenia

Dosage must be individualized. The absorption of enalapril maleate is not
affected by food.

Renal Status

DERMATOLOGIC
Rash
Pruritus

DOSAGE AND ADMINISTRATION

Use in conjunction with a diuretic and digitalis. Initiate therapy under close
medical supervision, usually in a hospital. Monitor blood pressure and
renal function before and during treatment with enalapril, because severe
hypotension, and more rarely, consequent renal failure have been reported
(see WARNINGS and PRECAUTIONS).
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ASSESSMENT OF UPPER EXTREMITY FUNCTIONAL ABILITY
IN RELATION TO RESTRICTION OF THE RANGE OF JOINT
MOTION. Kevin M. Rumball and Alan A. Giachino. Department of
Surgery, Ottawa General Hospital, Ottawa, Ont.

DESIGN RATIONALE FOR A NEW ANATOMIC METACARPO
PHALANGEAL JOINT PROSTHESIS. Pierre Beaumont, Sylvain
Gagnon, Jean-M. Page, Yves A. Ratron. Department of Orthopedic
Surgery, Hopital du Sacre Coeur, Montreal, Que.

The purpose of this study was to assess the disability that occurred
from restriction of upper extremity joint motion and to show which
joints when freed of restrictions would (a) improve performance on
objective tests and (b) most restore independence in the activities of
daily living. For 5 days, 15 healthy subjects wore right-upper-limb
splints with comparable restrictions of shoulder, elbow, wrist and
metacarpophalangeal joint motion. Objective and subjective scores were
recorded with all joints restricted and after alternately freeing of one of
the four joints. Performance and independence were most improved
with the metacarpophalangeal joints free.

The authors described a design for a prototype metacarpophalangeal
(MCP) joint prosthesis that would restore joint kinematics and balanced
hand function. Using data from previous studies at the Mayo Clinic on
MCP joint kinematics, the authors designed a metal-polyethylene,
uncemented, low constraint, resurfacing prosthesis, which required
preservation or reconstruction of the capsuloligamentous mechanism.
Anatomic factors, such as volar displacement of the instant centres of
rotation in flexion, contact surface profiles and freedom of movement,
as well as intra-articular forces involved in normal and pathologic
function, were taken into account. The new implant concept reproduced
the anatomy of the MCP joint, with the theoretical advantages of lower
constraint, increased durability, less loosening and better biocompatibili
ty than silicone.

JACCOUD’S ARTHROPATHY. Lisa M. Ronback and Carolyn L.
Kerrigan. Division of Plastic Surgery, Royal Victoria Hospital,
Montreal, Que.

Jaccoud’s arthropathy is a non-erosive, deforming arthropathy seen in
systemic lupus erythematosus, rheumatic fever and vasculitis. Typical
deformities include ulnar drift, swan neck, limited metacarpophalangeal
joint extension, boutonniere and “Z” deformities. Changes appear to
arise from periarticular inflammation. The literature concerning surgical
treatment of this arthropathy is extremely limited, but suggested
options include metacarpal shortening and Silastic arthroplasties. In
this paper the authors review the literature on Jaccoud’s arthropathy
and discuss three clinical cases. The charts of patients in the authors’
systemic lupus erythematosus registry are reviewed to establish the
prevalence of Jaccoud’s arthropathy in that population.

CARPOMETACARPAL ARTHROSIS: A QUESTION OF LENGTH?
Stephen Southerland, Geoffrey H.F. Johnston. Department of Ortho
pedic Surgery, Royal University Hospital, Saskatoon, Sask.

Osteoarthritis commonly affects the thumb carpometacarpal (CMC)
joint, although the reason for this is unclear. Biomechanically, longer
lever arms create greater forces across adjacent joints. The relationship
between first metacarpal length and thumb CMC arthrosis has not been
studied. The authors tested the hypothesis that a long first metacarpal
predisposes its CMC to degenerative change. Measurements of thumb
metacarpal and phalangeal length from 500 randomly selected radio
graphs were compared to similar measurements from 50 radiographs in
patients with thumb CMC osteoarthritis. Results revealed remarkable
consistency in thumb, index and long finger-length relationships.
Skeletal length ratios in hands with thumb CMC arthritis were no
different from those of the controls.

ASSESSMENT OF PROXIMAL POLE VASCULARITY IN SCAPH
OID NONUNION: A PRELIMINARY REPORT USING LASER
DOPPLER FLUOMETRY. Douglas C. Ross, Stuart D. Patterson,
James H. Roth, Susan E. Vokey. Department of Surgery, University of
Western Ontario, London, Ont.

Proximal pole vascularity of the ununited scaphoid has been assessed by
radiography, measurement of intraoperative bleeding and magnetic
resonance imaging (MRI). Intraoperative laser Doppler fluometry was
used in five patients with established nonunion. Flow to proximal and
distal poles was measured with the tourniquet inflated and after
deflation. The average value per 100 g of tissue for proximal pole flow
was 0.93 mL/min with the tourniquet inflated and 3.80 mL/min after
deflation. The ratio of distal pole to proximal pole flow was 1.72. One
patient with avascularity on MRI exhibited flow by laser Doppler, and
union was subsequently achieved. The authors conclude that laser
Doppler fluometry may be a sensitive indicator of proximal pole
perfusion.

EARLY RESULTS OF MODIFIED SCAPHOLUNATE ADVANCED
COLLAPSE WRIST RECONSTRUCTION. Gary R. McGillivary.
Department of Surgery, Dalhousie University, Halifax, NS

Twenty-six consecutive patients with scapholunate advanced collapse
(SLAC) underwent a modified reconstruction consisting of scaphoid
excision and four-corner fusion with correction of carpal collapse. All
patients were then independently evaluated for grip strength, pain and
range of motion. In 19 patients the follow-up was long enough (range
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from 8 to 38 months, mean 20 months) to permit evaluation.
Postoperative grip strength was 74% of normal. On average, preopera
tive range of motion was maintained. All but two patients (89%) were
pain free. This modified reconstruction for SLAC is an excellent
alternative to wrist arthrodesis.

RESULTS OF WRIST ARTHODESIS WITH PLATE FIXATION
AND ILIAC CREST BONE GRAFT. Robin R. Richards, Dorcas E.
Beaton, Thomas A. Barnhill. Division of Orthopedic Surgery, St.
Michael’s Hospital, Toronto, Ont.

In a prospective study the authors examined the fusion rate and
incidence of complications when a plate and bone grafting were used to
perform wrist arthrodesis in 60 patients: 50 with osteoarthritis, 8 with
neurologic disorders and 2 with rheumatoid arthritis. The mean age of
the patients was 32 years and the mean follow-up was 23 months. Each
wrist was fused in the desired position without subsequent procedures.
There were no iliac crest complications and no infections. One patient
had reflex sympathetic dystrophy. Two sustained distal radial fractures
at the plate-bone junction. Fifteen had plate removal for distal plate
tenderness. Fourteen had slight flexion contracture of the third
metacarpophalangeal joint. In conclusion, this technique is reliable,
assures fusion in the desired position and has a low complication rate.

HISTOLOGIC AND MECHANICAL CHARACTERIZATION OF
RHEUMATOID WRIST EXTENSORS. Martine J. Breault, David R.
Pichora, Sandip S. Gupta, Carolyn Small, Tim Bryant. Department of
Surgery, Queen’s University, Kingston, Ont.

Implants were once used to treat wrist rheumatoid arthritis, but because
implants migrate and dislocate arthrodesis is now preferred. Wrist
implant failure may be due to soft-tissue imbalance related to changes in
the tissue histologic and mechanical properties. A standardized protocol
was developed for testing wrist extensors harvested from patients who
underwent wrist arthrodesis. Specimens were examined under light and
scanning electron microscopy and were tested in a senohydraulic
Instron Universal Machine (Instron Canada Ltd., Burlington, Ont.).
Histologic and viscoelastic properties were significantly different be
tween normal and rheumatoid tissue for the 23 specimens tested. This
finding has clinical significance for soft-tissue reconstruction during
wrist surgery and stresses the importance of developing improved
methods of fixation.

FLEXOR CARPI RADIALIS TO EXTENSOR DIGITORUM COMMU
NIS TENDON TRANSFER TO RESTORE METACARPOPHALAN
GEAL JOINT EXTENSION. Robin R. Richards, Dorcas E. Beaton,
Alan R. Hudson. Division of Orthopedic Surgery, St. Michael’s
Hospital, Toronto, Ont.

The results of ulnar transfer of flexor carpi radialis to extensor
digitorum communis were reviewed with a minimum follow-up of 12
months (mean 20.6 months). Twenty-five patients (mean age 39 years)
who had no active extension of the metacarpophalangeal joint (MCPJ)
due to neural injury (8 brachial plexus, 7 radial nerve and 10 posterior
interosseous nerve) underwent transfer. All recovered active MCPJ
extension, and patient satisfaction was universal. With the wrist in the
neutral position, 21 had no extensor lag. Mean grip strength was
18.8 kg. Functional testing revealed deficits when compared with the
noninjured side (Jebsen 50.6%: Minnesota Rate of Manipulation Test
34.7%). No patient had wrist radial or ulnar deviation. The FCR can be
considered as an alternative method for restoration of MCPJ extension.

RESTORATION OF METACARPOPHALANGEAL EXTENSION IN
THE RHEUMATOID THUMB. Claude Manueddu, David E. Hastings,
Earl R. Bogoch. Division of Orthopedic Surgery, Wellesley Hospital,
Toronto, Ont.

The authors studied rerouting of the extensor pollicis longus muscle by
the Hastings method to restore active extension to the thumb in 10
patients with rheumatoid arthritis who had extensor lag and an intact
metacarpophalangeal joint. Other methods have previously been report
ed to be unsuccessful. Of the 10 patients, 6 had full active extension of
the thumb, 2 retained an extensor lag of 23° and 30° but were
improved from their preoperative state of —30° and —40° and 2 had a
fixed flexion deformity of 30° and 20° respectively. Preoperative fixed
flexion deformity is a contraindication to this procedure, and loss of
cartilage dorsally in the joint lessens the chances of success.

A BIOMECHANICAL ANALYSIS OF PERCUTANEOUS PINNING
FOR UNSTABLE EXTRA-ARTICULAR FRACTURES OF THE DIS
TAL RADIUS. James Collicut, Gary R. McGillivary, Michael Gross.
Department of Surgery, Dalhousie University, Halifax, NS

Percutaneous pinning is advocated for the treatment of unstable distal
radial fractures. Few guidelines exist for the optimal placement of pins.
In this study eight pinning configurations were assessed in vitro in 40
embalmed cadaver radii. Rigidity of intact specimens under axial and
bending loads in the coronal and sagittal planes was determined. A
transverse metaphyseal osteotomy was performed, and rigidity was
reassessed after reconstruction with 0.062-in Kirschner wires. Signifi
cant reductions were measured in the axial and bending rigidities of the
reconstructed specimens. No significant differences were observed
between the rigidity of the four, three and two crossed-pin configura
tions. Single-pin configurations were grossly unstable.

ABSORBABLE IMPLANTS FOR INTRA-ARTICULAR HAND FRAC
TURES. Mahmud Kara, Douglas C. Ross, James H. Roth, Robert S.
Richards. Department of Surgery, University of Western Ontario,
London, Ont.

The use of absorbable poly-p-dioxanone pins has been recently de
scribed for both large- and small-bone fractures. The ‘’uinors evaluated
this technique prospectively in six patients with intra-articular fractures
of the hand with significant displacement (three proximal interphalangeal joint [PIPJ]; three metacarpophalangeal joint [MCPJ]). The average
follow-up was 20 weeks. The mean range of movement for the PIPJ
injuries was good to excellent but was less satisfactory for MCPJ
injuries. There were no mechanical failures of the implants, and there
was no evidence of allergic or inflammatory reaction. The authors
conclude that poly-p-dioxanone pins in the treatment of intra-articular
fractures can provide stable fixation and are a useful adjunct in the
treatment of these fractures.

DYNAMIC TRACTION SPLINTING FOR PROXIMAL INTERPHALANGEAL JOINT INJURIES. Kenneth A. Murray. Department
of Surgery, St. Boniface General Hospital, Winnipeg, Man.

The proximal interphalangeal (PIP) joint is important in the overall
function of the digit. Injury to this joint can severely affect hand
function. Early active motion, as with other joint injuries, is important
in ensuring a good range of motion and functional outcome. The author
reviews experience of dynamic traction splinting at the PIP joint with a
variety of injuries. The benefits of this traction system are that it allows
early, active motion, traction that can aid in reduction of fragments and
provide a marked decrease in pain. This encourages patient compliance,
gives early range of motion and an enhanced result.
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THE MANAGEMENT OF METACARPOPHALANGEAL AND PROXI
MAL INTERPHALANGEAL JOINT ARTICULAR FRACTURES
USING DYNAMIC SKELETAL TRACTION AND IMMEDIATE MO
BILIZATION. Stuart D. Patterson, Shrikant Chinchalkar, Douglas C.
Ross, Carol Weekes, James H. Roth. Department of Surgery, Univer
sity of Western Ontario, London, Ont.

Twelve patients with joint articular fractures (10 proximal interphalangeal, 1 thumb metacarpophalangeal, 1 fifth digit metacarpophalangeal)
ranging in age from 8 to 65 years, were treated with dynamic skeletal
traction and immediate mobilization. All fractures were analysed under
image intensification, and the distraction force required for reduction
was determined. A mean force of 329.17 g (range from 200 to 450 g)
was applied. Active range of movement and tendon gliding were
undertaken for 6 weeks, resisted motion at 8 to 10 weeks and
unrestricted use at 12 to 14 weeks. At a minimum follow-up of 6
months, pain-free motion was present in 11 patients. Mean range of
movement for the proximal interphalangeal joints was 95.5°, for
the thumb metacarpophalangeal joint 80° and for the fifth digit
metacarpophalangeal joint 40°. Complications included two pintract infections, one mild scissoring and one volar plate contrac
ture.
EVALUATION OF A NEW ANCHORING DEVICE IN THE DISTAL
PHALANX. Robert J. Feibel. Department of Surgery, Ottawa General
Hospital, Ottawa, Ont.

Stainless steel wire (26 gauge) was secured to fresh frozen human
cadaver distal phalanges by (a) a dorsal tie-over button, (b) a 2-mm
self-tapping Luhr screw or (c) the Mitek Mini-GII (Mitek Industries,
Norwood, Mass.) suture anchoring device. The fixation systems were
stressed to failure along the phalangeal axis. All button tie-over wires
failed through the wire (mean force of 157.9 N). Screws and Mini-GII
anchors failed by pullout from bone (mean loads of 83.5 N and 82.3 N
respectively). There was no significant difference between results with
the Luhr screw and with the Mini-GII. The Mitek device should be
considered for repair of an avulsed flexor digitorum profundus, suture
of a collateral ligament or active Hunter tendon rod to bone and may
also be used for volar plate arthroplasty for dorsal fracture-dislocations
of the proximal interphalangeal joints.
OCCUPATIONAL EXPOSURE TO HAND VIBRATION IN NORTH
ERN ONTARIO GOLD MINERS. Philip P. Narini, Chris B. Novak,
Susan E. MacKinnon, Cathy Coulson-Roos. Division of Plastic Sur
gery, Sunnybrook Health Science Centre, Toronto, Ont.

Nineteen underground gold-mine drillers (mean age 35.4 years) who
operated vibration equipment and a control group of 16 gold mill
workers (mean age 31.0 years) who did not were evaluated with static
and moving two-point discrimination, vibration and cutaneous pressure
thresholds. Provocative tests, including Tinel’s, pressure and Phalen’s
sign, were also performed. The mean duration of vibration exposure was
14.3 years. Numbness, pain and weakness were reported in 12 miners
and 1 control subject. Vibration white finger was reported in 16 miners
and three control subjects. Miners had a higher incidence of positive
provocative tests at both carpal and cubital tunnels and higher
cutaneous pressure thresholds than controls. Significantly higher
vibration thresholds were found in miners (p < 0.05). A correlation
relationship between years of vibration exposure and vibration threshold
was found (r= 0.7).

SAFE AND EFFECTIVE BRACHIAL PLEXUS BLOCKS BY SUR
GEONS. Daniel S. Thomas, Carolyn L. Kerrigan. Division of Plastic
Surgery, Royal Victoria Hospital, Montreal, Que.

A quality assurance study was undertaken to establish the safety and
effectiveness of brachial plexus blocks performed by surgeons for
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emergency and elective hand surgery. Forty-five consecutive patients
received an axillary block consisting of 1% mepivacaine and lidocaine
hydrochloride. Safety was assessed by electrocardiogram pulse oximetry
and blood-pressure monitoring. Effectiveness was judged by a pain
questionnaire and neurologic testing. Eighty-two percent (37 of 45) of
blocks were completely successful. Supplemental local injections at the
operative site provided sufficient anesthesia for all other cases. Twothirds of patients judged the block procedure to be less or equal to the
pain of an intravenous insertion. This experience indicates that hand
surgeons can perform safe and effective brachial plexus blocks.

PALMAR CUTANEOUS SENSORY BRANCH OF THE MEDIAN
NERVE PASSING THROUGH THE PALMARIS LONGUS TENDON:
A CADAVERIC STUDY. Robert S. Richards, Paul Dowdy, Robert M.
McFarlane. Division of Plastic and Reconstructive Surgery, University
of Western Ontario, London, Ont.

The relationship of the palmar cutaneous branch of the median nerve to
the palmaris longus tendon was studied in 52 wrists from 27 preserved
cadavers. In three wrists the palmaris longus tendon was absent. The
palmar cutaneous branch arose from the median nerve at a mean of
4.0 cm proximal to the wrist crease. In two wrists, the palmar
cutaneous branch passed through the palmaris longus tendon 1.0 cm
and 1.5 cm proximal to its insertion into the palmar aponeurosis. When
this anomaly is present, the palmar cutaneous sensory branch of the
median nerve may be injured during harvesting for tendon grafting if
transection is not proximal to the insertion into the palmar aponeurosis.

TENOSYNOVIAL CHANGES IN PATIENTS WITH ACTIVITYASSOCIATED SYMPTOMS OF CARPAL TUNNEL SYNDROME.
Linda Mrkonjic, Peter T. Cropper, Brent A. Graham. Division of
Orthopedic Surgery, University of British Columbia, Vancouver
General Hospital, Vancouver, BC

Activity-associated changes in carpal canal pressures may be secondary
to dynamic variations in the volume of the flexor synovium. Samples of
flexor tenosynovium were collected from 21 patients who underwent
carpal tunnel release. Twelve cadaveric specimens, from individuals with
no history of carpal tunnel syndrome or inflammatory disease, formed a
control group. A blinded pathologist graded the histologic findings.
Synovial fibrosis was the most common histologic finding. Comparison
of pathologic changes with clinical etiologic factors, indicated that
patients with symptoms associated with strenuous upper extremity
activity were more likely to have significant synovial fibrosis than
patients not engaged in repetitive or vigorous hand use or cadaveric
controls. The authors conclude that flexor tenosynovial fibrosis in the
carpal canal may be important in the development of activity-associated
carpal tunnel syndrome.

RICHE-CANNIEU CONNECTION IN MEDIAN NERVE INJURIES.
Michelle M. Carr, J. Brian Boyd, C. Vaughan A. Bowen. Department of
Surgery, Toronto General Hospital, Toronto, Ont.

The Riche-Canriieu connection between the deep branch of the ulnar
nerve and the recurrent motor branch of the median nerve was
described 100 years ago. It has been considered rare and unimportant in
the interim. Electrophysiologists have recently shown that this connec
tion occurs in the majority of normal people and accounts for a variable
proportion of motor response in the thenar musculature. The authors
describe two cases of median-nerve injuries proven by operative
exploration, both with intact thenar function. They postulate that this
anomalous clinical presentation is due to the Riche-Cannieu connection
and present supportive clinical evidence. Such unusual clinical situa
tions emphasize the need for careful evaluation of nerve injuries.

A B S TR A C TS

A COMPARATIVE STUDY OF STEINDLER AND PECTORALIS
MAJOR FLEXORPLASTY. Andre Dumont, Dorcas E. Beaton, Alan R,
Hudson, Robin R. Richards. Division of Orthopedic Surgery, St.
Michael’s Hospital, Toronto, Ont.

The functional outcomes of two types of elbow flexorplasty performed
with shoulder arthrodesis for patients with brachial plexus injuries were
compared. Of 14 patients assessed, 5 had a pectoralis major tendon
transfer and 9 a modified Steindler flexorplasty. All patients had
brachial plexus lesions that were irreparable or unresponsive to
neurolysis, repair or grafting. Average follow-up was 60 months.
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IF IT ISN’T TENNIS ELBOW, WHAT MIGHT IT BE? Donald A.
Ranney, Richard Wells, Anne Moore. Department of Kinesiology,
University of Waterloo, Waterloo, Ont.

The musculoskeletal health of 146 female workers in five industries
characterized by repetitive upper limb activity was assessed clinically at
the work site and subsequently correlated with a number of ergonomic
factors. Data were collected on 288 extensor regions and 290 flexor
regions. Tenderness was found in the lateral epicondyle or common
extensor tendon, or both, in 26 workers and in the extensor muscle
bellies in 35. Tenderness was found in the medial epicondyle or common
flexor tendon, or both, in 12 workers and in the flexor muscle bellies in
23. Radial tunnel syndrome and pronator syndrome could explain the
forearm pain in some cases but not in the majority. Muscle ischemia
from prolonged static contraction was a more likely possibility and
evidence for this is presented.

138
1
2 0 0 .4
2 3 0 .0
1 7 6 .8
3852
NA

3 0 /3 0

* A n u m e ric a l s c o re o u t o f 10.

In the patient requiring stabilization of the shoulder and flexorplasty,
the pectoralis major tendon transfer is at least equivalent, if not
superior, to the modified Steindler flexorplasty in terms of range of
motion, strength and subjective measures.

EVALUATION OF RADIAL BOWING IN ULNAR CLUB HAND.
Jean Rousseau, Constantin Stanciu, Benoit Morin. Departm ent of
Orthopedic Surgery, Hopital Sainte-Justine, M ontreal, Que.

Ulnar hypoplasia is a rare congenital defect. The hand is stable on the
distal radius but syndactyly and absent rays are frequent. The radial
head is often dislocated or fused to the distal humerus. Radial bowing is
increased, but the natural history is unknown. Ulnar anlage resection is
recommend by some authors. Radial bowing was measured in eight
untreated patients with nine ulnar club hands at a mean follow-up of 5
years. The radial bowing did not progress in any patient whether the
radial head was dislocated or fused to the distal humerus. In five of nine
forearms a slow regression of radial bowing was seen. It was concluded
that prophylactic release of ulnar anlage is not indicated in ulnar club
hand.

NEUROLOGIC LESIONS WITH SUPRACONDYLAR FRACTURE
OF THE ELBOW IN CHILDREN. Marc Isler, Constantin Stanciu.
Department of Orthopedic Surgery, Hopital Sainte-Justine, Montreal,
Que.

FRACTIONAL FLEXOR TENDON LENGTHENING FOR SEVERE
METACARPAL FLEXION CONTRACTURE IN THE RHEUMATOID
HAND. David R. Pichora. Department of Surgery, Queen’s University,
Kingston, Ont.

Supracondylar fracture of the elbow in children has a significant
frequency of neurovascular complications. A prospective study was
made of 92 supracondylar fractures. Eighteen cases (20%) were
complicated by neurologic lesions. All fractures were of the extension
type, grade 2b or 3 (Gartlan classification). All lesions healed completely
in an average time of 20 weeks. The most frequently involved nerves
were the radial and median, with an equal incidence. The second most
frequent pattern was either the ulnar nerve, all three nerves or the
anterior interosseus nerve, with equal frequency. All other combinations
were less frequent. Results demonstrated excellent neurologic recovery.

Six patients with severe (90° to 120°) metacarpophalangeal joint
flexion contractures had Zancolli flexor tendon lengthening with
standard metacarpal osteotomy and intrinsic release during Swanson
arthroplasty. At a mean 11-month follow-up, a mean active range of
movement arc of 61° and a mean passive range of motion arc of 86°
were noted along with an actual mean active range of motion arc of 4°
to 63° of flexion. Because of its simplicity and lack of complications,
fractional flexor tendon lengthening is a successful procedure to correct
severe flexion deformity in the rheumatoid metacarpophalangeal joint
and obviates the need for excessive metacarpal resection.

PRIMARY MALIGNANT TUMOURS OF THE HAND. Narayana
Nandagopal, Alok Shah, Derek Younge. Department of Surgery, King
Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.

Thirteen noncutaneous tumours of the hand were studied retrospective
ly. Eleven tumours arose from soft tissues and 2 from bone. Four
tumours were located in the fingers and nine in other regions. Two
cases were staged as IIA, seven as IIB and four as III (metastases on
presentation). Five patients underwent amputation, four patients had
wide excision and another four patients underwent biopsy alone.
Radiotherapy was given to four patients and palliative chemotherapy to
another four. At follow-up, which ranged from 6 months to 10 years,
seven patients were alive and disease free and six had died of metastatic
disease. Functionally, radiotherapy was not detrimental. Wide resection
followed by radiotherapy may salvage proximal hand tumours, provid
ing reasonable function without compromising patient survival.

TUBERCULOSIS OF THE HAND. Mohammed A1 Qattan, C. Vaughan
A. Bowen. Department of Surgery, Toronto General Hospital, Toron
to, Ont.

Three patients with tuberculosis of hand are described. The first
presented with recurrent carpal tunnel syndrome with rice bodies
associated with tuberculous synovitis. The other two patients presented
with wrist pain and bony destruction with sinuses and successfully
underwent wrist fusion. A review of the literature is presented and a
classification for tuberculosis of the hand described. The authors
conclude th at since tuberculosis of the hand is now rarely seen,
the correct diagnosis is usually delayed. Awareness of the present
ing features will help in making an earlier and more effective
diagnosis and in early treatm ent.
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KNEE MENISCUS: BASIC AND
CLINICAL FOUNDATIONS. Edited by
Van C. Mow, Steven P. Arnosky and
Douglas W. Jackson. 204 pp. Illust.
Raven Press, New York. 1992. $89
(US). ISBN 0-88167-895-3

It is ironic that a structure that has
been considered to be a functionless
remnant of muscle origin, subject to
quick excision at the mere mention of a
knee problem now has a book dedicated
to its structure and function. It seems,
however, that the days of little respect
for the meniscus are now officially
gone. In this book, a well-organized
attempt is made to demonstrate why the
meniscus is such an important structure
and how it functions. The editors have
recruited contributors who have the
most experience in the various aspects
discussed in the book.
The material is well presented. The
text starts with the basic scientific
elements, including gross and micro
scopic anatomy with reference to the
biochemical and physiologic features
and the engineering principles. This
section is strong. The information given
is based on excellent research that has
been done in this field. The clinical
sections of the book, although well
written, do not solve many of the
difficult meniscal problems seen in clini
cal practice. Perhaps this is a reflection
of how little we know and can do with
such problems and how much more
work is necessary in this area.
It is unfortunate that the information
provided in this text was not available
at the time when meniscectomy was a
popular treatment for knee problems.
This text should be mandatory reading
for anyone who deals with knee disor
ders, and the information contained
therein should at least be understood.
Fellows and residents in orthopedics as
well as orthopedic researchers interest
ed in the meniscus will want this book
as a reference source. The orthopedic
surgeon in clinical practice will not find
this book helpful in handling clinical
problems. Overall, however, this text is
570

well written, easy to understand and
teaches some important lessons about
the knee meniscus and its function.
More importantly, it serves as a remind
er that nothing is without purpose and
that before excision of any anatomic
structure the potential complications
of such excision must be considered.

Anthony Miniaci, MD, FRCSC

Division of Orthopedic Surgery
University Hospital
339 Windermere Rd.
London, ON
N6A 5A5

HIGH TECH UROLOGY. TECHNO
LOGIC INNOVATIONS AND THEIR
CLINICAL APPLICATIONS. Joseph
A. Smith. 362 pp. Illust. W.B. Saun
ders Co., Philadelphia. 1992. $107
(US). ISBN 0-7216-3053-7

Rapid technologic advances in urology
and the flood of new information on
molecular biology have made it difficult
for the academic urologist to remain up
to date in all aspects of the specialty
and have greatly challenged the com
munity urologist. Furthermore, with
knowledge acquired from lay publica
tions, patients seek reassurance that
they are being treated appropriately and
in the most up-to-date fashion. Recog
nizing the need for an evaluation of new
technology, Joseph A. Smith has edited
this excellent text, which contains con
tributions from leaders in the field in
the United States. Theoretical and prac
tical aspects are covered, and there is
recognition that all that is new is not
necessarily beneficial.
Stone disease illustrates the farreaching management changes in urolo
gy over the past decade. The chapter on
extracorporeal shock-wave lithotripsy
covers the principles of shock-wave
physics and the design of the lithotripter. The second- and third-wave litho-
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tripters are compared and assessed
against the record of the original Dornier HM3 lithotripter. An efficiency
quotient is proposed, but stone-free
rates are also dependent on the action
of caliceal contractions as well as
shock-wave generation. The biologic
effects of shock waves are dealt with,
and the status of biliary lithotripsy is
reviewed.
The chapter on ureteronephroscopy
is excellent and covers all aspects of the
intelligent use of both solid and flexible
instruments. Therapeutic indications for
the techniques are described. The im
portance of inserting a safety guide wire
before the procedure is stressed. The
risks of using the stone basket, even
under ureteroscopic control, are empha
sized; the authors prefer a three- or
four-pronged grasper, because the
stone can be released if it proves too
large to remove intact.
It would have been logical to follow
these sections with the chapters on
percutaneous techniques and urologic
accessory devices, but these chapters
are placed later in the book. The anato
my and methods of percutaneous renal
puncture are well described, and the
explanation of multiple caliceal punc
ture by a Y-tract technique is com
mended. In addition, a method of retro
grade percutaneous nephrostomy is de
scribed. Complementary medical man
agement of stones is also given consid
eration. Endopyelotomy is discussed,
and the reasons for the small number of
failures are detailed. A method for per
cutaneous management of simple renal
cysts is described.
The physics of lasers and their appli
cation to urology is contained in a
valuable chapter, which brings the read
er up to date on this expensive tech
nology.
Urologists are generally poorly in
structed in the use of ultrasonography
and interpretation of the findings, so
the section on ultrasonography is par
ticularly welcome. It explains the funda
mentals and physical principles. The
section on imaging of the prostate
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gland is especially useful. The subject
of urodynamics is covered concisely,
and another chapter clarifies the prodi
gious capabilities of the flow cystometer.
The chapter on male infertility at
tempts to place the practising urologist
back in the forefront of management by
providing an understanding of recent
highly specialized techniques of investi
gation. Especially welcome is the excel
lent chapter on immunology and mole
cular biology, which will update and
solidify the urologist’s understanding of
this rapidly developing science. The
book concludes with chapters on the
practical aspects of stapling devices,
laparoscopy in urology and innovations
in pediatric urology.
The editor is to be congratulated on
producing such a timely work that is
stimulating and easy to read.

Norman W. Struthers, ChM, FRCSC
Division of urology
St. Michael’s Hospital
30 Bond St.
Toronto, ON
M5B 1W8

ATLAS OF TRANSVAGINAL SUR
GERY. Shlomo Raz. 262 pp. Ulust.
W.B. Saunders Company, Philadel
phia. 1992. $158. ISBN 0-72162431-6

I began my review of this book with
considerable scepticism because it is a
common belief that transvaginal sur
gery should be performed only by gyne
cologists. However, Dr. Raz, a urolo
gist, has demonstrated that this belief is
incorrect.
The book begins with a description
of the anatomy of pelvic support and its
relation to stress incontinence. This is
followed by a description of the instru
mentation required and the complica
tions of vaginal surgery. These chapters
are extremely well written. They con
tain the fundamental information re
quired by all vaginal surgeons and are
well illustrated, providing easy under
standing of the complex anatomy and
physiology of this region.

A wide variety of surgical conditions
are discussed. Conventional gynecologic
conditions such as cystocele, rectocele,
enterocele, vaginal prolapse, uterine
prolapse and vaginal wall cysts are
covered in detail. Conventional lower
urinary tract conditions such as vesico
vaginal fistula, urethral diverticula, in
fected Skene gland and urethral carun
cle are also thoroughly discussed.
The chapter on treatment of urinary
incontinence, for which the author is
well known, provides great detail; surgi
cal photographs and schematic dia
grams are used for increased under
standing. This chapter should be partic
ularly interesting to gynecologists since
they have probably not been exposed to
many of the surgical techniques de
scribed.
Only a few reference books have
been written on transvaginal surgery,
and most have been written by gynecol
ogists. This book provides an entirely
different approach and should therefore
be of great interest to the gynecologist.
This should be the reference text of
choice on transvaginal surgery for both
gynecologists and urologists.

Stephen S. Im, MD, FRCSC, FACOG
Department of Obstetrics and Gynecology
St. Michael’s Hospital
30 Bond St.
Toronto, ON
M5B 1W8

ENDOSCOPIC PARANASAL SINUS
SURGERY. 2nd edition. Dale H. Rice
and Stephen D. Schaefer. 256 pp.
Illust. Raven Press Ltd., New York.
1992. $115 (US). ISBN 0-88167-946-1

Limited access surgery has attracted
much attention in all the surgical spe
cialties. With appreciation of the signifi
cance of previously described physiolo
gy of the paranasal sinuses and the
advent of coronal computed tomogra
phy (CT) in the evaluation of sinus
disease, the application of limited access
surgery has led to important advances
in the management of acute and chron
ic sinus conditions.

The authors cannot be credited with
the increased interest in this branch of
rhinologic surgery, which has had a
strong following in Europe for over a
decade. They nevertheless produced the
first comprehensive review of the sub
ject in the initial edition of this book.
The second edition covers every as
pect of the anatomy, physiology and
evaluation of patients who may benefit
from endoscopic sinus surgery. There is
a detailed account of surgical tech
nique. At present there are two recog
nized approaches, the first popularized
by Messerklinger, who proposed an
anterior to posterior procedure primari
ly for the ostiomeatal complex with
persisting disease of frontal, anterior
ethmoidal and maxillary sinuses. Wigand proposed a posterior to anterior
approach for diseases of the sphenoid
and posterior ethmoid system. This text
shows how these techniques may be
applied after assessment of the patient
from the history, endoscopic examina
tion and interpretation of the CT scan.
One of the strengths of this edition
and the first one has been the photo
graphs of fresh cadaver dissections,
which are photographed from both the
best anatomic perspective and the
endoscopic view. The photographs
are interpreted by clear line draw
ings, allowing an excellent apprecia
tion of the paranasal sinus anatomy.
There are numerous CT scans, which
show not only the normal anatomy but
also the commonly seen pathologic fea
tures.
The title suggests that this text
describes primarily the operative proce
dure. However, the approach to the
subject is balanced with chapters on the
management of pediatric sinus disease,
a comprehensive account of medical
management and a review of complica
tions, which are relatively uncommon to
well-trained surgeons but which can
lead to significant morbidity and have
given rise to medicolegal concerns. The
authors have been ably helped by five
experts who have provided contribu
tions with respect to the radiologic
aspects, the medical management and
the accompanying diagrams.
Each chapter either gives specific
references or lists cited publications.
The book contains only 256 pages,
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and although many of these are taken
up with well-reproduced photographs
and diagrams the text is comprehensive
and has probably already established
itself as the pre-eminent reference for
those wishing to further their knowl
edge in this expanding area of otor
hinolaryngology.
This book is a virtual necessity for
rhinologic surgeons, and all otolaryn
gologists will find it extremely interest
ing. Although no text can take the
place of good training, the inclusion of
a chapter on the selection of instru
ments and the descriptions of operative
techniques will enable otolaryngologists
to apply this surgery to their practice.
Neurosurgeons and respirologists will
likely find it of interest since many of
the procedures described are applicable
to their patients.
This is a clearly written, excellently
illustrated text that can be highly rec
ommended.

Ronald S. Fenton, MB, BS, FRCSC
Associate professor in otolaryngology
University of Toronto.
Department of Otolaryngology
St. Michael's Hospital
30 Bond St.
Toronto, ON
M5B 1W8

MECHANICS OF HUMAN JOINTS —
PHYSIOLOGY, PATHOPHYSIOLO
GY AND TREATMENT. Edited by
Verna Wright and Eric L. Radin. 480
pp. Illust. Marcel Dekker Inc., New
York. 1993. $185 (US). ISBN
0-8247-8763-3
This book is coedited by two recognized
experts in the field of biomechanics.
Verna Wright is from the University of
Leeds, England, and Eric Radin is from
the Henry Ford Hospital in Detroit.
Contributions have been made by a
team of authors — anatomists, bioengi
neers, biologists, orthopedic surgeons
and physicians. The text is subdivided
into major sections that include the
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physiology of joints, mechanics, neuro
physiology, pathophysiology and treat
ment. The book is well illustrated and
referenced. Interestingly, there no sec
tions written by Verna Wright.
The anatomy and function of joints is
described in great detail in the mechan
ics section. Jacqueline Perry's descrip
tion of the mechanics of gait is excel
lent. However, only normal gait is de
scribed, which is disappointing since
orthopedic surgeons deal primarily with
disorders characterized by abnormal
gait. This is particularly relevant in
reconstructive surgery where abnormal
gait can affect implant loading. The
energy cost of walking is discussed with
reference to oxygen consumption dur
ing abnormal gait but is not discussed
in detail.
The chapter on knee-ligament recon
struction gives emphasis to the anterior
cruciate ligament and provides a good
general review of the topic but is lack
ing in specifics. The lack of illustrations
in this chapter is a major omission. I
enjoyed reading this section but did not
feel that it helped to resolve the uncer
tainty associated with the management
of isolated injuries of the anterior cruci
ate ligament.
There is a superb chapter by Antho
ny Unsworth in which he describes the
lubrication of the human joints. A natu
ral extension of this section would have
been an analysis of wear mechanisms in
artificial joints.
The section describing the properties
and physiologic functions of synovial
fluid in health and disease is excellent
and should be of particular interest to
orthopedic surgeons. The chapters re
lating to muscle physiology, elec
tromyelography and joint innervation
are also valuable.
There is an interesting chapter on
the pathophysiology of intervertebral
disc herniation. It describes the effect of
vibration on joints and the relation
between occupation and spinal prob
lems. The theories of vibration are
presented, but they are complex and
may be difficult for the average reader
to understand.
Finally, the treatment section is di
vided into two areas: the principles of
joint prostheses, by J.D. Blaha, and
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physiologically based treatments, by P.
Maquet. The joint replacement portion
is disappointingly brief. Little informa
tion is provided about joint wear and
implant failure. Maquet's description of
physiologically based treatments, how
ever, provides the reader with a wellillustrated description of the treatment
of osteoarthritis of the hip and knee by
osteotomy and soft-tissue release proce
dures. The biomechanical principles in
volved are clearly described and well
illustrated. Case reports are also used to
illustrate the biomechanical principles
involved in treatment.
The preface indicates that this book
is intended for physicians, orthopedic
surgeons, rehabilitationists and funda
mental scientists. Overall, there is too
much detail in some sections and not
enough in others to make the book of
compelling interest to practising ortho
pedic surgeons. Residents in orthopedic
surgery may find it useful as a musculo
skeletal basic science reference text, but
its main appeal, I suspect is for those
involved in research. The book is a
suitable addition to a hospital library,
but regrettably I think it has limited
interest for the average orthopedic sur
geon.

Ian J. Harrington, MD, FRCSC
Division of Orthopedic Surgery
Toronto East General
& Orthopaedic Hospital Inc.
University of Toronto
825 Coxwell Ave.
Toronto, ON
M4C 3E7

ORTHOPAEDIC TRAUMA PROTO
COLS. Edited by S.T. Hansen Jr. and
M.F. Swiontkowski. 393 pp. Illust.
Raven Press, New York. 1993. $150
(US). ISBN 0-88167-994-1
This book is edited by two orthopedic
surgeons with extensive experience in
the management of orthopedic and mul
tiple trauma. They have used their
experience at the Harborview Medical
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Center in Seattle, Wash., to put togeth
er a comprehensive text on the manage
ment of orthopedic trauma.
The book is divided into two main
sections. The first, 75 pages long, de
tails general considerations in the man
agement of trauma. These include mus
culoskeletal traumatology, the role of
the trauma surgeon in the management
of orthopedic trauma, nursing stan
dards (to which considerable attention
is given), anesthesia and rehabilitation.
All of these chapters are succinctly
written for the treating surgeon rather
than for the appropriate nonphysician
health care provider. However, the sec
tion on nursing is excellent for the
non-nursing health care provider.
The second main section of the text
is devoted to regional fracture manage
ment. The editors have selected a group
of contributors with recognized exper
tise in the management of musculoskel
etal trauma in the specific body parts to
be discussed. The depth and breadth of
the program at Harborview Medical
Center is reflected in that all of the
contributors work at this centre. Each
chapter is well illustrated with both line
drawings and appropriate radiographs;
because a single person provided all the
illustrations, the quality greatly exceeds
that found in most multiauthored
books. The surgical technique, where
appropriate, is well described, with ex
cellent preoperative and postoperative
examples. The references for each chap
ter are appropriate but not excessive.
This book will be of considerable
value to both orthopedic surgeons and
nonorthopedic surgeons involved in
trauma care. For the orthopedic sur
geon the book provides a succinct refer
ence manual for many specific fracture
types; it is also an excellent source of
reference material and illustrations. The
book will be of particular value to
residents in orthopedics for fracture
classification and treatment. For no
northopedic surgeons involved in the
management of polytrauma patients
with musculoskeletal injuries, this text
provides excellent topical suggestions
with respect to appropriate fracture
management.
The editors are to be congratulated
on producing a topical, well-illustrated

uniform text. I predict that this will be a
standard fracture textbook for many
years to come.

James P. Waddell, MD, FRCSC
Director, Trauma Services
St. Michael’s Hospital
30 Bond St.
Toronto, ON
M5B 1W8

LASERS IN HEAD AND NECK SUR
GERY. Edited by Edward C. Weisberger. 293 pp. Illust. Igaku-Shoin Medical
Publishers Inc., New York/HBJ-HoltSaunders Distribution Services, To
ronto. 1991. $87. ISBN 0-89640-181-2

This text provides an overview of the
current usage of lasers in the manage
ment of benign and malignant lesions in
the head and neck. Although the book
concentrates primarily on the proven
modalities of argon, carbon dioxide and
neodymium : yttrium-aluminum-garnet
lasers, the potential of new lasers such
as the potassium-titanyl-phosphate
(KTP), Excimer, gold vapour and tun
able dye lasers is also discussed.
The introductory chapters contain
descriptions of the physical character
istics of surgical lasers and the interac
tion of tissue with a variety of laser
wavelengths. This section is clear and
concise without the inclusion of com
plex mathematical formulae. There is
an excellent summation of the advan
tages and disadvantages of various
modes of operation: continuous, pulsed
and Q-switching. Following this section
are detailed descriptions of the neces
sary safety precautions and special
anesthetic requirements.
The book continues with a detailed
discussion of laser use in specific areas
of the head and neck. Individual chap
ters are devoted to lasers in dermatolog
ic surgery, rhinologic and paranasal
sinus surgery, surgery of the oral cavity
and pharynx, otologic and laryngologic
surgery, surgery on the tracheobronchi
al tree and surgery for palliation of
esophageal carcinoma.
The final two chapters cover the

possible future applications of lasers in
photodynamic therapy in head and neck
cancer, and in microvascular laser weld
ing of blood vessels and nerves.
As with most multiauthored books
there is some repetition. A major over
sight is the absence of any discussion of
lasers in ophthalmic surgery. Aside
from these shortcomings, this book is
an excellent introduction to current
laser use. The contributors are to be
commended for their detailed recom
mendations on laser type, power set
tings, mode of operation and spot size
in dealing with specific lesions, a very
valuable resource for the reader with
limited previous experience.
This book would be a valuable addi
tion to the library of all surgeons who
deal with lesions in the head and neck
as well as their colleagues in anesthesia
and dermatology.'

Ralph R.F. Ruby, MD, FRCSC, FACS
Department of Otolaryngology/Audiology
St. Joseph’s Health Centre
The University of Western Ontario
Third Floor
900 Richmond St.
London, ON
N6A 5B3

SURGICAL DECISION MAKING. 3rd
edition. Edited by L.W. Norton, G.
Steele Jr. and B. Eiseman. 342 pp.
Illust. W.B. Saunders Company/Harcourt Brace Jovanovich, Inc., Philadel
phia. 1 9 9 2 . $ 7 5 (U S ). ISBN
0-7216-6498-5

This edition of Surgical Decision Mak
ing follows a similar pattern to the two
previous editions in that individual sur
geons have been asked to provide their
personal approaches to a multiplicity of
surgical problems. In this edition, the
authors have been asked to justify their
choices not only on the basis of their
experience and current published infor
mation but also on the basis of cost and
outcome.
This edition has been expanded by
the inclusion of sections on transplanta
tion surgery and perioperative manage-
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ment; more than one-third of the au
thors are making their “first appear
ance" in this textbook.
The text is divided into a section on
surgery in general, followed by sections
on head and neck, cardiopulmonary,
gastrointestinal, breast, endocrine, vas
cular, pediatric and transplantation sur
gery. Subspecialty interest is seen in
sections on urology, gynecology and
fracture management. Under each of
these headings a specific topic is ap
proached by a short narrative section
that is accompanied on the facing page
by an algorithm that is referenced to
the text. Therefore, in the narrative on
the left-hand page a specific paragraph
will be labelled with a letter that can be
found in the algorithm. Review of the

algorithm allows the reader to get an
overview of the problem and the think
ing behind the author’s problem-solving
exercise; the thinking for each step in
the algorithm can be obtained from the
narrative. Although this may result in
some oversimplification of complex
problems, the editors point out that this
text is not intended to be definitive on
the problems discussed but to help the
reader understand the logic of the ap
proach used by recognized experts with
respect to each condition covered.
The value of this writing technique is
immediately evident when the reader
peruses unfamiliar specialty sections.
By reading the short narrative text,
reviewing the algorithm and returning
to the narrative text, the reader can,
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within a few minutes, get a good grasp
of the basic steps in dealing with many
common surgical problems.
This text will be of great value to
trainees in surgery and to surgeons
who are occasionally required to care
for patients with problems that are
outside that surgeon’s area of expertise.
It will be a valuable addition to the
library of any hospital in which surgical
procedures are performed.

James P. Waddell, MD, FRCSC
Professor of surgery
University of Toronto
St. Michael’s Hospital
30 Bond St.
Toronto, ON
M5B 1W8

^
^

The idea may relate
to virtually any aspect
^
of Canadian life. It can be
^
a new concept, process
or product that’s in use or
development and of benefit
to Canadians.
^
Nominations close February 11,1994.
For your nomination form, call or write:
THE MANNING AWARDS, 3900, 421-7 Ave.
S.W., Calgary, Alberta T2P 4K9, Telephone:
(403) 266-7571 FAX (403) 266-8154.
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The Canadian Journal of Surgery is pleased to accept classified advertisements. The deadline is 1 month before issue date. Classified rates:
$60 for the first 40 words or less, additional words 77<f each (additional $24 for frame). Special Display under 100 words, 55 X 55 mm, $140.
$18 charge (first insertion only) for CJS reply box numbers. Display rates available on request. VISA, MASTERCARD AND AMERICAN
EXPRESS ACCEPTED.
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ORTHOPEDIC SURGEON
Cambridge Memorial Hospital is seeking a
Canadian certified, Ontario licensed,
recent graduate in orthopedic surgery to
join the existing complement of two other
orthopedic surgeons. The candidate must
have a broad interest in orthopedics (no
subspecialty needed) and a willingness
to assume regular on-call duties in a
353-bed accreditated hospital.
Cambridge is in the heart of southwestern
Ontario and provides a high standard of
living, including excellent social, recre
ational and educational facilities.
For more information, contact: Dr. J.K.
Stapleton, Chief, Department of Surgery,
tel (519) 623-7200; or send a resume to:
Secretary, Orthopaedic
Surgeon Search Committee
Cambridge Memorial Hospital
700 Coronation Blvd.
Cambridge, ON
N1R3G2
S93-166

Fort St.
John is a
progressive
community
A full-time permanent General Surgeon
with F.R.C.P.C. qualification is required to
provide general surgical and m in or
orthopedicservices in our 64 bed accredited
acute care Hospital located in the City of
Fort St. John serving a population of
approximately 25,000. This is a private
practice position (fee for service). Gross
annual ea rnings are a p p ro x im a te ly
$200,000 to $250,000. There are two
qualified General Surgeons in Dawson
Creek, a community 50 miles away, which
would allow a call schedule for weekend
and vacation relief. There is an Obstetrician/
Gynecologist, Radiologist and Pathologist
on staff with excellent family physician
support. (Recruiting to replace the Medical
Internist is underway.)

northeastern
British
Columbia
offering a
variety o f
cultural
and
sporting
activities
and daily
air service

Please c o n ta ct:

Mrs. M. Asling,

Administrator.

to

S93-167

Vancouver
and
Edmonton.

Fort St. John General Hospital

9636 - 100th Ave., Fort St. John, B.C. V1J 1Y3
Tel: (604) 785-6611 Local 260 Fax: (604) 785-4060

CLASSIFIED ADVERTISING Unlike a tabloid or newspaper that is read today and discarded tomorrow, an adver
tisement in the Classified Advertising section of CJS is read today and reread tomorrow.
CJS is the only Canadian publication exclusively for surgeons. No other Canadian surgical publication reaches over 6000
subscribers every 2 months, giving wide coverage for your advertising dollar.
Average issue readership of CJS (81%) is among the highest of any medical journal in Canada, the latest readership studies confirm the best and most cost efficient way to reach Canadian surgeons is through the pages of CJS.
LET CJS CLASSIFIED ADS WORK FOR YOU
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POSITION WANTED - GENERAL AND
VASCULAR SURGEON: - FRCSC certified in
general and vascular surgery, wishes to relo
cate. Well-trained, energetic, with 2 years
experience. Would like to keep a combined
practice in general and vascular surgery.
Reply to: Box 524, CJS.
-S93-169

GENERAL SURGEON: ON - Well-estab
lished group practice is looking to replace a
retiring partner/surgeon to serve a communi
ty of 30 0 00 + located 25 minutes west of
London. Town population 10 0 0 0 + . Fully
computerized, modern clinic adjacent to a
fully accredited, well-equipped hospital using
116 acute care beds. Busy emergency de
partment. Preference will be given to orthopedics/gynecology. Essentials include la
paroscopy skills and fellowship status. Onein-three on-call schedule for this pleasant
community. Large referral base guaranteed.
Associate to full partnership attainable.
Please contact or send CV to: Steven Wong,
c/o Strathroy Medical Clinic, 376 Carrie
St., Strathroy, ON N7G 3E3; tel (519)
2 4 5 -0 4 3 0 .
-S92-128

GENERAL SURGERY PRACTICE FOR
SALE: ON - Southern Ontario community.
"C ap” reached yearly. Orthopedic experience
beneficial. Send CV to: Box 519, CJS.

GENERAL SURGEON: MICHIGAN, US Wanted for third partner by tw o busy Ameri
can surgeons in large midwestern city. Must
be US graduate; willingness to work hard a
must. Competitive salary with benefits for 1
year, associate status may be offered after 1
year to appropriate individual. Must be BE/BC
with strong interest in trauma and critical
care. Additional interest in laparoscopy, en
doscopy or breast surgery is a plus. No
vascular or gynecology. Position available
Jan. 1, 1994. Send CV to: Box 525, CJS.
-S93-170

GENERAL SURGEON
THE WINNIPEG CLINIC, a large multispecial
ty clinic with a full range of ancillary services
has an opening for a GENERAL SURGEON.
Must have Canadian fellowship and Canadi
an citizenship or landed immigrant status.

FELLOWSHIP IN
ENDOUROLOGY AND ESWL
This 1-year postgraduate fellowship offers a
wide range of clinical experience in endourology including percutaneous surgery,
ureteroscopy, ESWL and laparoscopic sur
gery in urology. Approximately 50% of the
fellow's time will be spent in the laboratory
participating in projects related to endourologic and shock wave lithotripsy re
search. Salary will commensurate with the
level of training.
Please reply with curriculum vitae to:
Dr. John Denstedt
Chief of Urology
St. Joseph's Health Centre
2 68 Grosvenor St.
London, ON N6A 4V2
-S93-163

We ofer a full range of benefits with a
negotiable financial arrangement.
Interested applicants are invited to contact
Dr. V. Taraska, Chairman
Recruitment Committee
The Winnipeg Clinic
4 2 5 St. Mary Ave.
Winnipeg, Manitoba
R3C 0N2
Fax: (204) 9 43-2164

ADVERTISERS’ INDEX
INDEX DES ANN0NCEURS
Ansell Canada Inc.
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-S93-172

-S93-171

GENERAL SURGEON
A great opportunity to join a Toronto clinic
with an international reputation as a leader
in new techniques. Our client seeks an
additional, competent, compatible and
adaptable MD, FRCSC to join their team.
Learn new skills in office outpatient and
colon surgery, as well as video
colonoscopy, and step into a busy practice
with a large existing patient load.
Some of the many benefits include regular
hours, with rare emergency or night work,
and no administrative burden.
If you value a stimulating and supportive
environment, with above-average fee-forservice income potential, this could be a
rewarding way to advance your medical
career and improve the quality of your life.
Interested candidates are invited to submit
a current curriculum vitae,
in CONFIDENCE to

Juergen K. Mueller
Senior Consultant

Canadian Medical Association
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